Annual Report 2017 SUNOPTA
Annual Report 2017 SUNOPTA
Annual Report 2017 SUNOPTA
OUR VISION
To be the most innovative,
vertically integrated provider of
organic ingredients and healthy
food solutions.
FINANCIAL HIGHLIGHTS
All dollar amounts in U.S. $ millions, except per share amounts, and in accordance with U.S. GAAP
(1) Operating income is defined as “earnings (loss) from continuing operations before the following” excluding the
impact of “other income/expense items” and goodwill impairments.
(2) Refer to pages 46, 47, 56 and 57 of the 2017 Form 10-K for a tabular reconciliation of Adjusted earnings (loss)
and Adjusted earnings (loss) per diluted share to the most directly comparable GAAP measure.
(3) Refer to pages 48 and 58 of the 2017 Form 10-K for a tabular reconciliation of Adjusted EBITDA and Adjusted
EBITDA, excluding flexible resealable pouch and nutrition bar to the most directly comparable GAAP measure.
(4) Working capital is defined as current assets less current liabilities, excluding cash and cash equivalents, bank
indebtedness, current portion of long-term debt and current assets/liabilities held for sale.
During 2017, our efforts under the Value Creation Plan have
yielded an improved business mix and a more efficient, reliable
and higher-quality production network. We also reinvested
savings generated from our productivity initiatives into building
the talent and infrastructure necessary to drive future growth.
Although there is still a lot of work to be done, I am confident
that we are entering 2018 with a solid foundation to drive long-
term profitable growth.
• Expansion project to add incremental freezing capacity, storage, and retail bagging capabilities
to our Mexican frozen fruit facility (which we now wholly-own, following our acquistion of the
remaining non-controlling interests in July 2017). This project will also allow us to take advantage
of diversification of fruit varieties sourced from Mexico and is expected to provide the highest
quality and lowest cost frozen fruit solutions to our customers.
• Expansion project to add a second roasting and processing line at our organic cocoa facility in The
Netherlands. This expansion is expected to double processing capacity in addition to adding new
capabilities, all in support of increased demand and future growth opportunities in cocoa.
• Addition of a new sunflower oil processing line at our Bulgarian sunflower facility, which is
expected to drive incremental margin through volume growth and production efficiency.
• Investment into our roasted snacks capabilities at our Crookston, Minnesota facility, which also
involves the planned closure of our Wahpeton, North Dakota roasting facility. This expansion is
expected to be operational in the third quarter of 2018, which will support further growth of a
variety of roasted grains, seeds and other plant based snacks.
• Discontinuation of flexible resealable pouch and nutrition bar product lines and operations in the
fourth quarter of 2017, and related closure of our Carson City, Nevada nutrition bar processing
facility.
• Consolidation of certain soy and specialty grain volume and closure of a grain-handling facility
in Moorhead, Minnesota in the third quarter of 2017 to enhance facility utilization and reduce
operating costs.
Since the initiation of the Value Creation Plan, we have implemented portfolio changes that are expected
to yield approximately $7.9 million of annualized adjusted EBITDA benefits.
• Advances in food safety and quality efforts across the entire manufacturing footprint.
• Rollout of a new continuous improvement methodology (“SunOpta 360”) across our network of
aseptic beverage facilities, which is helping to drive an expected 20% improvement in output from
existing aseptic lines in 2018, in addition to enhanced production capabilities that will add new
value-added non-dairy alternatives.
• Actions taken to right-size the incoming 2018 fruit crop, in connection with the implementation of
new sales and operations planning (“S&OP”) tools within Consumer Products, which is expected
to reduce storage costs, lower working capital, and operationally better prepare our frozen fruit
operations for the start of the upcoming fruit season.
• Continued identification and implementation of productivity initiatives focusing on manufacturing
efficiencies, purchasing synergies and effective supply chain management.
• Working capital optimization efforts leading to a significant year-over-year improvement in
operating cash flows.
Since the initiation of the Value Creation Plan, we have implemented process improvements and cost
savings that are expected to yield approximately $6.9 million of annualized adjusted EBITDA benefits.
In 2017, we have implemented go-to-market improvements through strategic pricing actions expected to
yield approximately $1.2 million of annualized adjusted EBITDA benefits. In 2018, efforts under the go-to-
market pillar are focused on driving incremental sales volume.
• Filling the positions of Chief Executive Officer, Chief Human Resources Officer, Chief Information
Officer, Chief Quality Officer, Senior Vice President of Operations and Senior Vice President of
Supply Chain, as well as the appointment of new General Managers to lead our Healthy Beverage
and Healthy Fruit platforms.
• Additional hiring of other management-level positions in the areas of sales, marketing, customer
service, engineering, operations, quality and other functional support services.
• Progress on an enterprise resource planning implementation project at the Mexican frozen fruit
facility, with expectation that the new system will be operational during the second quarter of
2018. Restructuring of the Sales & Operations Planning (S&OP) process and tools in the frozen
fruit operations, which is expected to drive greater discipline and accuracy in the fruit pack plan,
ensuring grower commitments are aligned with commercial demand.
• Addition of experienced directors of quality for each of our product platforms and plant and
quality assurance managers in several facilities.
• Continued focus on customer service and working capital levels as S&OP processes and support
systems are refined.
• Under new leadership, shifting the focus of the internal audit function towards value-
added business process improvements that are designed to support and ensure we sustain
improvements made as part of the Value Creation Plan.
During the first phase of the Value Creation Plan we are targeting the implementation of $30 million of
productivity driven annualized EBITDA enhancements over 2017 and 2018. To date, we are pleased to
report that we have implemented over $16 million of annualized productivity savings, and remain on-
track to deliver the balance in 2018.
For 2017, these EBITDA enhancements were offset by expenses associated with the Value Creation
Plan, including structural investments made in the areas of quality, sales, marketing, operations and
engineering resources, as well as non-structural third-party consulting support, severance and recruiting
costs. This was consistent with our plan and these investments have helped to establish the people,
processes and systems that we need to be successful as we transition to the second phase of our Value
Creation Plan.
One year in, I am pleased with the impact the Value Creation Plan has had on our business performance.
We saw increased gross margins across all of our businesses, with the exception of frozen fruit, during
the fourth quarter of 2017 reflecting our portfolio optimization and operational excellence efforts. We
have also generated and started to convert a significant sales opportunity pipeline across all of our
product lines and within multiple sales channels with both existing and new customers. There is still
work to be done to get all of our businesses back to growth and to their targeted margin profiles;
however, I feel good about the progress we have made to date.
Unfortunately, much of this progress was masked by the underperformance of frozen fruit, and our
organization is taking action to address this under-performance.
2017 Annual Report
In 2018, we are focused on lowering costs by leveraging procurement and processing capabilities at our
recently expanded Mexican frozen fruit facility, while operating our Californian facilities in a more cost
effective manner. We are also right sizing our inventories to current demand with a focus on improving
overall fruit quality while reducing storage costs and working capital. As we enter 2018, we have been
focused on building a pipeline of sales opportunities, rebuilding relationships with key customers
and developing opportunities with new customers, all while establishing the correct assortment,
merchandising, pricing and innovation strategies. We believe the combination of these efforts will allow
us to stabilize and return this business to growth over time.
A year ago, I joined SunOpta based on its significant growth potential as a result of its positioning in
organic and non-GMO ingredients, as well as its consumer packaged capabilities that are squarely aimed
at the fast growing healthy and better-for-you segment of the food industry. Today, I remain enthusiastic
about the significant opportunities that exist for SunOpta and I am equally committed to delivering on
the promise of value creation for our shareholders. Let me reiterate what we will do:
Thank you for your investment in SunOpta and for your confidence and support of me and my team.
DAVID J. COLO
President & Chief Executive Officer
FORM 10-K/A
Amendment No. 1
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended December 30, 2017
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to
SUNOPTA INC.
(Exact Name of Registrant as Specified in Its Charter)
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes No
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes No
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has
been subject to such filing requirements for the past 90 days. Yes No
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive
Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter
period that the registrant was required to submit and post such files). Yes No
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be
contained, to the best of the registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of
this Form 10-K or any amendment to this Form 10-K.
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting
company, or emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and
“emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filer Accelerated filer Non-accelerated filer (Do not check if a smaller reporting company)
Smaller reporting company Emerging growth company
If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No
Aggregate market value of the common equity held by non-affiliates of the registrant, computed using the closing price as reported on the
NASDAQ Global Select Market for the registrant’s common shares on July 1, 2017, the last business day of the registrant’s most recently
completed second fiscal quarter, was approximately $765 million. The registrant’s common shares trade on the NASDAQ Global Select
Market under the symbol STKL and on the Toronto Stock Exchange under the symbol SOY.
The number of shares of the registrant’s common stock outstanding as of February 23, 2018 was 86,805,091.
Documents Incorporated by Reference: Portions of the SunOpta Inc. Definitive Proxy Statement for the 2018 Annual Meeting of
Shareholders are incorporated by reference into Part III of this Annual Report on Form 10-K.
EXPLANATORY NOTE
SunOpta Inc. (the “Company”) filed its Annual Report on Form 10-K for the fiscal year ended December 30, 2017 (the “Original Filing”)
with the U.S. Securities and Exchange Commission (the “SEC”) on March 1, 2018. The Company is filing this Amendment No. 1 (the
“Amendment”) to its Original Filing solely to revise the following typographical error in the Report of Independent Registered Public
Accounting Firm related to their Opinion on the Financial Statements included in Item 8 of Part II of the Original Filing:
x Under the Basis for Opinion, the first sentence has been corrected to state: “These financial statements are the responsibility of the
Company’s management.” In the Original Filing, this sentence stated: “The Company's management is responsible for maintaining
effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial
reporting, included in the accompanying Management's Annual report on Internal Control Over Financial Reporting.”
In addition, pursuant to the rules of the SEC, the exhibit list included in Item 15 of Part IV of the Original Filing has been amended to contain
currently-dated certifications from the Company’s Chief Executive Officer and Chief Financial Officer, as required by Sections 302 and 906
of the Sarbanes-Oxley Act of 2002. The certifications of the Company’s Chief Executive Officer and Chief Financial Officer are attached
as exhibits to this Amendment.
Except as described above, this Amendment does not amend or update any other information contained in the Original Filing. The Original
Filing continues to speak as of the date of the Original Filing, and other than expressly indicated in this Amendment, the Company has not
updated the disclosures contained therein to reflect any events which occurred at a date subsequent to the filing of the Original Filing and
does not modify or update in any way disclosures made in the original Form 10-K. The Company has included a complete copy of the
Original Filing, as amended per above, in this filing.
SUNOPTA INC.
FORM 10-K
For the year ended December 30, 2017
TABLE OF CONTENTS
Basis of Presentation 2
Forward-Looking Statements 2
PART I
Item 1 Business 5
Item 1A Risk Factors 17
Item 1B Unresolved Staff Comments 31
Item 2 Properties 32
Item 3 Legal Proceedings 33
Item 4 Mine Safety Disclosures 33
PART II
Item 5 Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of
Equity Securities 34
Item 6 Selected Financial Data 37
Item 7 Management’s Discussion and Analysis of Financial Condition and Results of Operations 38
Item 7A Quantitative and Qualitative Disclosures About Market Risk 67
Item 8 Financial Statements and Supplementary Data 68
Item 9 Changes in and Disagreements With Accountants on Accounting and Financial Disclosure 68
Item 9A Controls and Procedures 69
Item 9B Other Information 70
PART III
PART IV
Except where the context otherwise requires, all references in this Annual Report on Form 10-K for the fiscal year ended
December 30, 2017 (“Form 10-K”) to “SunOpta”, the “Company”, “we”, “us”, “our” or similar words and phrases are to
SunOpta Inc. and its subsidiaries, taken together.
In this report, all currency amounts presented are expressed in thousands of United States (“U.S.”) dollars (“$”), except per
share amounts, unless otherwise stated. Other amounts may be presented in thousands of Canadian dollars (“C$”), euros (“€”)
and Mexican pesos (“M$”), as well as British pounds (“£”). The following table sets forth, for the periods indicated, the rate
of exchange for the Canadian dollar, euro, and Mexican peso, expressed in U.S. dollars, based on Bank of Canada exchange
rates. These rates are provided solely for convenience, and do not necessarily reflect the rates used by us in the preparation of
our financial statements.
Forward-Looking Statements
This Form 10-K contains forward-looking statements which are based on our current expectations and assumptions and involve
a number of risks and uncertainties. Generally, forward-looking statements do not relate strictly to historical or current facts
and are typically accompanied by words such as “anticipate”, “estimate”, “target”, “intend”, “project”, “potential”, “continue”,
“believe”, “expect”, “could”, “would”, “should”, “might”, “plan”, “will”, “may”, “predict”, the negatives of such terms, and
words and phrases of similar impact and include, but are not limited to references to future financial and operating results,
plans, objectives, expectations and intentions; our ability to implement the four pillars and achieve the objectives of our strategic
Value Creation Plan, including realizing our targeted adjusted earnings before income taxes, depreciation and amortization
(“EBITDA”), expected benefits from adjusted EBITDA enhancements implemented to-date, and targeted working capital
efficiencies; estimated losses and related insurance recoveries associated with the recall of certain roasted sunflower kernel
products; anticipated timing for completion of the expansion of our Mexican frozen fruit facility; anticipated timing of the
consolidation of our roasted snack operations and related closure of our Wahpeton, North Dakota, facility; other possible
operational consolidations; rationalization of assets and operations; business strategies; plant and production capacities;
revenue generation potential; anticipated construction costs; competitive strengths; goals; capital expenditure plans; business
and operational growth and expansion plans; anticipated operating margins and operating income targets; gains or losses
associated with business transactions; cost reductions; rationalization and improved efficiency initiatives; proposed new
product offerings; future growth of our business and global markets for our products; and other statements that are not historical
facts. These forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation
Reform Act of 1995, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities
Exchange Act of 1934, as amended. These forward-looking statements are based on certain assumptions, expectations and
analyses we make in light of our experience and our interpretation of current conditions, historical trends and expected future
developments, as well as other factors that we believe are appropriate in the circumstances.
Whether actual results and developments will be consistent with and meet our expectations and predictions is subject to many
risks and uncertainties. Accordingly, there are important factors that could cause our actual results to differ materially from
our expectations and predictions. We believe these factors include, but are not limited to, the following:
x failure or inability to implement our value creation strategies to achieve anticipated benefits;
x conflicts of interest between our significant investors and our other stakeholders;
x product liability suits, recalls and threatened market withdrawals that may arise or be brought against us;
x food safety concerns and instances of food-borne illnesses that could harm our business;
x litigation and regulatory enforcement concerning marketing and labeling of food products;
x that our customers may choose not to buy products from us;
x changes and difficulty in predicting consumer preferences for natural and organic food products;
x technology failures that could disrupt our operations and negatively impact our business;
x the potential for data breaches and the need to comply with data privacy and protection laws and regulations;
x fluctuations in exchange rates, interest rates and the prices of certain commodities;
x increased vulnerability to economic downturns and adverse industry conditions due to our level of indebtedness;
x restrictions under the terms of our debt and equity instruments on how we may operate our business;
x our ability to renew our revolving asset-based credit facility (the “Global Credit Facility”) when it becomes due on
February 10, 2021;
x ability to meet the financial covenants under the Global Credit Facility or to obtain necessary waivers from our lenders;
x our ability to achieve the estimated benefits or synergies to be realized from business acquisitions;
x unexpected disruptions in our business, including disruptions resulting from business acquisitions;
x that we do not currently intend to, and are restricted in our ability to, pay any cash dividends on our common shares
in the foreseeable future;
x dilution in the value of our common shares through the exchange of convertible preferred stock, exercise of stock
options, participation in our employee stock purchase plan and issuance of additional securities; and
x impact of the publication of industry analyst research or reports about our business on the value of our common shares.
All forward-looking statements made herein are qualified by these cautionary statements, and our actual results or the
developments we anticipate may not be realized. Our forward-looking statements are based only on information currently
available to us and speak only as of the date on which they are made. We do not undertake any obligation to publicly update
our forward-looking statements, whether written or oral, after the date of this report for any reason, even if new information
becomes available or other events occur in the future, except as may be required under applicable securities laws. The foregoing
factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are
included in this report. For a more detailed discussion of the principal factors that could cause actual results to be materially
different, you should read our risk factors in Item 1A, Risk Factors, included elsewhere in this report.
Item 1. Business
INTRODUCTION
SunOpta, a corporation organized under the laws of Canada in 1973, is a leading global company operating businesses focused
on a healthy products portfolio that promotes sustainable well-being. We are focused on sourcing non-genetically modified
(“non-GMO”) and organic ingredients and manufacturing healthy food and beverage products. We operate an integrated “field-
to-table” business model leveraging our global ingredient sourcing platform to process and market non-GMO and organic
ingredients for retailers, food manufacturers and foodservice operators. We also manufacture packaged products focused on
the high growth healthy beverages, healthy fruit and healthy snacks categories for our retail, foodservice and branded food
customers. We believe we are a North American market leader in non-dairy organic aseptic beverages, premium refrigerated
private label orange juice, individually quick frozen (“IQF”) organic fruit, healthy premium fruit snacks, and the global sourcing
and supply of non-GMO and organic raw materials and ingredients. Our scalable global sourcing platform makes us one of the
leading suppliers of non-GMO and organic raw materials and ingredients in the food industry, and provides us leading insights
into emerging food and beverage trends. Our product portfolio is strategically aligned with the fast-growing consumer demand
for high quality, healthy non-GMO and organic food and beverage products.
Our vertically integrated business model makes us a preferred partner to our retail (e.g., grocery, mass, club, natural and
specialty chains), foodservice and branded food customers. We deliver a diverse, innovative portfolio of high quality, food and
beverage products supported by our global sourcing platform, scalable operating footprint, manufacturing expertise and
commitment to innovation. This platform enables us to consistently supply our customers with a broad range of non-GMO and
organic ingredients as well as high quality healthy food and beverage products that cater to the evolving demands of today’s
consumers. As a leading supplier of non-GMO and organic ingredients to the food industry, we leverage our insights into
emerging consumer tastes and preferences to develop innovative new food and beverage products.
Our diverse consumer products portfolio utilizes non-GMO and organic raw materials and ingredients that are sourced primarily
by our vertically integrated global ingredients capabilities, and consists of three main commercial platforms:
x Healthy Beverages – We offer a full line of aseptic beverages, including non-dairy beverages (including almond, soy,
coconut, rice and others), broths, teas and nutritional beverages. We also offer refrigerated premium juices, shelf-
stable juices and functional waters. We believe we are the leading North American provider of non-dairy organic
aseptic beverages and premium refrigerated private label organic orange juice.
x Healthy Fruit – We offer IQF fruit for retail (e.g., strawberries, blueberries, mango, pineapple, blends and other berries
and fruit), IQF and bulk frozen fruit for foodservice (e.g., purées, fruit cups and smoothies), and custom fruit
preparations for industrial use. We believe we are the leading North American provider of private label non-GMO and
organic IQF fruit.
x Healthy Snacks – We offer fruit snacks (including bars, twists, ropes and bite-sized varieties) and roasted grain and
seed snacks. We believe we are a leading North American provider of premium healthy fruit snacks. During 2017,
we exited our flexible resealable pouch and nutrition bar product lines and operations, which were formerly part of
the Healthy Snacks platform.
Our global ingredients platform is focused on the procurement and sale of non-GMO and organic grains and seeds (including
ancient grains and seeds), fruits, vegetables, sweeteners, coffees, nuts and other products as ingredients in both raw material
and processed ingredient forms. In addition to supplying ingredients for our own healthy food and beverage product portfolio,
we are a leading supplier of raw materials and processed ingredients to a number of global food manufacturers and foodservice
operators. Our vertically integrated model allows us to leverage our scalable and diverse supply of high quality non-GMO and
organic ingredients, adding value to a product at multiple stages of the supply chain and delivering comprehensive non-GMO
and organic food ingredients and packaged goods solutions to our customers’ evolving demands. This model allows us to
generate additional revenue from our global ingredients customers by providing them with high quality healthy food and
beverage products.
Using our vertically integrated business model, we process non-GMO and organic food ingredients into consumer-packaged
products. Our food ingredients are converted from raw materials, and our raw materials are sourced from approximately 5,000
Our commitment and proactive approach to new product development and innovation drives our ability to introduce new higher
margin food and beverage products to the market. The resources of our advanced innovation center in Edina, Minnesota,
support our product development activities, with a dedicated team of food scientists, engineers and technicians, who proactively
engage customers in creating and developing new products. Our innovation platform supports our leadership position in non-
GMO and organic food and strengthens our relationships with our retail, foodservice and contract manufacturing customers.
On October 7, 2016, we entered into a strategic partnership with Oaktree Capital Management L.P., a private equity investor
(together with its affiliates, “Oaktree”). On October 7, 2016, Oaktree invested $85.0 million through the purchase of
cumulative, non-participating Series A Preferred Stock (the “Preferred Stock”) of our wholly-owned subsidiary, SunOpta Foods
Inc. (“SunOpta Foods”).
Following the strategic partnership, with the assistance of Oaktree, we conducted a thorough review of our operations,
management and governance, with the objective of maximizing our ability to deliver long-term value to our shareholders. As
a product of this review our management and the Board of Directors developed a Value Creation Plan built on four pillars:
portfolio optimization, operational excellence, go-to-market effectiveness and process sustainability. The Value Creation Plan
is a broad-based initiative focused on increasing shareholder value through strategic investments made in the people and assets
of the Company to deliver sustained profitable growth. We expect the Value Creation Plan to be implemented in phases, and
span several years.
As part of the first phase of the Value Creation Plan, we are targeting implementation of $30 million of productivity-driven
annualized enhancements of adjusted EBITDA, in the first phase of the plan, to be implemented over 2017 and 2018. During
fiscal 2017, these adjusted EBITDA benefits were offset by expenses associated with the Value Creation Plan, including
structural investments made in the areas of quality, sales, marketing, operations and engineering resources, as well as non-
structural third-party consulting support, severance, and recruiting costs. The plan also calls for increased investment in capital
upgrades at several manufacturing facilities to enhance food safety and manufacturing efficiencies. Over time, these
investments are expected to yield additional improvement in adjusted EBITDA beyond the $30 million of initial productivity-
driven savings. During 2017, we progressed against each of the four pillars of the Value Creation Plan and we believe we are
on track to achieve targeted productivity enhancements, while continuing to make the necessary structural investments we
believe will accelerate growth and drive long-term value. Progress on each of the four pillars of the Value Creation Plan is
highlighted below:
Portfolio Optimization
The focus of the portfolio optimization pillar is to simplify the business, investing where structural advantages exist, while
exiting businesses or product lines where we are not effectively positioned. Highlights include:
x Expansion project to add incremental freezing capacity, storage, and retail bagging capabilities to our Mexican frozen
fruit facility (which we now wholly-own, following our acquistion of remaining non-controlling interests in July
2017). This project should enable diversification of the fruit varieties sourced from Mexico, and is expected to drive
incremental cost savings, in addition to enhanced profitability from retail bagging capabilities.
x Expansion project to add a second roasting and processing line at the our organic cocoa facility in the Netherlands.
This expansion is expected to approximately double processing capacity in addition to adding new capabilities, all in
support of increased demand and future growth opportunities in cocoa.
x Addition of a new oil processing line at our Bulgarian sunflower facility, which is expected to drive incremental
margins through growth and production efficiency.
x Investment into our roasted snacks capabilities at our Crookston, Minnesota, facility, which also involves the planned
closure of our Wahpeton, North Dakota, roasting facility. This expansion is expected to be operational in the third
quarter of 2018, which will support further growth of a variety of roasted grains and seeds.
x Consolidation of certain soy and specialty grain volume and closure of a grain-handling facility in Moorhead,
Minnesota, in the third quarter of 2017, to enhance facility utilization and reduce operating costs.
x Closure of our San Bernardino, California, juice facility in the fourth quarter of 2016.
x Consolidation of our ingredients processing operations in the fourth quarter of 2016, and the related closure of a soy
extraction facility located in Heuvelton, New York.
Since the initiation of the Value Creation Plan, we have implemented portfolio changes that are expected to yield approximately
$7.9 million of annualized adjusted EBITDA benefits.
Operational Excellence
The focus of the operational excellence pillar is to ensure food quality and safety, coupled with improved operational
performance and efficiency. We expect these efforts to generate productivity improvements and cost savings in manufacturing,
procurement and logistics. Highlights include:
x Advances in food safety and quality efforts across the entire manufacturing footprint.
x Rollout of a new continuous improvement methodology (“SunOpta 360”) across our network of aseptic beverage
facilities, which is helping to drive an expected 20% improvement in output from existing aseptic lines in 2018, in
addition to enhanced production capabilities that will add new value-added non-dairy alternatives.
x Actions taken to right-size the incoming 2018 fruit crop, in connection with the implementation of new sales and
operations planning (“S&OP”) tools within Consumer Products, which is expected to reduce storage costs and lower
working capital, and operationally better prepare our frozen fruit operations for the start of the upcoming fruit season.
x Incremental counter-seasonal harvest opportunities enabled by the expansion of the Mexican fruit processing
operations, allowing procurement to leverage lower cost sourcing alternatives.
x Working capital optimization efforts leading to a significant year-over-year improvement in operating cash flows.
Since the initiation of the Value Creation Plan, we have implemented process improvements and cost savings that are expected
to yield approximately $6.9 million of annualized adjusted EBITDA benefits.
Go-To-Market Effectiveness
The focus of the go-to-market effectiveness pillar is to optimize customer and product mix in existing sales channels, and
identify and penetrate new high-potential sales channels. We expect efforts under this pillar to improve revenue growth and
profitability over time. Highlights include:
x Continued growth of the pipeline of commercial opportunities across all consumer product platforms, with a growing
diversity of opportunities across categories and channels where we are currently under-represented.
x Filling of the new position of Chief Customer Officer for Consumer Products, as well as hiring a new head of
marketing.
x Addition of new commercial talent in the areas of sales, marketing, and research and development, which has furthered
the development of control branded products that are expected to enhance access to the foodservice channel.
x Creation of a new foodservice distribution network, leveraging third parties, which will support our plan to grow and
diversify penetration into the foodservice channel.
Process Sustainability
The focus of the process sustainability pillar is to ensure we have the infrastructure, systems and skills to sustain the business
improvements and value captured from the Value Creation Plan. Broadening the skillset and experience of our leadership team
is a critical component to the process sustainability pillar of the Value Creation Plan. Highlights include:
x Filling the positions of Chief Executive Officer, Chief Human Resources Officer, Chief Information Officer, Chief
Quality Officer, Senior Vice President of Operations and Engineering, and Senior Vice President of Supply Chain, as
well as the appointment of a new General Manager to lead our Healthy Fruit platform.
x Additional hiring of other management-level positions in the areas of sales, marketing, customer service, engineering,
operations, quality, and other functional support services.
x Progress on an enterprise resource planning implementation project at the Mexican frozen fruit facility, with
expectation that the new system to be operational during the second quarter of 2018.
x Restructuring of S&OP process and tools in the frozen fruit operations, which is expected to drive greater discipline
and accuracy into the fruit pack plan, ensuring grower commitments are aligned with commercial demand.
x Continued focus on customer service and working capital levels as S&OP processes and support systems are refined.
x Under new leadership, shifting the focus of the internal audit function towards value-added business process
improvements that are designed to support and ensure we sustain improvements made as part of the Value Creation
Plan.
In 2018, it is expected that the majority of future adjusted EBITDA benefits achieved under the Value Creation Plan will be
focused on the operational excellence and go-to-market effectiveness pillars.
The statements we make in this Form 10-K about the expected results of the Value Creation Plan, including the timing for
completion of measures undertaken, expected improvements in earnings, adjusted EBITDA, working capital efficiencies,
expected cash flows, and expected costs, are forward-looking statements. Forward-looking statements contained in this Form
10-K are based on certain factors and assumptions regarding expected growth, results of operations, performance, and business
prospects and opportunities. While we consider these assumptions to be reasonable, based on information currently available,
they may prove to be incorrect. Forward-looking statements are also subject to certain factors, including risks and uncertainties
that could cause actual results to differ materially from what we currently expect. These factors are more fully described in the
“Risk Factors” section at Item 1A of this Form 10-K. Adjusted EBITDA is a non-GAAP measures that management uses when
assessing the performance of our operations. See footnote (3) to the “Consolidated Results of Operations for Fiscal Years 2017
and 2016” table in management’s discussion and analysis of financial condition and results of operations at Item 7 of this Form
10-K for a discussion on the use of this non-GAAP measure and for a reconciliation of adjusted EBITDA from loss from
continuing operations, which we consider to be the most directly comparable U.S. GAAP financial measure.
Board of Directors
On November 6, 2017, Derek Briffett was appointed to the Company’s Board of Directors, increasing the size of the Board to
nine directors. Mr. Briffett also serves on the Company’s Audit Committee. Mr. Briffett most recently served as Chief
Operating Officer from 2013 to 2015 for Associated Brands, which was acquired by Treehouse Foods, leading operations,
supply chain and co-manufacturing sales in addition to finance, information technology and customer service.
Management
Effective January 31, 2018, Colin Smith no longer serves as Chief Operating Officer (“COO”) of Consumer Products, due to
his acceptance of a new role at Oaktree. Mr. Smith is a Managing Director and member of the Portfolio Transformation Team
at Oaktree, and was appointed COO of Consumer Products in February 2017, following Oaktree’s investment in, and strategic
partnership with, SunOpta in October 2016. Mr. Smith’s position with Consumer Products will be eliminated following his
departure. Mr. Smith will continue to act as an advisor to the Company for matters related to the Value Creation Plan.
ACQUISITION HISTORY
SunOpta has been built through business acquisitions and significant internal growth. The following is a summary listing of
business operations that we have acquired and retained since the inception of SunOpta. This summary does not include
acquisitions that were subsequently divested.
SEGMENT INFORMATION
x Global Ingredients aggregates our North American-based Raw Material Sourcing and Supply and European-based
International Sourcing and Supply operating segments focused on the procurement and sale of specialty and organic
grains and seeds, raw material ingredients, value-added grain- and cocoa-based ingredients, and organic commodities.
x Consumer Products consists of three main commercial platforms: Healthy Beverages, Healthy Fruit and Healthy
Snacks. Healthy Beverages includes aseptic packaged products including non-dairy beverages, broths and teas;
refrigerated premium juices; and shelf-stable juices and functional waters. Healthy Fruit includes IQF fruits for retail;
IQF and bulk frozen fruit for foodservice; and custom fruit preparations for industrial use. Healthy Snacks is focused
on fruit snack offerings, and formerly included our flexible resealable pouch and nutrition bar product lines, which we
exited in 2017.
Financial information for each reportable segment describing revenues from external customers, a measure of profit or loss,
and total assets for the last three fiscal years, as well as financial information about geographic areas for the last three fiscal
years, is presented in note 24 of the Consolidated Financial Statements.
Global Ingredients
Global Ingredients aggregates our North American and international raw material sourcing and supply operating segments
focused on the procurement, processing and sale of specialty and organic grains, seeds, fruits, grain- and cocoa-based
ingredients, and other commodities, which are used primarily in applications serving the natural and organic food industry. Its
operations are centered in Amsterdam, the Netherlands; Edina, Minnesota; and Scotts Valley, California.
Global Ingredients sources raw materials, ingredients and certain grain-based food products from approximately 65 countries
around the world, which include:
x Organic fruit- and vegetable-based raw materials and ingredients, sweeteners, cocoa, coffees, ancient grains, nuts,
seeds and pulses and other organic food products.
x Identity preserved (“IP”), non-GMO and organic seeds and grains including soy, corn and sunflower for food
applications, with control maintained at every stage of production, from seed selection and growing through storage,
processing and transportation.
x Seed- and grain-based animal feed and pet food products that originate from select organic and non-GMO soy, corn,
sunflower and other commodities.
Global Ingredients also engages in processing and contract manufacturing services that include:
x Seed and grain conditioning services for soy, corn and sunflower.
x Grain milling for corn, with various granulations and batch sizing.
x Dry and oil roasting and packaging, including in-shell sunflower and sunflower kernels, corn, soy- and legume-based
snacks.
x Liquid (concentrates and oil) and dried format seed, grain and cocoa based ingredients utilizing non-GMO and organic
soy, corn, sunflower, rice, and cocoa.
x Specialty and organic functional ingredients, including maltodextrins, tack blends, flavor enhancing products,
including snack coatings, cheese powders and flavor systems.
Competition—Global Ingredients
Food ingredients are considered niche items often sourced, developed or processed for specific customers or industry segments.
Global Ingredients competes with large seed, grain, raw material and specialty ingredient suppliers for customers and competes
with other companies active in the international commercial seed, grain and raw material procurement market for supply. Its non-
GMO and organic specialty products compete in the smaller niche commercial non-GMO and organic seed, grain and raw material
markets. Key to competing in these markets is access to transportation, supply and relationships with producers. Competitors
include major food companies with food ingredient divisions, other food ingredient and sourcing companies, and consumer food
companies that also engage in the development and sale of food ingredients. Many of these competitors have financial and
technical resources, as well as production and marketing capabilities that are greater than our own.
As a leading provider of IP, non-GMO and organic, grains, seeds, grain- and cocoa-based ingredients, and other raw materials,
Global Ingredients has well established sales and marketing capabilities, including technically oriented sales teams strategically
located close to specific geographic sourcing and/or sales regions. Its specialty grains, seeds and other raw materials and
ingredients are sold to food manufacturers and producers worldwide, including some of the largest U.S. consumer-packaged
food companies. In addition, in our estimation, it maintains one of the largest organic raw material ingredient sourcing and
supply networks in the world, working closely to develop and manage global organic supply and link these supplies with
diverse customer needs. It also provides procurement and ingredient processing support to the Consumer Products operating
segment.
No customers accounted for more than 10% of revenues from our Global Ingredients segment in 2017.
Suppliers—Global Ingredients
Global Ingredients has an extensive established IP, organic soy, corn and sunflower grower network in North America, with
many relationships existing for over 25 years. It also has a network of growers in Europe, South America, Africa and Asia.
Because weather conditions and other factors can limit the availability of raw materials in a specific geography, it continues to
focus on expanding production and sourcing capabilities to other parts of the world to ensure supply in years when local
production is below normal levels. By diversifying supply, it also has the ability to divert available product based on market
demand and customer requirements in order to maximize return.
Organic raw material ingredient suppliers include growers, processors and traders of organic fruit- and vegetable-based
ingredients, sweeteners and other food products. The diversity of our supplier base helps to ensure continual supply by
providing contra-seasonal solutions to mitigate crop and quality risks. Organic food suppliers are required to meet stringent
organic certification requirements equivalent to the U.S. Department of Agriculture (“USDA”) National Organic Program,
European Union (“EU”) standards, or others.
Consumer Products
Consumer Products provides healthy and organic food products that are primarily consumer-packaged to retailers, foodservice
distributors and major global food manufacturers with a variety of branded and private label products. Consumer Products’
packaged food products are categorized into the following three main commercial platforms:
x Healthy Beverages
x Aseptic beverages including almond, soy, coconut, rice and other non-dairy beverages, as well as adjacent
categories such as broths, teas and nutritional beverages. Specializing in aseptic product offerings, Consumer
Products produces a variety of pack sizes, including multi-serve and single-serve formats, all shelf stable
with long shelf lives.
x Organic and conventional beverage products, including shelf stable and refrigerated juices, specialty
beverages, and functional waters. Consumer Products partners with third-party fillers to provide extended
shelf life refrigerated packaging formats to its customers.
x Healthy Fruit
x IQF natural and organic frozen fruits and vegetables, including strawberries, blueberries, raspberries, mango,
peppers, broccoli, blends and many other items. Consumer Products produces a variety of packaging formats,
including tubs, stand-up pouches, cups and polybags to address the needs of its retail and foodservice
customers.
x Specialty fruit toppings and bases, which are custom formulated to provide unique flavor and texture profiles
for a wide range of specialized applications. Applications include fruit bases for yogurts, ice creams, cheeses,
smoothies, shakes, frozen desserts, bakery fillings, health bars, various beverages, dressings, marinades, dips
and sauces, and fruit toppings for foodservice applications.
x Our frozen fruit operations consist of five facilities that extend from central Mexico to California, as well as
a production facility in Kansas. Strategically our north to south footprint on the west coast allows us to
maximize access to supply of fruit over the course of the full growing season, while our operation in the
Midwest serves as a lower-cost launching pad to deliver product to the east coast. Our fruit ingredient
operations are located in California.
x Healthy Snacks
x Natural and organic fruit-based snacks in bar, twist, rope and bite size shapes, with the ability to add a variety
of ingredients.
x Our healthy snack platform maintains bi-coastal production which helps to minimize delivery costs to our
customers.
Competition—Consumer Products
Consumer Products’ healthy beverage and healthy snack offerings compete with major food manufacturing companies, as well
as a number of other regional manufacturers. Its healthy fruit offerings face competition from both branded and private label
fruit providers. It faces competition when securing fruit and vegetable raw materials; however, due to the location of its
processing facilities, it is able to source these raw materials from a number of growing regions and suppliers. Integrated
sourcing through Global Ingredients, which supplies a number of core raw materials, combined with in-house processing and
packaging capabilities, provides Consumer Products with a low-cost advantage over many of its competitors.
Consumer Products supplies the private-label retail market, including large retailers and club stores, branded food companies,
food manufacturers, foodservice distributors, quick service and casual dining restaurants located principally in North America.
In addition, it markets branded food products under SunOpta-controlled brands, including Sunrich® Naturals and Pure
Nature™. Consumer Products generally conducts its business with customers on the basis of purchase orders and price
quotations, without other formal agreements related to minimum or maximum supplies or pricing.
In 2017, Costco Wholesale, Starbucks Corporation and Walmart Inc. accounted for approximately 17%, 15% and 11%,
respectively, of revenues from our Consumer Products operating segment and approximately 10%, 9% and 6%, of our
consolidated revenues, respectively. No other customers accounted for more than 10% of revenues from our Consumer
Products operating segment in 2017.
Suppliers—Consumer Products
Consumer Products’ raw materials are subject to the availability of fruit and vegetable supply, which is based on conditions
that are beyond our control. Fresh and frozen fruits, berries, and vegetables are sourced directly from a large number of
suppliers throughout the U.S., Mexico and globally, or through Global Ingredients. We believe our scale and location close to
growing areas makes Consumer Products’ an attractive customer for fruit growers.
Corporate Services
Our corporate headquarters is located in Mississauga, Ontario. In addition, centralized information technology, human
resources, operations, research and development, legal and financial shared services groups are located in Edina, Minnesota.
Employees of Corporate Services provide support services across the organization including management, finance, legal,
operations, business development, information technology, research and development, human resources and administrative
functions.
REGULATION
We are subject to a wide range of governmental regulations and policies in various countries and regions where we operate, including
the U.S., Canada, Mexico, the Netherlands, throughout the rest of the EU, China and Ethiopia. Outside of the U.S., regulations
concerning the sale or characterization of food ingredients vary substantially from country to country, and we take appropriate steps
to comply with such regulations. These laws, regulations and policies are implemented, as applicable in each jurisdiction, on the
national, federal, state, provincial and local levels. For example, we are affected by laws and regulations related to: seed, fertilizer
and pesticides; the purchasing, harvesting, transportation and warehousing of grain and other products; the processing, packaging
and sale of food, including wholesale operations; and product labeling and marketing, food safety and food defense. We are also
affected by government-sponsored price supports, acreage set aside programs and a number of environmental regulations.
U.S. Regulations
Our activities in the U.S. are subject to regulation by various government agencies, including the Food and Drug Administration
(“FDA”), the Federal Trade Commission (“FTC”), the Environmental Protection Agency (“EPA”), the USDA, Occupational Safety
and Health Administration (“OSHA”), and the Departments of Commerce and Labor, as well as voluntary regulation by other
bodies. Various state and local agencies also regulate our activities.
We currently manufacture and distribute a number of organic products that are subject to the standards set forth in the Organic
Foods Production Act and the regulations adopted thereunder by the National Organic Standards Board. In addition, our organic
products may be subject to various state regulations. We believe that we are in material compliance with the organic regulations
applicable to our business, and we maintain an organic testing and verification process. Generally, organic food products are
produced using:
x no genetically engineered seeds or crops, sewage sludge, long-lasting pesticides, herbicides or fungicides; and
x food processing practices intended to protect the integrity of the organic product and disallow irradiation, genetically
modified organisms or synthetic preservatives.
After becoming certified, organic operations must retain records concerning the production, harvesting, and handling of
agricultural products that are to be sold as organic for a period of five years. Any organic operation found to be in violation of
the USDA organic regulations is subject to enforcement actions, which can include financial penalties or suspension or
revocation of their organic certificate.
As a manufacturer and distributor of food products, we are subject to the Federal Food, Drug and Cosmetic Act, the Fair
Packaging and Labeling Act and regulations promulgated thereunder by the FDA and the FTC. This regulatory framework
governs the manufacture (including composition and ingredients), labeling, packaging and safety of food in the U.S.
State and local statutes and regulations may impose additional food safety, labeling, and packaging requirements. For instance,
the California Safe Drinking Water and Toxic Enforcement Act of 1986 (commonly referred to as “Proposition 65”) requires,
with a few exceptions, that a specific warning appear on any consumer product sold in California that contains a substance,
above certain levels, listed by that state as having been found to cause cancer or birth defects. We believe we are in material
compliance with state and local statutes and regulations as they apply to our business.
Environmental Regulations
We are also subject to various U.S. federal, state and local environmental regulations. Some of the key environmental regulations
in the U.S. include, but are not limited to, the following:
x Air quality regulations – air quality is regulated by the EPA and certain city/state air pollution control groups.
Emission reports are filed annually.
x Waste treatment/disposal regulations – solid waste is either disposed of by a third-party or, in some cases, we have a
permit to haul and apply the sludge to land. Agreements exist with local city sewer districts to treat waste at specified
levels of Biological Oxygen Demand (“BOD”), Total Suspended Solids (“TSS”) and other constituents. This can
require weekly/monthly reporting as well as annual inspection.
x Sewer regulations – we have agreements with the local city sewer districts to treat waste at specified limits of BOD
and TSS. This requires weekly/monthly reporting as well as annual inspection.
x Hazardous chemicals regulations – Various reports are filed with local city/state emergency response agencies to
identify potential hazardous chemicals being used in our facilities.
x Storm water – all facilities are inspected annually and must comply with an approved storm water plan to protect water
supplies.
We are subject to certain safety regulations, including OSHA regulations. These regulations require us to comply with certain
manufacturing safety standards to protect our employees from accidents. We believe that we are in material compliance with
all employee safety regulations applicable to our business.
Outside of the U.S., regulations concerning the sale or characterization of food ingredients vary substantially from country to
country, and we take appropriate steps to comply with such regulations.
In Canada, the sale of food is currently regulated under various federal and provincial laws, principally the federal Food and Drugs
Act (“FADA”), Canada Agricultural Products Act (“CAPA”), and the Canadian Environmental Protection Act, 1999 (“CEPA”),
along with their supporting regulations. Some of the key Canadian regulatory instruments include but are not limited to the
following:
x Food and Drug Regulations (under the FADA) – food and drugs are subject to specific regulatory requirements, including
composition (such as food additives, fortification, and food standards), packaging, labeling, advertising and marketing,
and licensing requirements. New requirements regarding nutrition and ingredient labeling and food color were introduced
on December 14, 2016. To the extent the new labeling requirements apply to products manufactured and sold by the
Company, we will have a five-year transitional period to adopt them. Amendments dealing with food colour specifications
and the removal of synthetic colour certification requirements came into effect immediately.
x Organic Products Regulations, 2009 (“OPR”) (under the CAPA) – the OPR require mandatory certification to the revised
national organic standard for agricultural products that are to be represented as organic in international and inter-provincial
SUNOPTA INC. 14 December 30, 2017 10-K
trade, or that bear the federal organic agricultural product legend (or federal logo). Except for certain exceptions and
conditions, a U.S.-Canada Organic Equivalence Arrangement is currently in place whereby agricultural products produced
and processed in conformity with the USDA National Organic Program are considered to be equivalent to the requirements
of the OPR.
x Canada Consumer Product Safety Act (“CCPSA”) – the CCPSA provides oversight and regulation of consumer
products with respect to manufacturers, importers, and retailers. It includes, without limitation, the ability to require
product recalls, mandatory incident reporting, document retention requirements, increased fines and penalties, and
packaging and labeling requirements. While the CCPSA does not apply to food, it does apply to its packaging with
respect to safety. It is possible that there will be amendments introduced to the FADA, to capture the essence of the
regulatory oversight found in the CCPSA. We have no way of anticipating if and when that may occur.
x Consumer Packaging and Labeling Act (“CPLA”) – the CPLA and its supporting regulations outline requirements for
packaging and labeling of products, including food products. The CPLA sets out labeling requirements relating to the
description of the product, net quantity and dealer information, as well as packaging standards. The CPLA also
includes a prohibition against false or misleading labeling.
x Canada Food Inspection Agency Act (“CFIAA”) – the CFIAA grants power to the Canadian Food Inspection Agency
(the “CFIA”), which is tasked with the administration and enforcement of certain Canadian food legislation. By virtue
of the CFIAA and CAPA, the CFIA has the power to inspect and, if deemed necessary, recall certain products,
including fresh fruit and vegetables, processed foods and organic foods, if the Minister believes that such products
pose a risk to the public, animal or plant health.
x Processed Products Regulations (“PPR”) (under the CAPA) – the PPR regulates the grading, packing and marking of
processed products that are produced in Canada for inter-provincial or export trade or imported into Canada. Under
the PPR, processed food products are those that are prepared to assure preservation of the food product in transport,
distribution and storage. The PPR establishes requirements with respect to the content, preparation, packing and
marking of processed food products.
In January, 2017, the Government of Canada published the second version of its proposed Safe Food for Canadians Regulations
(“SFCR”) under the authority of the Safe Food for Canadians Act (“SFCA”). Publication of the SFCR was accompanied by a
90-day public consultation period that ended on April 21, 2017. In January, 2018, the CFIA published a report summarizing
submissions received pursuant to the proposed SFCR. The final regulations are expected to be published in the spring of 2018.
If and when they become effective, the SFCR will consolidate 13 existing Canadian regulations and the food labeling provisions
of the CPLA, and thereby establish a comprehensive set of regulations which govern all food sectors subject to CFIAA
oversight, including federally registered sectors and food that is destined for import, export or interprovincial trade. Principal
elements of the SCFR which are likely to impact the Company include licensing requirements for the import, export and
interprovincial trade of food, traceability requirements, reporting requirements and timelines, preventative controls, an export
certificate request process, prescribed container sizes and weights for certain products, labeling regulations and standards of
identity and expansion of organic certification to service providers and additional products. The licensing requirements will
be immediate for sectors such as meat, eggs and other previously federally registered sectors and up to three years for other
sectors.
We are subject to Dutch and European Commission (“EC”) regulations and policies. Our European subsidiary, The Organic
Corporation (“TOC”), is involved in the sourcing, supplying, processing, marketing, selling and distribution of organic food
products and, as such, is subject to standards for production, labeling and inspection of organic products contained in EC
Regulation 2092/91 (and its subsequent amendments). TOC is certified by Skal, the inspection body for the production (trading
and selling) of organic products in the Netherlands. Products certified as organic by an EU-recognized inspection body, such
as Skal, can be marketed within the entire EU. In addition, under the terms of an equivalency arrangement between the U.S.
and the EU, organic operations certified to the USDA organic or EU organic standards may be labeled and sold as organic in
both the U.S. and EU.
TOC is also affected by general food legislation both at EU and Dutch level relating to product safety and hygiene, among
others. TOC is BRC Agents and Brokers certified in the Netherlands and manages a fully computerized system that manages
the traceability of each product. In addition, TOC also considers and abides by EU and local legislation with regard to
packaging and packaging waste. TOC is also subject to the regulations and policies of the countries outside of the EU in which
it operates, including China and Ethiopia.
Research and development and new product, process and packaging innovation are key priorities of our Company and
initiatives are focused on continuous improvement of our existing product portfolios and continuing efforts to improve
production process to reduce costs and improve efficiencies, as well as the development of innovative new products. Innovation
is a key pillar for us and a necessity in the natural and organic foods categories. We believe our commitment and proactive
approach to new product development and innovation is important to our ability to introduce new higher-margin food and
beverage products to the market.
Our innovation center located in Edina, Minnesota, supports our product development team of highly trained and experienced
food scientists and technologists that are dedicated to the research and development of new product offerings, as well as
addressing product development opportunities for our customers. These opportunities include new and custom formulations,
innovations in packaging formats, and new production processes and applications. Applications and technical support provided
to our customers include all aspects of product development from concept to commercial launch, as well as ongoing
manufacturing and processing support.
We continue to develop new products to maximize the capabilities of our aseptic packaging facilities, including the development
of non-dairy-based beverages that address the growing consumer demand for beverages that satisfy allergy concerns and
provide a unique nutritional profile, as well as broths, teas and nutritional beverages. In addition, we continue to develop new
fruit-based beverages, and fruit- and grain-based snacks, as well as innovative fruit ingredient systems for the dairy, foodservice
and beverage industries. We are also continually looking to develop new value-added products for our customers that leverage
our global sourcing platform.
INTELLECTUAL PROPERTY
The nature of a number of our products and processes requires that we create and maintain patents, trade secrets and trademarks.
Our policy is to protect our technology, brands and trade names by, among other things, filing patent applications for technology
relating to the development of our business in the U.S. and in selected foreign jurisdictions, registering trademarks in the U.S.,
Canada and selected foreign jurisdictions where we sell products, and maintenance of confidentiality agreements with outside
parties and employees.
Our success will depend, in part, on our ability to protect our products, trade names and technology under U.S. and international
patent laws and other intellectual property laws. We believe that we own or have sufficient rights to use all of the proprietary
technology, information and trademarks necessary to manufacture and market our products; however, there is always a risk
that patent applications relating to our products or technologies will not result in patents being issued, or, if issued, will be later
challenged by a third party, or that current or additional patents will not afford protection against competitors with similar
technology.
We also rely on trade secrets and proprietary know-how and confidentiality agreements to protect certain technologies and
processes. Even with these steps taken, our outside partners and contract manufacturers could gain access to our proprietary
technology and confidential information. All employees are required to adhere to internal policies, which are intended to
further protect our technologies, processes and trade secrets.
PROPERTIES
We operate 22 processing facilities in seven U.S. states, as well as Canada, Mexico, the Netherlands, Bulgaria, and Ethiopia.
In addition, we also own and lease a number of office and distribution locations in the U.S., Canada, Mexico, Europe, Ethiopia
and China, and lease and utilize public warehouses to satisfy our storage needs. We also lease farmland that we sublease to
fruit growers. For more details see Item 2. Properties, included elsewhere in this report.
ENVIRONMENTAL HAZARDS
We believe that, with respect to both our operations and real property, we are in material compliance with environmental laws
at all of our locations.
As at December 30, 2017, we had a total of approximately 1,800 full-time employees (December 31, 2016 – 2,000). We also
employ up to 1,700 seasonal employees in the U.S. and Mexico during peak fruit seasons each year. We consider our relations
with our employees to be good and have not experienced any work stoppages, slowdowns or other serious labor problems that
have materially impeded our business operations.
AVAILABLE INFORMATION
Our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, and amendments to those
reports filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (the “Exchange Act”), are
available free of charge on our website at www.sunopta.com as soon as reasonably practicable after we file such information
electronically with, or furnish it to, the U.S. Securities and Exchange Commission (the “SEC”) and applicable Canadian
Securities Administrators (the “CSA”).
Our business, operations and financial condition are subject to various risks and uncertainties, including those described below
and elsewhere in this report. We believe the most significant of these risks and uncertainties are described below, any of which
could adversely affect our business, financial condition and results of operations and could cause actual results to differ
materially from the results contemplated by the forward-looking statements contained in this report. In such case, the trading
price of our common stock could decline, and our shareholders may lose all or part of their investment. There may be additional
risks and uncertainties not presently known to us or that we currently consider immaterial. Consequently, you should not
consider the following to be a complete discussion of all possible risks or uncertainties applicable to our business. These risk
factors should be read in conjunction with the other information in this report and in the other documents that we file from time
to time with the SEC and the CSA.
Risks Related to Our Value Creation Plan, Significant Investors and Shareholder Activism
The implementation of our Value Creation Plan could pose a number of risks that could have an adverse impact on our
business, financial condition and results of operations
Following our strategic partnership with Oaktree, we conducted a thorough review of our operations, management and
governance, with the objective of maximizing our ability to deliver long-term value to our shareholders. As a product of this
review, our management and the Board developed a Value Creation Plan built on four pillars: portfolio optimization,
operational excellence, go-to-market effectiveness and process sustainability. The Value Creation Plan is a broad-based
initiative focused on increasing shareholder value through strategic investments made to the people and assets of the Company
to deliver sustained profitable growth. We expect the Value Creation Plan to be implemented in phases, and span several years.
In connection with the Value Creation Plan, we are implementing a number of operational actions to improve our profitability
and streamline our operations for long-term success. These actions may include rationalization or consolidation of certain of
our operations or facilities, reinvestment in certain of our operations or facilities, investments in personnel, processes and tools,
as well as other cost saving initiatives. These actions could consume capital resources and could also give rise to impairment
and other restructuring charges that would be both cash and non-cash in nature, and these charges could be material.
The implementation of the Value Creation Plan could have a material impact on our operations, strategy, governance,
management and future prospects. For example, in 2016, we announced the closures of our San Bernardino, California, juice
facility and Heuvelton, New York, soy extraction facility, resulting in impairment charges amounting to $13.2 million.
Similarly, in 2017, we announced the exits from flexible resealable pouch and nutrition bar product lines and operations, as
well as the consolidation of our roasted snack operations, resulting in impairment charges of $18.2 million relating to these
assets. Certain actions that we take may lead to additional write-downs of assets and/or charges in future periods. In addition,
we cannot predict whether the actions we take will achieve our goals of improving our profitability and financial performance
and delivering long-term value to our shareholders. The ongoing implementation of our Value Creation Plan could expose us
to a number of other risks, including the following:
x distraction of management;
x difficulties in hiring, retaining and motivating key personnel as a result of uncertainty generated by the review and the
implementation of any resulting recommendations;
x increases in general and administrative expenses associated with the need to retain and compensate business and
recruiting consultants and other advisors.
The occurrence of any one or more of the above risks could have an adverse impact on our business, financial results, liquidity
and financial condition.
Our significant investors may have interests that conflict with those of our debtholders and other stakeholders
As at December 30, 2017, Oaktree held a 19.8% voting interest in the Company through its holdings of 11,333,333 special
voting shares and 8,092,699 common shares of the Company. Oaktree has also nominated two members of the Board and is
entitled to designate two nominees for election to the Board so long as it beneficially owns or controls at least 11.1% of SunOpta
Inc.’s common stock on an as-exchanged basis. If Oaktree beneficially owns or controls less than 11.1% but more than 5% of
SunOpta Inc.’s common stock on an as-exchanged basis, it will be entitled to designate one nominee. In addition, Engaged
Capital has nominated one member of our Board.
Oaktree is assisting us with our efforts to improve our operations, management and governance. Oaktree’s objectives and
perspectives as an equity investor in SunOpta may not always be aligned with those of other stakeholders, including our
debtholders and smaller shareholders.
The interests of Oaktree and Engaged Capital, as well as their affiliates, may differ from the interests of our other stakeholders
in material respects. For example, our large investors and their affiliates may have an interest in directly or indirectly pursuing
acquisitions, divestitures, financings or other transactions that, in their judgment, could enhance their other equity investments,
even though such transactions might involve risks to us, including risks to our liquidity and financial condition. Our large
investors and their affiliates are in the business of making or advising on investments in companies, including businesses that
may directly or indirectly compete with certain portions of our business. They may also pursue acquisition opportunities that
may be complementary to our business, and, as a result, those acquisition opportunities may not be available to us.
A concentration of ownership within our large investors could potentially be disadvantageous to, or conflict with, interests of
our debtholders or smaller shareholders. In addition, if any significant shareholder were to sell or otherwise transfer all or a
large percentage of its holdings, we could find it difficult to raise capital, if needed, through the sale of additional equity
securities.
Our business could be negatively impacted as a result of shareholder activism or an unsolicited takeover proposal or a proxy
contest
In recent years, proxy contests and other forms of shareholder activism have been directed against numerous public companies.
If a proxy contest or an unsolicited takeover proposal was made with respect to us, we could incur significant costs in defending
the Company, which would have an adverse effect on our financial results. Shareholder activists may also seek to involve
themselves in the governance, strategic direction and operations of the Company. Such proposals may disrupt our business
and divert the attention of our management and employees, and any perceived uncertainties as to our future direction resulting
from such a situation could result in the loss of potential business opportunities, be exploited by our competitors, cause concern
to our current or potential customers, and make it more difficult to attract and retain qualified personnel and business partners,
all of which could adversely affect our business. In addition, actions of activist shareholders may cause significant fluctuations
in our stock price based on temporary or speculative market perceptions or other factors that do not necessarily reflect the
underlying fundamentals and prospects of our business.
Product liability suits, recalls and threatened market withdrawals, could have a material adverse effect on our business
Many of our products are susceptible to harmful bacteria, and the sale of food products for human consumption involves the
risk of injury or illness to consumers. Such injuries may result from inadvertent mislabeling, tampering by unauthorized third
parties, faulty packaging materials, product contamination, or spoilage. Under certain circumstances, we or our customers may
be required to recall or withdraw products, which may lead to a material and adverse effect on our business, financial condition
or result of operations. Our customers may also voluntarily recall or withdraw a product we manufactured or packaged, even
without consulting us, which could increase our potential liability and costs and result in lost sales. A product recall or
withdrawal could result in significant losses due to the costs of the recall, the destruction of product inventory, and lost sales
For example, on May 3, 2016, we announced a voluntary recall of certain sunflower kernel products that have the potential to
be contaminated with Listeria monocytogenes bacteria, and a number of our customers initiated recalls of their products that
contain the affected sunflower kernels as an ingredient or component. Additionally, we ceased production at our roasting
facilities for the period from April 21, 2016 until on or about May 15, 2016, while we put in place corrective and preventive
actions. While we have recognized estimated losses of $47.5 million related to this recall, we may need to revise our estimates
to be materially larger as we continue to work with our customers to substantiate the claims received to date and any additional
claims that may be received. Consequently, we may not be able to determine the full extent of the losses related to the recall
for some time and certain factors impacting these losses, such as our customers’ processes for developing their claims, the
timing of submission of any such claims, and the terms of our customers’ insurance policies and related coverage, which are
beyond our control. Revisions of our estimated losses and costs may occur at any time as we continue this process.
We have general liability and product recall insurance policies with aggregate limits of $47.0 million under which we expect
to recover the sunflower kernel recall-related costs, less applicable deductibles. As at December 30, 2017, we had recognized
recoveries up to the limit of the coverage available under our insurance policies. Consequently, to the extent any losses are
excluded under the insurance policies or additional losses are recognized related to existing or new claims, these excluded or
excess losses will be recognized as a charge to future earnings.
Even if a situation does not necessitate a recall or market withdrawal, product liability claims might be asserted against us. If
a product recall or withdrawal were to lead to a decline in sales of a similar or related product sold by a customer or other third
party, that party could also initiate litigation against us. While we are subject to governmental inspection and regulations and
believe our facilities and those of our co-packers comply in all material respects with all applicable laws and regulations, if the
consumption of any of our products causes, or is alleged to have caused, a health-related illness in the future, we may become
subject to claims or lawsuits relating to such matters. Even if a product liability claim is unsuccessful or is not fully pursued,
the negative publicity surrounding any assertion that our products caused illness or physical harm could adversely affect our
reputation with existing and potential customers and consumers and our corporate and brand image.
Moreover, future claims or liabilities of this sort might not be covered by our insurance or by any rights of indemnity or
contribution that we may have against others. Further, we may incur claims or liabilities for which we are not insured or that
exceed the amount of our insurance coverage. A product liability judgment against us or a further product recall could have a
material and adverse effect on our business, financial condition and results of operations.
Food safety concerns and instances of food-borne illnesses caused by third parties could harm our business
Our internal processes and training may not be fully effective in preventing contamination of food products that could lead to
food-borne illnesses. We rely on third-party suppliers and distributors, which increases the risk that food-borne illness incidents
(such as e. coli, salmonella or listeria) could occur outside of our control and at multiple locations. If consumers lose confidence
in the safety and quality of our products or organic products generally, even in the absence of a recall or a product liability
case, our business, financial condition and results of operations could be materially and adversely affected. Instances of food-
borne illnesses, whether real or perceived, and whether or not traceable to our operations or a result of our actions or omissions,
could cause negative publicity about us or the products we serve, which could adversely affect sales. Food safety concerns and
instances of food-borne illnesses and injuries caused by contaminated products sold by third parties could cause customers to
shift their preferences, even if no food-borne illnesses or injuries are traced to our products. As a result, our sales may decline.
Loss of customers as a result of these health concerns or negative publicity could harm our business.
Litigation and regulatory enforcement concerning marketing and labeling of food products could adversely affect our
business and reputation
The marketing and labeling of any food product in recent years has brought increased risk that consumers will bring class action
lawsuits and that the FTC and/or state attorneys general will bring legal action concerning the truth and accuracy of the
marketing and labeling of the product. Examples of causes of action that may be asserted in a consumer class action lawsuit
include fraud, unfair trade practices, and breach of state consumer protection statutes (such as Proposition 65 in California).
The FTC and/or state attorneys general may bring legal action that seeks removal of a product from the marketplace, and
impose fines and penalties. Even when not merited, class claims, action by the FTC or state attorneys general enforcement
actions can be expensive to defend and adversely affect our reputation with existing and potential customers and consumers
We are affected by a wide range of governmental regulations in Canada, the U.S., Mexico and several countries in Europe,
among others. These laws and regulations are implemented at the national level (including, among others, federal laws and
regulation in Canada and the U.S.) and by local subdivisions (including, among others, state laws in the U.S. and provincial
laws in Canada). We are also subject to regulations of the EU and the regulatory authority of regulatory agencies in several
different countries. Examples of regulatory agencies influencing our operations include: the USDA, the FDA, the DHS, the
EPA, the CFIA, and Skal, among others.
Examples of laws and regulations that affect us include laws and regulations applicable to:
x the purchasing, harvesting, transportation and warehousing of seeds, grain and other products;
x the product labeling and marketing of food and food products, food safety and food defense.
These laws and regulations affect various aspects of our business. For example, certain food ingredient products manufactured
by SunOpta may require pre-market approval by the FDA that the ingredient is generally recognized as safe, or “GRAS.” We
believe that most food ingredients for which we have commercial rights are GRAS. However, this status cannot be determined
until actual formulations and uses are finalized. As a result, we may be adversely impacted if the FDA determines that our
food ingredient products do not meet the criteria for GRAS.
In addition, certain USDA regulations set forth the minimum standards producers must meet in order to have their products
labeled as “certified organic”, and we currently manufacture a number of organic products that are covered by these regulations.
While we believe our products and our supply chain are in compliance with these regulations, changes to food regulations may
increase our costs to remain in compliance. We could lose our “organic” certification if a facility becomes contaminated with
non-organic materials or if we do not use raw materials that are certified organic. The loss of our “organic” certifications could
materially and adversely affect our business, financial condition and results of operations.
Our business is subject to the Perishable Agricultural Commodities Act (“PACA”). PACA regulates fair trade standards in the
fresh produce industry and governs our purchases of fresh produce and sales of frozen produce. We source fresh produce under
licenses issued by the USDA, as required by PACA. Our failure to comply with the PACA requirements could, among other
things, result in civil penalties, suspension or revocation of our licenses to sell produce and in certain cases, criminal
prosecution, which could have a material and adverse effect on our business, financial condition and results of operations.
Changes in any government laws and regulations applicable to our operations could increase our compliance costs, negatively
affect our ability to sell certain products or otherwise adversely affect our results of operations. In addition, while we believe
we are in material compliance with all laws and regulations applicable to our operations, we cannot assure you that we have
been, or will at all times be, in compliance with all food production and health requirements, or that we will not incur material
costs or liabilities in connection with these requirements. Our failure to comply with any laws, regulations or policies applicable
to our business could result in fines, lawsuits, enforcement actions, penalties or loss in the ability to sell certain products, any
of which could materially and adversely affect our business, financial condition and results of operations.
We may require additional capital, which may not be available on favorable terms or at all
We have grown via a combination of internal growth and acquisitions requiring available financial resources. Our ability to
raise capital, through equity or debt financing, is directly related to our ability to both continue to grow and improve returns
from our operations. Debt or equity financing may not be available to us on favorable terms or at all. In addition, any future
equity financing would dilute our current shareholders and may result in a decrease in our share price if we are unable to realize
adequate returns. We will not be able to continue to fund internal growth and/or acquire complementary businesses within the
natural and organic food industries without continued access to capital resources.
As a result of business acquisitions, a significant portion of our total assets is comprised of intangible assets and goodwill. We
are required to perform impairment tests of our goodwill and other intangible assets annually, or at any time when events occur
that could affect the value of these assets. We may engage in additional acquisitions, which could result in our recognition of
additional intangible assets and goodwill. If the financial performance of the acquired businesses is not as strong as we
anticipate, we could be required to record significant impairments to intangible assets and/or goodwill, which could materially
and adversely impact our business, financial condition and results of operations.
For example, in 2017, we recognized a goodwill impairment charge of $115.0 million related to the Healthy Fruit reporting
unit of the Consumer Products operating segment, and, in 2016, we recognized a goodwill impairment charge of $17.5 million
related to the Sunflower reporting unit of the Raw Material Sourcing and Supply operating segment.
We operate businesses in highly competitive product and geographic markets in the U.S., Canada, Europe and various other
international markets. We compete with various U.S. and international commercial grain procurement marketers, major
companies with food ingredient divisions, other food ingredient companies, trading companies, and consumer-packaged food
companies that also engage in the development and sale of food ingredients and other food companies involved in natural and
organic foods. These competitors may have financial resources and staff larger than ours and may be able to benefit from
economies of scale, pricing advantages and greater resources to launch new products that compete with our offerings. We have
little control over and cannot otherwise affect these competitive factors. If we are unable to effectively respond to these
competitive factors or if the competition in any of our product markets results in price reductions or decreased demand for our
products, our business, financial condition and results of operations may be materially and adversely affected.
Our customers generally are not obligated to continue purchasing products from us
Many of our customers buy from us under purchase orders, and we generally do not have long-term agreements with or
commitments from these customers for the purchase of products. We cannot provide assurance that our customers will maintain
or increase their sales volumes or orders for the products supplied by us or that we will be able to maintain or add to our existing
customer base. Decreases in our customers’ sales volumes or orders for products supplied by us may have a material adverse
effect on our business, financial condition and results of operations.
Our relationships with our key customers are critical to the success of our business and our results of operations. Our three
largest customers accounted for approximately 24% of revenues for the year ended December 30, 2017. The loss, decrease or
cancellation of business with any of our large customers could materially and adversely affect our business, financial condition
and results of operations.
Consumer preferences for natural and organic food products are difficult to predict and may change
Our success depends, in part, on our ability and our customers’ ability to offer products that anticipate the tastes and dietary
habits of consumers and appeal to their preferences on a timely and affordable basis. A significant shift in consumer demand
away from our products or products that utilize our integrated foods platform, or a failure to maintain our current market
position, could reduce our sales and harm our business. Consumer trends change based on a number of factors, including
nutritional values, a change in consumer preferences or general economic conditions. Additionally, there is a growing focus
among some consumers to buy local food products in an attempt to reduce the carbon footprint associated with transporting
food products from longer distances, which could result in a decrease in the demand for food products and ingredients that we
import from other countries or transport from remote processing locations or growing regions. Further, failures by us or our
competitors to deliver quality products could erode consumer trust in the organic certification of foods. These changes could
lead to, among other things, reduced demand and price decreases, which could have a material and adverse effect on our
business, financial condition and results of operations.
Our supply chain is complex. We rely on suppliers for our raw materials and for the manufacturing, processing, packaging and
distribution of many of our products. The inability of any of these suppliers to deliver or perform for us in a timely or cost-
effective manner could cause our operating costs to rise and our margins to fall. Many of our products are perishable and
require timely processing and transportation to our customers. Additionally, many of our products can only be stored for a
limited amount of time before they spoil and cannot be sold. We must continuously monitor our inventory and product mix
against forecasted demand or risk having inadequate supplies to meet consumer demand as well as having too much inventory
that may reach its expiration date. If we are unable to manage our supply chain efficiently and ensure that our products are
available to meet consumer demand, our operating costs could increase and our margins could fall, which could have a material
and adverse effect on our business, financial condition and results of operations.
Some of our operations are subject to seasonal supply fluctuations. For example, we purchase strawberries and other fruit from
farmers during the peak California growing season, which occurs during the first two quarters of the year. As a result, our costs
may be higher during these periods. We may not be successful in counteracting or smoothing out the effects of seasonality, and
we expect that certain parts of our operations will continue to remain subject to significant seasonality.
Part of our supply source also depends in part on a seasonal temporary workforce comprised primarily of migrant workers.
Changes in immigration laws or policies that discourage migration to the U.S. and political or other events (such as war,
terrorism or health emergencies) that make it more difficult for individuals to immigrate to or migrate throughout the U.S.
could adversely affect the migrant worker population and reduce the workforce available for farms and production facilities in
the U.S. Additionally, increased competition from other industries for migrant workers could increase our costs and adversely
affect our business, financial condition and results of operations.
Volatility in the prices of raw materials and energy could increase our cost of sales and reduce our gross margins
Raw materials represent a significant portion of our cost of sales. Our cost to purchase services and materials, such as grains,
fruits and other commodities, processing aids, and natural gas, can fluctuate depending on many factors, including weather
patterns, economic and political conditions and pricing volatility. In addition, we must compete for limited supplies of these
raw materials and services with competitors having greater resources than us. If our cost of materials and services increases
due to any of the above factors, we may not be able to pass along the increased costs to our customers.
We enter into a number of exchange-traded commodity futures and options contracts to partially hedge our exposure to price
fluctuations on transactions to the extent considered practicable for minimizing risk from market price fluctuations. Futures
contracts used for hedging purposes are purchased and sold through regulated commodity exchanges. Our inventories,
however, may not be completely hedged, due in part to our assessment of exposure from expected price fluctuations and an
inability to hedge a number of raw materials.
Exchange purchase and sales contracts may expose us to risks that a counterparty to a transaction is unable to fulfill its
contractual obligation. We may be unable to hedge 100% of the price risk of each transaction due to timing and availability of
hedge contracts and third-party credit risk. In addition, we have a risk of loss from hedge activity if a grower does not deliver
the commodity as scheduled. We also monitor the prices of natural gas and from time to time lock in a percentage of our
natural gas needs based on current prices and expected trends.
An increase in our cost of sales resulting from an increase in the price of raw materials and energy could have a material and
adverse effect on our business, financial condition and results of operations.
Our future results of operations may be adversely affected by the availability of organic and non-GMO ingredients
Our ability to ensure a continuing supply of organic and non-GMO ingredients at competitive prices depends on many factors
beyond our control, such as the number and size of farms that grow organic and non-GMO crops, climate conditions, changes
in national and world economic conditions, currency fluctuations and forecasting adequate need of seasonal ingredients.
The organic and non-GMO ingredients that we use in the production of our products (including, among others, fruits,
vegetables, nuts and grains) are vulnerable to adverse weather conditions and natural disasters, such as floods, droughts, water
scarcity, temperature extremes, frosts, earthquakes and pestilences. Natural disasters and adverse weather conditions (including
the potential effects of climate change) can lower crop yields and reduce crop size and crop quality, which in turn could reduce
our supplies of organic or non-GMO ingredients or increase the prices of organic or non-GMO ingredients. If our supplies of
organic or non-GMO ingredients are reduced, we may not be able to find enough supplemental supply sources on favorable
Adverse weather conditions and natural disasters could impose costs on our business
Our various food products, from seeds and grains to ingredients, fruits, vegetables and other inputs, are vulnerable to adverse
weather conditions and natural disasters, including windstorms, hurricanes, floods, droughts, fires, temperature extremes and
earthquakes, some of which are common but difficult to predict, as well as crop disease and infestation. Severe weather
conditions may occur with higher frequency or may be less predictable in the future due to the effects of climate change.
Unfavorable growing conditions could reduce both crop size and crop quality. In extreme cases, entire harvests may be lost in
some geographic areas. Adverse weather conditions or natural disasters may adversely affect our supply of one or more food
products or prevent or impair our ability to ship products as planned. These factors can increase costs, decrease our sales
volumes and revenues and lead to additional charges to earnings, which may have a material adverse effect on our business,
financial condition and results of operations.
A significant portion of our fruit supply is sourced from California, which experienced severe drought conditions between fall
2011 and fall 2015 due to extremely low levels of rainfall. Such conditions resulted in lost crops as well as increased water
costs for growers in California. In particular, we depend on growers in California for strawberries. In January 2014, a drought
state of emergency was declared in California and, among other actions, legislation was passed requiring monitoring of
groundwater pumping, which limits the amount of groundwater for which farmers can drill. Strawberry growers are largely
dependent on well water, and diminishing groundwater resources could lead to a reduced strawberry supply. In April 2015,
statewide mandatory water conservation measures were imposed in California, including increased water use reporting by
agricultural water users, enhancing the state’s ability to enforce against diversions and unreasonable use of water in an effort
to curtail wasteful water practices in agricultural fields. Precipitation returned to more normal levels in 2016 and early 2017,
and the drought emergency was lifted in April 2017. However, drought conditions are a recurring feature of California’s
climate, and existing and future water conservation laws could negatively impact the agricultural industry in California and
have a material adverse effect on our business, financial condition and results of operations.
An interruption at one or more of our manufacturing facilities could negatively affect our business, and our business
continuity plan may prove inadequate
We own or lease, manage and operate a number of manufacturing, processing, packaging, storage and office facilities. We
may be unable to accept and fulfill customer orders as a result of disasters, epidemics, business interruptions or other similar
events. Some of our inventory and manufacturing facilities are located in areas that are susceptible to harsh weather, and the
production of certain of our products is concentrated in a few geographic areas. In addition, we store chemicals used in the
equipment for quick freezing of fruit or used for cooling processes during ingredient processing, and our storage of these
chemicals could lead to risk of leaks, explosions or other events. Although we have a business continuity plan, we cannot
provide assurance that our business continuity plan will address all of the issues we may encounter in the event of a disaster or
other unanticipated issue. Our business interruption insurance may not adequately compensate us for losses that may occur
from any of the foregoing. In the event that a natural disaster, or other catastrophic event were to destroy any part of any of
our facilities or interrupt our operations for any extended period of time, or if harsh weather or epidemics prevent us from
delivering products in a timely manner, our business, financial condition and results of operations could be materially and
adversely affected. In addition, if we fail to maintain our labor force at one or more of our facilities, we could experience delays
in production or delivery of our products, which could also have a material adverse effect on our business, financial condition
and results of operations.
Technology failures could disrupt our operations and negatively impact our business
In the normal course of business, we rely on information technology systems to process, transmit, and store electronic
information. For example, our production and distribution facilities and inventory management utilize information technology
to increase efficiencies and limit costs. Information technology systems are also integral to the reporting of our results of
operations. Furthermore, a significant portion of the communications between, and storage of personal data of, our personnel,
customers, consumers and suppliers depends on information technology. Our information technology systems may be
vulnerable to a variety of interruptions, as a result of updating our enterprise platform or due to events beyond our control,
including, but not limited to, natural disasters, terrorist attacks, telecommunications failures, computer viruses, hackers, and
other security issues. These events could compromise our confidential information, impede or interrupt our business
operations, and may result in other negative consequences, including remediation costs, loss of revenue, litigation and
reputational damage.
We maintain certain personal data, including personal data regarding our personnel, customers, consumers and suppliers. This
data is maintained on our own systems as well as that of third parties we use in our operations. If a breach or other breakdown
results in disclosure of confidential or personal information, we may suffer reputational, competitive and/or business harm.
While we have implemented administrative and technical controls and taken other preventive actions to reduce the risk of cyber
incidents and protect our information technology, they may be insufficient to prevent physical and electronic break-ins, cyber-
attacks or other security breaches to our computer systems. The costs relating to any data breach could be material, and we
currently do not carry insurance against the risk of a data breach. Any data breach or other access of our systems by unauthorized
persons could have a material adverse effect on our business, financial condition and results of operations.
Changes in laws and regulations of privacy and protection of user data could adversely affect our business
We are subject to data privacy and protection laws and regulations that apply to the collection, transmission, storage and use
of proprietary information and personally-identifying information. The regulatory environment surrounding information
security and data privacy varies from jurisdiction to jurisdiction and is constantly evolving and increasingly demanding. The
restrictions imposed by such laws continue to develop and may require us to incur substantial costs, adopt additional compliance
measures, such as notification requirements and corrective actions in the event of a security breach, and/or change our current
or planned business models. We are already subject to strict data privacy laws in the European Union and other jurisdictions
governing the collection, transmission, storage and use of employee data and personally-identifying information. The General
Data Protection Regulation (“GDPR”), coming into effect in Europe in May 2018, creates a range of new compliance
obligations and increases financial penalties for non-compliance and extends the scope of the European Union data protection
law to all companies processing data of European Union residents, regardless of the company’s location. The GDPR and other
privacy and data protection laws may be interpreted and applied differently from country to country and may create inconsistent
or conflicting requirements. Such regulations increase our compliance and administrative burden significantly. While we have
developed and are executing comprehensive plans to meet these requirements and do not currently foresee significant obstacles
that would prevent timely compliance, these plans are subject to many variables that could delay or otherwise affect
implementation.
If our current security measures and data protection policies and controls are found to be non-compliant with relevant laws or
regulations in any jurisdiction where we conduct business, we may be subject to penalties and fines, and may need to expend
significant resources to implement additional data protection measures. In addition, we may be required to modify the features
and functionality of our system offerings in a way that is less attractive to customers.
If we lose the services of our key management, our business could suffer
Our prospects depend to a significant extent on the continued service of our key executives, and our continued growth depends
on our ability to identify, recruit and retain key management personnel. We are also dependent on our ability to continue to
attract, retain and motivate our personnel. We do not typically carry key person life insurance on our executive officers. If we
lose the services of our key management or fail to identify, recruit and retain key personnel, our business, financial condition
and results of operations may be materially and adversely impacted.
If we face labor shortages or increased labor costs, our results of operations and our growth could be adversely affected
Labor is a significant component of the cost of operating our business. Our ability to meet our labor needs while controlling
labor costs is subject to external factors, such as employment levels, prevailing wage rates, minimum wage legislation, changing
demographics, health and other insurance costs and governmental labor and employment requirements. In the event of
increasing wage rates, if we fail to increase our wages competitively, the quality of our workforce could decline, while
increasing our wages could cause our earnings to decrease. If we face labor shortages or increased labor costs because of
increased competition for employees from our competitors and other industries, higher employee-turnover rates, unionization
of farm workers or increases in the federal- or state-mandated minimum wage, change in exempt and non-exempt status, or
other employee benefits costs (including costs associated with health insurance coverage or workers’ compensation insurance),
our operating expenses could increase and our business, financial condition and results of operations could be materially and
adversely affected.
Our competitors include major food ingredient and consumer-packaged food companies that also engage in the development
and sale of food and food ingredients. Many of these companies are engaged in the development of food ingredients and other
packaged food products and frequently introduce new products into the market. Existing products or products under
development by our competitors could prove to be more effective or less costly than our products, which could have a material
adverse effect on the competitiveness of our products and our business.
Our success depends in part on our ability to protect our intellectual property rights. We rely primarily on patent, copyright,
trademark and trade secret laws to protect our proprietary technologies. Our policy is to protect our technology by, among
other things, filing patent applications for technology relating to the development of our business in the U.S. and in selected
foreign jurisdictions.
Our trademarks and brand names are registered in the U.S., Canada and other jurisdictions. We intend to keep these filings
current and seek protection for new trademarks to the extent consistent with business needs. We also rely on trade secrets and
proprietary know-how and confidentiality agreements to protect certain of the technologies and processes that we use.
The failure of any patents, trademarks, trade secrets or other intellectual property rights to provide protection to our technologies
would make it easier for our competitors to offer similar products, which could result in lower sales or gross margins.
Changes in laws or regulations governing foreign trade or taxation could adversely affect our business
Changes in governmental laws or regulations affecting foreign trade or taxation, or the introduction of new laws or regulations,
may have a direct or indirect effect on our business or those of our customers or suppliers. Such changes could increase the
costs of doing business for the Company, our customers, or suppliers, or restrict our actions, causing our results of operations
to be adversely affected.
The current President of the United States has expressed an intention to change existing trade agreements, such as the North
American Free Trade Agreement (“NAFTA”). Any changes to NAFTA could impact our Mexican and Canadian operations.
Changes in U.S. political, regulatory and economic conditions or laws and policies governing foreign trade with countries
where we or our customers operate, in particular Canada, Mexico and Europe, could adversely affect our operating results and
our business.
Tax laws are dynamic and subject to change as new laws are passed and new interpretations of the law are issued or applied.
The U.S. recently enacted significant tax reform, and certain provisions of the new law may adversely affect us. In addition,
governmental tax authorities are increasingly scrutinizing the tax positions of companies. Many countries in the European
Union, as well as a number of other countries and organizations such as the Organization for Economic Cooperation and
Development, are actively considering changes to existing tax laws that, if enacted, could increase our tax obligations in
countries where we do business. If U.S. or other foreign tax authorities change applicable tax laws, our overall taxes could
increase, and our business, financial condition and results of operations may be adversely impacted.
We are affected by governmental agricultural policies such as price supports and acreage set aside programs and these types of
policies may affect our business. The production levels, markets and prices of the grains and other raw products that we use
in our business are materially affected by government programs, which include acreage control and price support programs of
the USDA. Revisions in these and other comparable programs, in the U.S. and elsewhere, could have a material and adverse
effect on our business, financial condition and results of our operations.
We are, and expect to continue to be, subject to substantial federal, state, provincial and local environmental regulation. Some
of the key environmental regulations to which we are subject include air quality regulations of the EPA and certain city, state
and provincial air pollution control groups, waste treatment/disposal regulations, sewer regulations under agreements with local
city sewer districts, regulations governing hazardous substances, storm water regulations and bioterrorism regulations. For a
more detailed summary of the environmental regulations and policies to which we are subject, see “Item 1. Business—
Regulation” of this report. Our business also requires that we have certain permits from various state, provincial and local
In the event that our safety procedures for handling and disposing of potentially hazardous materials in certain of our businesses
were to fail, we could be held liable for any damages that result, and any such liability could exceed our resources. We may
be required to incur significant costs to comply with environmental laws and regulations in the future. In addition, changes to
environmental regulations may require us to modify our existing plant and processing facilities and could significantly increase
the cost of those operations.
The foregoing environmental regulations, as well as others common to the industries in which we participate, can present delays
and costs that can adversely affect business development and growth. If we fail to comply with applicable laws and regulations,
we may be subject to civil remedies, including fines, injunctions, recalls or seizures, as well as potential criminal sanctions,
which could have a material adverse effect on our business, financial condition and results of operations. In addition, any
changes to current regulations may impact the development, manufacturing and marketing of our products, and may have a
negative impact on our future results.
Climate change laws could have an impact on our financial condition and results of operations
Legislative and regulatory authorities in the U.S., Canada and internationally will likely continue to consider numerous
measures related to climate change and greenhouse gas emissions. In order to produce, manufacture and distribute our products,
we and our suppliers use fuels, electricity and various other inputs that result in the release of greenhouse gas emissions.
Concerns about the environmental impacts of greenhouse gas emissions and global climate change may result in environmental
taxes, charges, regulatory schemes, assessments or penalties, which could restrict or negatively impact our operations, as well
as those of our suppliers, who would likely pass all or a portion of their costs along to us. We may not be able to pass any
resulting cost increases along to our customers. Any laws or regulations regarding greenhouse gas emissions or other climate
change laws enacted by the U.S., Canada or any other international jurisdiction where we conduct business could materially
and adversely affect our business, financial condition and results of operations.
Fluctuations in exchange rates, interest rates and commodity prices could adversely affect our business, financial condition,
results of operations or liquidity
We are exposed to foreign exchange rate fluctuations as our non-U.S.-based operations are translated into U.S. dollars for
financial reporting purposes and we also sell product in currencies that are different from the currency used to purchase
materials, or process finished goods. We are exposed to changes in interest rates as a significant portion of our debt bears
interest at variable rates. We are exposed to price fluctuations on a number of commodities as we hold inventory and enter into
transactions to buy and sell products in a number of markets. Additional qualitative and quantitative disclosures about these
risks can be found in “Item 7A. Quantitative and Qualitative Disclosures About Market Risk” of this report. As a result of
these exposures, fluctuations in exchange rates, interest rates and certain commodities could adversely affect our business,
financial condition, results of operations or liquidity.
We source our products from numerous suppliers and growers from around the world. Outside of the U.S. and Canada, we
have processing, packaging and warehousing facilities in Mexico, Europe, Africa and Asia. Our international operations and
customers expose us to certain risks inherent in doing business abroad, including:
x exposure to local economic conditions, expropriation and nationalization, foreign exchange rate fluctuations and
currency controls;
x compliance with anti-corruption and anti-bribery laws, including the U.S. Foreign Corrupt Practices Act;
For example, we have significant operations in Mexico, including a facility in the State of Michoacán, near areas where there
have been incidents of unrest, which may heighten the risks of our international operations described above.
As we continue to expand our business globally, we may have difficulty anticipating and effectively managing these and other
risks that our international operations may face, which may adversely impact our business, financial condition and results of
operations. In addition, any acquisition of businesses with operations outside of the U.S. and Canada may exacerbate this risk.
A significant portion of our assets and certain of our executive officers and directors are located outside of the U.S.; it may
be difficult to effect service of process and enforce legal judgments upon us and certain of our executive officers and
directors
A significant portion of our assets and certain of our executive officers and directors are located outside of the U.S. As a result,
it may be difficult to effect service of process within the U.S. and enforce judgment of a U.S. court obtained against us or our
executive officers and directors. Particularly, our stakeholders may not be able to:
x effect service of process within the U.S. on us or certain of our executive officers and directors;
x enforce judgments obtained in U.S. courts against us or certain of our executive officers and directors based upon
the civil liability provisions of the U.S. federal securities laws;
x enforce, in a court outside of the U.S., judgments of U.S. courts based on the civil liability provisions of the U.S.
federal securities laws; or
x bring an original action in a court outside of the U.S. to enforce liabilities against us or any of our executive officers
and directors based upon the U.S. federal securities laws.
Our level of indebtedness could adversely affect our financial condition and prevent us from fulfilling our debt obligations
Our level of indebtedness could adversely affect our business, financial condition and results of operations, including, without
limitation, impairing our ability to obtain additional financing for working capital, capital expenditures, debt service
requirements or other general corporate purposes. In addition, we will have to use a substantial portion of our cash flow to pay
principal, premium (if any) and interest on our indebtedness, which will reduce the funds available to us for other purposes. If
we do not generate sufficient cash flows to satisfy our debt service obligations, we may have to undertake alternative financing
plans, such as refinancing or restructuring our debt, selling assets, reducing or delaying capital investments or seeking to raise
additional capital. Our level of indebtedness will also make us more vulnerable to economic downturns and adverse industry
conditions, and may compromise our ability to capitalize on business opportunities and to react to competitive pressures as
compared to our competitors.
Our debt and equity agreements restrict how we may operate our business, and our business may be materially and adversely
affected if these restrictions prevent us from implementing our business plan
The agreements governing our debt and preferred equity instruments contain restrictive covenants that limit the discretion of
our management with respect to certain business matters. These covenants place restrictions on, among other things, our ability
to obtain additional debt financing, to create other liens, to complete a merger, amalgamation or consolidation, to make certain
distributions or make certain payments, investments and guarantees and to sell or otherwise dispose of certain assets. These
restrictions may hinder our ability to execute on our growth strategy or prevent us from implementing parts of our business
plan.
The Global Credit Facility matures on February 10, 2021. We may not be able to renew this facility to the same level or size,
or on terms as favorable as at present. A reduced facility may impact our ability to finance our business, requiring us to scale
back our operations and our use of working capital. Alternatively, obtaining credit on less favorable terms would have a direct
impact on our profitability and operating flexibility. Our senior secured second lien notes mature on October 9, 2022. Our
ability to refinance these notes upon maturity will depend on the capital markets and our financial condition at such time. As
a result, we may not be able to obtain refinancing at commercially reasonable terms, which could have a material and adverse
impact on our business, financial condition and results of operations. Alternatively, we may have to undertake alternative
financing plans, such as restructuring our debt, selling assets, reducing or delaying capital investments, or seeking to raise
additional capital.
Our business could be materially and adversely affected if we are unable to meet the financial covenants of the Global
Credit Facility
Our ability to comply with the financial covenants under the Global Credit Facility agreement will depend on the success of
our businesses, our operating results, and our ability to achieve our financial forecasts. Various risks uncertainties and events
beyond our control could affect our ability to comply with the financial covenants and terms of the Global Credit Facility
agreement. Failure to comply with our financial covenants and other terms could result in an event of default and the
acceleration of amounts owing under this agreement, unless we are able to negotiate a waiver. The lenders could condition any
such waiver on an amendment to the agreement on terms (including, but not limited to, the payment of consent fees) that may
be unfavorable to us. If we are unable to negotiate a covenant waiver or replace or refinance the Global Credit Facility
agreement on favorable terms, our business, financial condition and results of operations will be materially and adversely
impacted.
We may not be able to effectively manage our growth and integrate acquired companies
From time to time we may pursue acquisition opportunities that are consistent with our overall growth strategy. In October
2015, for example, we completed the acquisition of Sunrise Holdings (Delaware), Inc., which was the largest acquisition in the
history of our company. Our ability to effectively integrate past or future business acquisitions, including our ability to realize
potentially available marketing opportunities and cost savings in a timely and efficient manner will have a direct impact on our
future results. We may encounter problems in connection with the integration of any new businesses, such as challenges relating
to the following:
x the amount of cost savings that may be realized as a result of integrating an acquired product or business;
x integrating acquired operations that have management teams and company cultures that differ from our own;
x implementation of an integrated enterprise-wide accounting and information system and consolidation of back office
accounting;
x integration of businesses that operate in new geographic areas, including difficulties in identifying and gaining access
to customers in new markets; and
x in the case of foreign acquisitions, uncertainty regarding foreign laws and regulations and difficulty integrating
operations and systems as a result of cultural, systems and operational differences.
If we experience any of these problems in the integration of acquisitions, they could have a material and adverse effect on our
business, financial condition and results of operations.
We may not have accurately estimated the benefits or synergies to be realized from business acquisitions
Our expected benefits and synergies from acquired businesses may not be realized if our cash flow estimates associated with
the assets of those businesses are materially inaccurate or if we fail to identify operating problems or liabilities prior to
acquisition. We perform inspections of the assets to be acquired, which we believe to be generally consistent with industry
practices. However, the accuracy of our assessments of the assets and our estimates are inherently uncertain. There could also
be environmental or other problems that were not discovered in the course of our due diligence and inspections. If problems or
risks are identified after the closing of an acquisition, there may be limited recourse against the former owners.
When we acquire a business, we often assume or otherwise become subject to liabilities of acquired businesses, including
contingent liabilities that may depend on the outcome of legal and administrative proceedings or other events. As a result, we
may become subject to liabilities that are unknown to us or that cannot be quantified at the time of the acquisition. If we
become subject to significant liabilities or other obligations as a result of an acquisition, our business could be materially
affected. Moreover, to the extent we have contractual rights to indemnification against losses and liabilities of businesses we
acquire, the amount of indemnification available could be limited and may not be sufficient to cover the actual losses we suffer.
In response to an acquisition, the customers may cease or reduce their business with the combined company, which could
negatively affect our business. Similarly, current or prospective employees may experience uncertainty about their future roles
with the combined company. This may adversely affect our ability to attract and retain key management, marketing and
technical personnel. In addition, the diversion of the attention of our respective management teams away from day-to-day
operations during the pendency of the business acquisition could have an adverse effect on our financial condition and operating
results.
We may, from time to time, divest businesses that are no longer a strategic fit or no longer meet our growth or profitability
targets. Our profitability may be impacted by gains or losses on the sales of such businesses, or lost operating income or cash
flows from such businesses. Additionally, we may be required to record asset impairment or restructuring charges related to
divested businesses, or indemnify buyers for liabilities, which may reduce our profitability and cash flows. For example, in
2017 and 2016, we recognized asset impairment and facility closure costs of $33.3 million, as well as related employee
termination costs of $8.4 million, in connection with portfolio optimization measures taken under the Value Creation Plan,
including the exits from flexible resealable pouch and nutrition bar product lines and operations. We may also not be able to
negotiate such divestitures on terms acceptable to us. Such potential divestitures will require management resources and may
divert management’s attention from our day-to-day operations. If we are not successful in divesting such businesses, our
business could be harmed.
Our operating results and share price are subject to significant volatility
Our net sales and operating results may vary significantly from period to period due to:
x management’s ability to execute our business strategies focused on improved operating earnings;
x legal and administrative cases (whether civil, such as environmental or product related, or criminal), settlements,
judgments and investigations;
In addition, our share price may be highly volatile compared to larger public companies. Certain announcements could have a
significant effect on our share price, including announcements regarding:
Higher volatility increases the chance of larger than normal price swings which reduces predictability in the price of our
common shares and could impair investment decisions. In addition, price and volume trading volatility in the stock markets
can have a substantial effect on our share price, frequently for reasons other than our operating performance. These broad
market fluctuations could adversely affect the market price of our common shares.
Periods of volatility in the overall market and the market price of a company’s securities, is often followed by securities class
action litigation alleging material misstatements or omissions in disclosures provided to shareholders. Such litigation, if
instituted against us, could result in substantial costs and a diversion of our management’s attention and resources.
Our debt instruments restrict, and our future debt instruments may restrict, our ability to pay dividends to our shareholders,
and we do not currently intend to pay any cash dividends on our common shares in the foreseeable future; therefore, our
shareholders may not be able to receive a return on their common shares until their shares are sold
We have never paid or declared any cash dividends on our common shares. We do not anticipate paying any cash dividends
on our common shares in the foreseeable future because, among other reasons, we currently intend to retain any future earnings
to finance the growth of our business. In addition, the covenants included in our debt instruments, and the covenants to be
The future issuance of additional common shares in connection with the exchange of convertible preferred stock, exercise
of stock options, participation in our employee stock purchase plan and issuance of additional securities could dilute the
value of our common shares
We have unlimited common shares authorized but unissued. Our articles of amalgamation authorize us to issue these common
shares, and we may also issue options, rights, warrants and appreciation rights relating to common shares for consideration and
on terms and conditions established by the Board in its sole discretion.
The exchange of outstanding convertible preferred stock, exercise of stock-based awards, participation in our employee stock
purchase plan, and issuance of additional securities in connection with acquisitions or otherwise could result in dilution in the
value of our common shares and the voting power represented thereby. Furthermore, to the extent common shares are issued
pursuant to the exchange of outstanding convertible preferred stock, exercise of stock-based awards, participation in our
employee stock purchase plan and issuance of additional securities, our share price may decrease due to the additional amount
of common shares available in the market. The subsequent sales of these shares could encourage short sales by our shareholders
and others, which could place further downward pressure on our share price. Moreover, the holders of our stock options may
hedge their positions in our common shares by short selling our common shares, which could further adversely affect our stock
price.
If securities or industry research analysts do not publish or cease publishing research or reports about our business or if
they issue unfavorable commentary or downgrade our common shares, our share price and trading volume could decline
The trading market for our common shares relies in part on the research and reports that securities and industry research analysts
publish about us, our industry, our competitors and our business. We do not have any control over these analysts. Our share
price and trading volumes could decline if one or more securities or industry analysts downgrade our common shares, issue
unfavorable commentary about us, our industry or our business, cease to cover our Company or fail to regularly publish reports
about us, our industry or our business.
None.
The following table lists the location, description, ownership and segment of our principal properties:
Executive Offices
Our executive head office is located at 2233 Argentia Drive, Suite 401, Mississauga, Ontario.
Employment Matter
On April 19, 2013, a class-action complaint, in the case titled De Jesus, et al. v. Frozsun, Inc. d/b/a Frozsun Foods, was filed
against Sunrise Growers, Inc. (then named Frozsun, Inc.) in California Superior Court, Santa Barbara County seeking damages,
equitable relief and reasonable attorneys’ fees for alleged wage and hour violations. This case includes claims for failure to
pay all hours worked, failure to pay overtime wages, meal and rest period violations, waiting-time penalties, improper wage
statements and unfair business practices. The putative class includes approximately 10,000 non-exempt hourly employees from
Sunrise’s production facilities in Santa Maria and Oxnard, California. The parties attended mediation on October 12, 2017 and
reached a general agreement to resolve the matter on a class-wide basis. The parties are negotiating the remaining details of
the settlement which is subject to court approval. It is anticipated that the parties will seek preliminary approval of the
settlement from the court in March 2018. The Company expects to recover the full amount payable under the settlement
through insurance coverage and an escrow account established in connection with the Company’s acquisition of Sunrise
Holdings (Delaware), Inc. in October 2015.
Product Recall
On November 20, 2017, Treehouse Foods, Inc., several of its related entities, and its insurer filed a lawsuit against the Company
in the Circuit Court of Cook County, Illinois titled Treehouse Foods, Inc. et al. v. SunOpta Grains and Food, Inc. The
Company was served with the Summons and Complaint on January 24, 2018. The plaintiffs allege economic damages resulting
from the Company’s 2016 voluntary recall of certain roasted sunflower kernel products due to the potential for Listeria
monocytogenes contamination. The case includes claims for breach of express and implied warranty, negligence, strict liability,
and indemnity seeking $16.2 million in damages. There are no allegations of personal injury. The Company intends to
vigorously defend itself against these claims. The Company cannot reasonably predict the outcome of this claim, nor can it
estimate the amount of loss, or range of loss, if any, that may result from this claim.
In addition to the above mentioned matters, from time to time, we are involved in litigation incident to the ordinary conduct of
our business. For a discussion of certain legal proceedings, see note 23 of the consolidated financial statements included at Item
15 of this Form 10-K.
Not Applicable.
Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases Equity
Securities
Our common shares trade in U.S. dollars on The NASDAQ Global Select Market under the symbol “STKL”, and in Canadian
dollars on the TSX under the symbol “SOY”.
The following table indicates the high and low sales prices for our common shares for each quarterly period during the past
two fiscal years on the NASDAQ and TSX. The prices shown are representative inter-dealer prices, do not include retail mark-
ups, markdowns or commissions and do not necessarily reflect actual transactions.
NASDAQ TSX
High Low High Low
$ $ C$ C$
Fiscal 2017
First quarter 7.60 6.00 10.08 8.05
Second quarter 10.20 6.30 13.53 8.53
Third quarter 10.20 8.00 13.23 9.94
Fourth quarter 9.65 6.95 12.37 8.88
Fiscal 2016
First quarter 6.77 4.12 9.88 5.38
Second quarter 5.69 3.16 7.18 4.14
Third quarter 7.17 4.22 9.39 5.47
Fourth quarter 7.70 5.73 10.09 7.58
As at December 30, 2017, we had approximately 420 shareholders of record. We have never paid cash dividends on our
common stock and do not anticipate paying dividends in the foreseeable future. Our future dividend policy will depend on our
earnings, capital requirements and financial condition, requirements of the financial agreements to which we are then a party
and other factors considered relevant by our board of directors. Additionally, the terms of our existing debt instruments include
covenants that restrict our ability to pay dividends to shareholders. The receipt of cash dividends by U.S. shareholders from a
Canadian corporation, such as we are, may be subject to Canadian withholding tax.
The following table provides information as at December 30, 2017 with respect to our common shares that may be issued under
the Company’s stock incentive and employee share purchase plans:
Number of Securities
Number of Remaining Available
Securities to be for Future Issuance
Issued Upon Weighted-Average Under Equity
Exercise of Exercise Price of Compensation Plans
Outstanding Outstanding (Excluding Securities
Options, Warrants, Options, Warrants Reflected in Column
Plan Category and Rights and Rights (a))
(a) (b) (c)
Equity compensation plans approved by
securities holders:
2013 Stock Incentive Plan(1) 5,601,836 $7.51(3) 3,674,298
Employee Share Purchase Plan - - 1,112,073
Equity compensation plans not approved by
securities holders:
CEO Plan(2) 851,720 $7.00(3) -
Total 6,453,556 $7.44 4,786,371
(1) Represents common shares of the Company issuable in respect of 3,306,728 stock options, 775,356 restricted stock units (“RSUs”) and 1,519,752
performance share units (“PSUs”) granted to selected employees and directors of the Company.
(2) Represents common shares of the Company issuable in respect of 473,940 performance-based stock options, 100,000 RSUs and 277,780 PSUs granted
to the Chief Executive Officer of the Company.
(3) Vested RSUs and PSUs entitle the holder to receive one common share per unit without payment of additional consideration. Accordingly, these units
are disregarded for purposes of computing the weighted-average exercise price.
This performance graph shall not be deemed “filed” for purposes of Section 18 of the Exchange Act or incorporated by
reference into any filing of SunOpta under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be
expressly set forth by specific reference in such filing.
The following graph compares the five-year cumulative shareholder return on our common shares to the cumulative total return
of the S&P/TSX Composite and the NASDAQ Industrial Indices for the period which commenced December 29, 2012.
250.00
200.00
150.00
SunOpta Inc.
NASDAQ Industrial
100.00 S&P/TSX Composite
50.00
-
2012 2013 2014 2015 2016 2017
Assumes that $100.00 was invested in our common shares and in each index on December 29, 2012.
The following information has been derived from financial statements prepared in accordance with accounting principles
generally accepted in the United States of America (“U.S. GAAP”). The information set forth below is not necessarily indicative
of results of future operations, and should be read in conjunction with the consolidated financial statements and related notes
thereto prepared in accordance with U.S. GAAP contained in Item 8 of this report, as well as the discussion in Item 7,
“Management’s Discussion and Analysis of Financial Condition and Results of Operations”.
(1) Includes the results of operations of Sunrise Holdings (Delaware), Inc. (acquired October 9, 2015), Niagara Natural Fruit Snack Company Inc. (assets
acquired August 11, 2015) and Citrusource, LLC (acquired March 2, 2015) from the respective dates of acquisition.
(2) Includes the results of operations of Organic Land Corporation OOD (acquired December 31, 2012) from the date of acquisition.
(3) Includes a goodwill impairment charge of $115.0 million related to the Healthy Fruit reporting unit of the Consumer Products operating segment, as well
as a charge of $18.2 million for the impairment of long-lived assets associated with the exit from flexible resealable pouch and nutrition bar product lines
and operations, and consolidation of roasted snack operations, as well as the closure of a juice processing facility located in San Bernardino, California.
(4) Includes a goodwill impairment charge of $17.5 million related to the Sunflower reporting unit of the Raw Material Sourcing and Supply operating
segment, as well as a charge of $13.3 million for the impairment of long-lived assets associated with the closure of the San Bernardino juice facility and
a soy extraction facility located in Heuvelton, New York.
(5) Includes a charge for the impairment of investment of $8.4 million, as well as a gain on disposal on assets of $1.3 million.
This Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) section provides
analysis of our operations and financial position for the fiscal year ended December 30, 2017 and includes information available
to February 28, 2018, unless otherwise indicated herein. It is supplementary information and should be read in conjunction
with the consolidated financial statements included elsewhere in this report.
Certain statements contained in this MD&A may constitute forward-looking statements as defined under securities laws.
Forward-looking statements may relate to our future outlook and anticipated events or results and may include statements
regarding our future financial position, business strategy, budgets, litigation, projected costs, capital expenditures, financial
results, taxes, plans and objectives. In some cases, forward-looking statements can be identified by terms such as “anticipate”,
“estimate”, “target”, “intend”, “project”, “potential”, “continue”, “believe”, “expect”, “could”, “would”, “should”, “might”,
“plan”, “will”, “may”, “predict”, or other similar expressions concerning matters that are not historical facts. To the extent any
forward-looking statements contain future-oriented financial information or financial outlooks, such information is being
provided to enable a reader to assess our financial condition, material changes in our financial condition, our results of
operations, and our liquidity and capital resources. Readers are cautioned that this information may not be appropriate for any
other purpose, including investment decisions.
Forward-looking statements contained in this MD&A are based on certain factors and assumptions regarding expected growth,
results of operations, performance, and business prospects and opportunities. While we consider these assumptions to be
reasonable, based on information currently available, they may prove to be incorrect. Forward-looking statements are also
subject to certain factors, including risks and uncertainties that could cause actual results to differ materially from what we
currently expect. These factors are more fully described in the “Risk Factors” section at Item 1A of this Form 10-K.
Forward-looking statements contained in this commentary are based on our current estimates, expectations and projections,
which we believe are reasonable as of the current date. You should not place undue importance on forward-looking statements
and should not rely upon this information as of any other date. Other than as required under securities laws, we do not undertake
to update any forward-looking information at any particular time.
Unless otherwise noted herein, all currency amounts in this MD&A are expressed in U.S. dollars. All tabular dollar amounts
are expressed in thousands of U.S. dollars, except per share amounts.
Overview
x Global Ingredients aggregates our North American-based Raw Material Sourcing and Supply and European-based
International Sourcing and Supply operating segments focused on the procurement and sale of specialty and organic
grains and seeds, raw material ingredients, value-added grain- and cocoa-based ingredients, and organic commodities.
x Consumer Products consists of three main commercial platforms: Healthy Beverages, Healthy Fruit and Healthy
Snacks. Healthy Beverages includes aseptic packaged products including non-dairy beverages, broths and teas;
refrigerated premium juices; and shelf-stable juices and functional waters. Healthy Fruit includes individually quick
frozen (“IQF”) fruits for retail; IQF and bulk frozen fruit for foodservice; and custom fruit preparations for industrial
use. Healthy Snacks is focused on fruit snack offerings, and formerly included our flexible resealable pouch and
nutrition bar product lines, which we exited in 2017.
For a more detailed description of our operating groups and their businesses, please see the “Business” section at Item 1 of this
Form 10-K.
Fiscal Year
We operate on a fiscal calendar that results in a given fiscal year consisting of a 52- or 53-week period ending on the Saturday
closest to December 31. Fiscal years 2017, 2016 and 2015 were each 52-week periods ending on December 30, 2017, December
31, 2016, and January 2, 2016, respectively.
On October 7, 2016, we entered into a strategic partnership with Oaktree Capital Management L.P., a private equity investor
(together with its affiliates, “Oaktree”). On October 7, 2016, Oaktree invested $85.0 million through the purchase of
cumulative, non-participating Series A Preferred Stock (the “Preferred Stock”) of our wholly-owned subsidiary, SunOpta Foods
Inc. (“SunOpta Foods”).
Following the strategic partnership, with the assistance of Oaktree, we conducted a thorough review of our operations,
management and governance, with the objective of maximizing our ability to deliver long-term value to our shareholders. As
a product of this review our management and the Board of Directors developed a Value Creation Plan built on four pillars:
portfolio optimization, operational excellence, go-to-market effectiveness and process sustainability. The Value Creation Plan
is a broad-based initiative focused on increasing shareholder value through strategic investments made to the people and assets
of the Company to deliver sustained profitable growth. We expect the Value Creation Plan to be implemented in phases, and
span several years.
During 2017 and 2016, costs incurred in connection with measures taken under the Value Creation Plan included inventory
and long-lived asset impairment charges and facility closure costs primarily related to the closures of our San Bernardino,
California, juice and Heuvelton, New York, soy extraction facilities; the exits from flexible resealable pouch and nutrition bar
product lines and operations; and consolidations of our grain handling and roasted snack operations. In addition, we incurred
employee recruitment, relocation, retention and severance costs related to exit activities and organizational changes within
management and executive teams, and recruiting efforts in the areas of quality, sales, marketing, operations and engineering.
We also incurred third-party legal advisory, consulting and temporary labor costs in support of the Value Creation Plan.
The following table summarizes costs incurred since the inception of the Value Creation Plan to December 30, 2017:
Employee
Asset recruitment, Consulting
impairments retention and fees and
and facility termination temporary
closure costs costs labor costs Total
$ $ $ $
Fiscal 2016
Costs incurred and charged to expense 11,522 2,763 4,041 18,326
Cash payments - (694) (2,384) (3,078)
Non-cash adjustments (11,522) (266) - (11,788)
Balance payable, December 31, 2016 - 1,803 1,657 3,460
Fiscal 2017
Costs incurred and charged to expense 21,766 11,618 16,528 49,912
Cash payments, net of proceeds on disposal of assets (10,746) (9,683) (18,185) (38,614)
Non-cash adjustments (11,720) 689 - (11,031)
Balance payable (receivable), December 30, 2017 (1) (700) 4,427 - 3,727
(1) Balance receivable under asset impairments and facility closure costs represents remaining proceeds on the sale of nutrition bar equipment received
at closing on January 3, 2018. Total proceeds were $0.9 million.
In addition to the costs reflected in the preceding table, we made capital investments at several of our manufacturing facilities
to enhance food safety and production efficiency.
(1) Inventory write-downs and facility closure costs recorded in cost of goods sold were allocated to the Consumer Products operating segment.
(2) Consulting fees and temporary labor costs, and employee recruitment, relocation and retention costs recorded in selling, general and administrative
expenses were allocated to Corporate Services.
(3) For the year ended December 30, 2017, asset impairment and employee termination costs recorded in other expense were allocated as follows: Raw
Material Sourcing and Supply operating segment - $2.1 million; Consumer Products operating segment - $20.6 million; and Corporate Services -
$1.1 million. For the year ended December 31, 2016, asset impairment and employee termination costs recorded in other expense were allocated as
follows: Raw Material Sourcing and Supply operating segment - $1.6 million; Consumer Products operating segment - $10.6 million; and Corporate
Services - $2.1 million.
We do not expect to incur and expense significant additional direct costs related to the Value Creation Plan beyond 2017;
however, we will continue to incur annual lease costs of approximately $0.5 million related to our nutrition bar processing
facility, until such time that we can locate an interested party to assume the lease. This lease extends until December 2020.
Our expectation for additional costs related to the Value Creation Plan does not include currently unforeseen asset impairment
charges or employee-related costs that may arise from future actions taken under the plan.
For more information regarding the Value Creation Plan, see note 4 to the consolidated financial statements at Item 15 of this
Form 10-K.
During the second quarter of 2016, we announced a voluntary recall of certain roasted sunflower kernel products due to
potential contamination with Listeria monocytogenes bacteria. Estimated losses related to the recall totaled $47.5 million as at
December 30, 2017, compared with $40.0 million as at December 31, 2016, comprised of estimates for customer losses and
direct incremental costs that we incurred. Our estimates for customer losses are provisional and were determined based on an
assessment of the information available up to the date of filing of this Form 10-K, including a review of customer claims
received as of that date and consideration of the extent of potential additional claims that have yet to be received. We have
general liability and product recall insurance policies with aggregate limits of $47.0 million under which we expect to recover
recall-related costs. As at December 30, 2017, we had recognized recoveries up to the limit of the coverage available under
our insurance policies. Consequently, to the extent any losses or out-of-pocket costs are excluded under the insurance policies
or additional losses are recognized related to existing or new claims, these excluded or excess losses or costs will be recognized
as a charge to future earnings. As at December 30, 2017, we had settled customer claims and direct costs in the amount of
$40.5 million, which settlements were fully funded under our general liability and product recall insurance policies.
For more information regarding the recall, see note 6 to the consolidated financial statements at Item 15 of this Form 10-K.
Business Development
x On April 6, 2016, we completed the sale of our 66% holding of common shares of Opta Minerals Inc. (“Opta
Minerals”). The sale of Opta Minerals was consistent with our objective of divesting our non-core assets in order to
become a pure-play organic and healthy foods company. We have no continuing involvement with Opta Minerals.
For more information regarding the sale of Opta Minerals, see note 5 to the consolidated financial statements at Item 15 of this
Form 10-K.
x On October 9, 2015, we acquired 100% of the issued and outstanding common shares of Sunrise Holding (Delaware),
Inc. (“Sunrise”), for total consideration of $472.7 million in cash (the “Sunrise Acquisition”). Sunrise is a processor
x On August 11, 2015, we acquired the net operating assets of Niagara Natural Fruit Snack Company Inc. (“Niagara
Natural”), for a cash purchase price of $6.5 million, plus contingent consideration of $2.3 million. Niagara Natural is
a manufacturer of all-natural fruit snacks, and is located in the Niagara Region of Ontario.
Sunrise, Niagara Natural and Citrusource have been included in the Consumer Products operating segment since their
respective dates of acquisition. For more information regarding these acquisitions, see note 2 to the consolidated financial
statements at Item 15 of this Form 10-K.
The preparation of financial statements in conformity with U.S. GAAP requires management to make certain estimates and
assumptions that affect the reported amounts of assets and liabilities, related revenues and expenses, and disclosure of gain and
loss contingencies at the date of the financial statements. The estimates and assumptions made require us to exercise our
judgment and are based on historical experience and various other factors that we believe to be reasonable under the
circumstances. We continually evaluate the information that forms the basis of our estimates and assumptions as our business
and the business environment generally changes. The use of estimates is pervasive throughout our financial statements. The
following are the accounting estimates which we believe to be most significant to our business.
Revenue Recognition
We recognize revenue at the time of delivery of the product and when all of the following have occurred: a sales agreement is
in place; the price is fixed or determinable; and collection is reasonably assured. Consideration given to customers such as
value incentives, rebates, early payment discounts and other discounts are recorded as reductions to revenues at the time of
sale.
Accounts Receivable
Our accounts receivable primarily includes amounts due from our customers. The carrying value of each account is carefully
monitored with a view to assessing the likelihood of collection. An allowance for doubtful accounts is provided for as an
estimate of losses that could result from customers defaulting on their obligation to us. In assessing the amount of reserve
required, a number of factors are considered including the age of the account, the credit-worthiness of the customer, payment
terms, the customer’s historical payment history and general economic conditions. Because the amount of the reserve is an
estimate, the actual amount collected could differ from the carrying value of the amount receivable. Note 8 of the consolidated
financial statements at Item 15 of this Form 10-K provides an analysis of the changes in the allowance for doubtful accounts.
Inventory
Inventory is our largest current asset and consists primarily of raw materials and finished goods held for sale. Inventories are
valued at the lower of cost and estimated net realizable value except for certain grain inventories that are carried at market
value. In order to determine the value of inventory at the balance sheet date, we evaluate a number of factors to determine the
adequacy of provisions for inventory. These factors include the age of inventory, the amount of inventory held by type, future
demand for products, and the expected future selling price we expect to realize by selling the inventory. Our estimates are
judgmental in nature and are made at a point in time, using available information, expected business plans, and expected market
conditions. As a result, the actual amount received on sale could differ from our estimated value of inventory. We perform a
review of our inventory by operation and product line on a quarterly basis. Note 9 of the consolidated financial statements at
Item 15 of this Form 10-K provides an analysis of the movements in the inventory reserve.
Intangible Assets
We evaluate amortizable intangible assets acquired through business combinations for impairment if events or changes in
circumstances indicate that the carrying amounts of these assets may not be recoverable. Our evaluation is based on an
assessment of potential indicators of impairment, such as an adverse change in the business climate that could affect the value
Impairment exists when the carrying amount of an amortizable intangible asset is not recoverable through undiscounted future
cash flows and its carrying value exceeds its estimated fair value. A discounted cash flow analysis is typically used to determine
fair value using estimates and assumptions that market participants would apply. Some of the estimates and assumptions
inherent in a discounted cash flow model include the amount and timing of the projected future cash flows, and the discount
rate used to reflect the risks inherent in the future cash flows. A change in any of these estimates and assumptions could produce
a different fair value, which could have a material impact on our results of operations. In addition, an intangible asset's expected
useful life can increase estimation risk, as longer-lived assets necessarily require longer-term cash flow forecasts, which for
some of our long-lived assets can be in excess of 20 years. In connection with an impairment evaluation, we also reassess the
remaining useful life of the intangible asset and modify it, as appropriate.
Goodwill
Goodwill represents the excess in a business combination of the purchase price over the estimated fair value of the identifiable
net assets acquired. Goodwill is not amortized but is instead tested for impairment at least annually, or whenever events or
circumstances change between the annual impairment tests that would indicate the carrying amount of goodwill may be
impaired. We perform the annual test for goodwill impairment in the fourth quarter of each fiscal year. Prior to fiscal 2017,
we performed a quantitative test for goodwill impairment by comparing the carrying amount of each reporting unit to its
estimated fair value (Step 1). If the carrying amount exceeded the reporting unit’s fair value, there was a potential impairment
of goodwill. Any impairment of goodwill was measured by comparing the implied fair value of goodwill with its carrying
amount (Step 2). The implied fair value of goodwill was determined by deducting the fair value of all the assets and liabilities
of the reporting unit from the reporting unit’s fair value as determined in Step 1.
Effective with the fiscal 2017 annual impairment test, we elected the early adoption of Accounting Standards Update 2017-04,
“Simplifying the Test for Goodwill Impairment”, which simplifies the accounting for goodwill impairment by eliminating the
requirement to calculate the implied fair value of goodwill as contemplated by Step 2 of the prior goodwill impairment model.
Instead, impairment charges are recognized based on the excess of a reporting unit’s carrying amount over its fair value as
contemplated by Step 1 of the prior goodwill impairment test model.
Goodwill is tested for impairment at the reporting unit level, which is defined as an operating segment or one level below. Our
Raw Material Sourcing and Supply operating segment comprises two reporting units, namely Grains and Sunflower. Our
International Sourcing and Supply operating segment consists of one reporting unit. Our Consumer Products operating segment
comprises three reporting units based on commercial platforms, namely Healthy Beverages, Healthy Fruit and Healthy Snacks.
The fair values of our reporting units are determined using an income approach (discounted cash flow method). We believe an
income approach provides the most reliable indication of fair value as it reflects forecasted revenues and earnings based on
business and market conditions that are unique to each individual reporting unit, which a market approach may not fully
incorporate. Because the business is assumed to continue in perpetuity, the discounted cash flows include a terminal value.
Cash flows to perpetuity are forecasted based on projected revenue growth and our planned business strategies in future periods.
Examples of planned strategies would include a plant or line expansion at an existing facility; a reduction of working capital at
a specific location; and price increases or cost reductions within a reporting unit. The discount rate is based on a reporting
unit’s targeted weighted-average cost of capital, which is not necessarily the same as our weighted-average cost of capital.
These assumptions are subject to change and are impacted by our ability to achieve our forecasts and by economic conditions
that may impact future results and result in projections not being attained. Each year we re-evaluate the assumptions used to
reflect changes in the business environment.
Based on the results of the annual impairment test performed for the years ended December 30, 2017 and December 31, 2016,
we recognized goodwill impairment charges of $115.0 million and $17.5 million, respectively, related to our Healthy Fruit
reporting unit in 2017 and our Sunflower reporting unit in 2016. None of the goodwill balances of our other reporting units
were considered to be at risk of impairment, as the fair value of those reporting units substantially exceeded their carrying
values – that is, a hypothetical 10% decrease in the fair value of any of our other reporting units would not have triggered a
goodwill impairment. The results of our annual impairment tests for goodwill are described in note 11 of the consolidated
financial statements at Item 15 of this Form 10-K.
Business acquisitions are accounted for by the acquisition method of accounting. Under this method, the purchase price is
allocated to the assets acquired and the liabilities assumed based on the fair value at the time of the acquisition. Any excess
purchase price over the fair value of identifiable assets acquired and liabilities assumed is recorded as goodwill. We believe
the fair values assigned to the assets acquired and liabilities assumed are based on reasonable assumptions; however, these
assumptions may be incomplete or inaccurate, and unanticipated events and circumstances may occur.
The assumptions and estimates with respect to determining the fair value of customer relationship intangible assets acquired
are among the most significant in our acquisition accounting and generally require the most judgment. Key variables in
determining the fair value of customer relationships are the estimated customer attrition rate and the percentage of revenue
growth attributable to existing customers. Changes to either or both of these variables could have a significant impact on the
customer relationships intangible assets’ values, and changes to the estimated customer attrition rate could have a significant
impact on the estimated useful lives of these assets. The expected customer attrition rate assumed in the estimate of fair value
for the customer relationships intangible assets is generally supported by an analysis of historical attrition of the acquired
business’s customers and consideration of its amortization policy of previously acquired customer relationships, amortization
policies adopted for acquired customer relationships by other companies in similar transactions, and the contractual terms
between the acquired business and its customers. The percentage of revenue growth attributable to existing customers assumed
in the estimate of fair value for the customer relationships intangible assets is typically supported by an analysis of the acquired
business’s historical and forecasted revenue growth rates by customer. Changes in any of the assumptions or estimates used
in determining the fair value of the customer relationship intangible assets could have a significant impact on the amounts
assigned to goodwill in the purchase price allocation. Future net earnings can be affected by changes in these estimates resulting
in an increase or decrease in amortization expense, or impairment of the intangible assets and/or goodwill. Note 2 of the
consolidated financial statements at Item 15 of this Form 10-K provide information with respect to businesses acquired, and
note 11 outlines annual amortization expense relating to these intangibles.
Some acquisitions involve contingent consideration to be potentially paid based on the achievement of specified future financial
targets by the acquired business. Acquisition-related contingent consideration is initially recognized as a liability at estimated
fair value and re-measured each reporting period with changes in the estimated fair value recognized in earnings. These
estimates of fair value involve uncertainties as they include assumptions about the likelihood of achieving the specified financial
targets, projections of future financial performance, and assumed discount rates. A change in any of these assumptions could
produce a different fair value, which could impact the amounts assigned to assets and liabilities in the purchase price allocation,
or the amounts recognized in earnings to reflect subsequent changes in the carrying value of the liability. Note 7 of the
consolidated financial statements at Item 15 of this Form 10-K includes disclosures regarding the estimated fair value of
contingent consideration.
Contingencies
We make estimates for payments that are contingent on the outcome of uncertain future events. These contingencies include
accrued but unpaid bonuses; tax-related matters; and claims or litigation. In establishing our estimates, we consider historical
experience with similar contingencies and the progress of each contingency, as well as the recommendations of internal and
external advisors and legal counsel. We re-evaluate all contingencies as additional information becomes available; however,
given the inherent uncertainties, the ultimate amount paid could differ from our estimates.
In particular, as discussed above under “Recall of Certain Roasted Sunflower Kernel Products”, we had recognized estimated
losses of $47.5 million related to this recall as at December 30, 2017. These estimates are provisional and were determined
based on an assessment of the information available up to the date of filing of this report, including a review of customer claims
received as of that date and consideration of the extent of potential additional claims that have yet to be received. We may
need to revise these estimates to be materially larger as we continue to work with our customers to substantiate the claims
received to date and any additional claims that may be received.
Income Taxes
We are liable for income taxes in the U.S., Canada, and other jurisdictions where we operate. Our effective tax rate differs
from the statutory tax rate and will vary from year to year primarily as a result of numerous permanent differences, investment
and other tax credits, the provision for income taxes at different rates in foreign and other provincial jurisdictions, enacted
statutory tax rate increases or reductions in the year, the benefit of cross-jurisdictional financing structures, changes due to
foreign exchange, changes in valuation allowance based on our recoverability assessments of deferred tax assets, and favorable
or unfavorable resolution of various tax examinations.
While we believe we have adequately provided for all tax positions, amounts asserted by taxing authorities could differ from
our accrued position. Accordingly, additional provisions on federal, provincial, state and foreign tax-related matters could be
recorded in the future as revised estimates are made or the underlying matters are settled or otherwise resolved.
Gross Profit
Global Ingredients 67,682 64,374 3,308 5.1%
Consumer Products 77,405 61,578 15,827 25.7%
Total gross profit 145,087 125,952 19,135 15.2%
(1) When assessing the financial performance of our operating segments, we use an internal measure of operating income that excludes other income/expense
items and goodwill impairments determined in accordance with U.S. GAAP. This measure is the basis on which management, including the Chief
Executive Officer (“CEO”), assesses the underlying performance of our operating segments.
We believe that investors’ understanding of our financial performance is enhanced by disclosing the specific items that we exclude from segment
operating income. However, any measure of operating income excluding any or all of these items is not, and should not be viewed as, a substitute for
operating income prepared under U.S. GAAP. These items are presented solely to allow investors to more fully understand how we assess financial
performance.
(2) When assessing our financial performance, we use an internal measure of earnings from continuing operations, net of non-controlling interests,
determined in accordance with U.S. GAAP that includes dividends and accretion on convertible preferred stock and excludes specific items recognized
in other income/expense, impairment losses on goodwill, long-lived assets and investments, other unusual items that are identified and evaluated on an
individual basis, which due to their nature or size, we would not expect to occur as part of our normal business on a regular basis. We believe that the
identification of these excluded items enhances an analysis of our financial performance of our business when comparing those operating results between
periods, as we do not consider these items to be reflective of normal business operations.
The following table presents a reconciliation of adjusted earnings/loss from loss from continuing operations, which we consider to be the most directly
comparable U.S. GAAP financial measure. In addition, in recognition of our exit from flexible resealable pouch and nutrition bar product lines and
operations (as described above under “Value Creation Plan”), we have prepared this table in a columnar format to present the effect of these operations
on our consolidated results for the current and comparative period. We believe this presentation assists investors in assessing the results of the operations
we have exited and the effect of those operations on our financial performance.
Adjusted for:
Goodwill impairment(a) 115,000 - 115,000
Costs related to the Value Creation Plan(b) 32,160 17,752 49,912
Product withdrawal and recall costs(c) 1,142 - 1,142
Recovery of legal settlement(d) (1,024) - (1,024)
Reversal of stock-based compensation(e) (546) - (546)
Other(f) 442 - 442
Net income tax effect(g) (18,332) (6,923) (25,255)
Change in unrecognized tax benefits(h) (452) - (452)
Impact of change in enacted U.S. corporate tax rates(i) (8,437) - (8,437)
Adjusted loss (8,315) (0.10) (4,032) (0.05) (12,347) (0.14)
Adjusted for:
Costs related to business acquisitions(j) 27,802 - 27,802
Costs related to the Value Creation Plan(k) 18,326 - 18,326
Goodwill impairment(l) 17,540 - 17,540
Legal settlement and litigation-related legal fees(m) 10,850 - 10,850
Product withdrawal and recall costs(n) 5,693 - 5,693
Inventory reserves and liquidation sales to de-risk positions(o) 3,428 - 3,428
Plant start-up costs(p) 1,565 - 1,565
Write-off of debt issuance costs(q) 215 - 215
Other(r) 1,642 - 1,642
Gain on settlement of contingent consideration(s) (1,715) - (1,715)
Net income tax effect(g) (25,825) - (25,825)
Change in unrecognized tax benefits(h) (1,268) - (1,268)
Adjusted earnings (loss) 7,099 0.08 (1,276) (0.01) 5,823 0.07
(a) Reflects the impairment of goodwill associated with the Healthy Fruit reporting unit of the Consumer Products operating segment.
(b) Reflects inventory write-downs and facility closure costs of $3.2 million recorded in cost of goods sold; consulting fees, temporary labor,
employee recruitment, relocation and retention costs, and bad debt reserves of $22.9 million recorded in selling, general and administrative
(“SG&A”) expenses; and asset impairment charges and employee termination costs of $23.8 million recorded in other expense (as described
above under “Value Creation Plan”).
(c) Reflects costs related to the recall of certain sunflower kernel products, including a $0.7 million adjustment for the estimated lost gross profit
in the first quarter of 2017 caused by the sunflower recall, which reflected a shortfall in revenues against prior year volumes of approximately
$3.3 million, less associated cost of goods sold of approximately $2.6 million; and $0.4 million of product withdrawal costs not eligible for
reimbursement under our insurance policies, which were recorded in other expense.
(d) Reflects a recovery on the early extinguishment of a rebate obligation that arose from the prior settlement of a flexible resealable pouch
product recall dispute with a customer (see (m) below), which was recorded in other income.
(e) Reflects the reversal to SG&A expenses of previously recognized stock-based compensation related to performance share units granted to
certain employees as the performance conditions were not achieved.
(f) Other included fair value adjustments related to contingent consideration arrangements; severance costs unrelated to the Value Creation Plan;
and gain/loss on the sale of assets, which were recorded in other expense.
(g) Reflects the tax effect of the preceding adjustments to earnings and reflects an overall estimated annual effective tax rate of approximately
30% on adjusted earnings before tax.
We believe that investors’ understanding of our financial performance is enhanced by disclosing the specific items that we exclude from earnings/loss
attributable to SunOpta Inc. to compute adjusted earnings/loss. However, adjusted earnings/loss is not, and should not be viewed as, a substitute for
earnings prepared under U.S. GAAP. Adjusted earnings/loss is presented solely to allow investors to more fully understand how we assess our financial
performance.
(3) We use a measure of adjusted EBITDA when assessing the performance of our operations, which we believe are useful to investors’ understanding of
our operating profitability by excluding non-operating expenses, such as interest and income taxes, and non-cash expenses, such as depreciation,
amortization, stock-based compensation and asset impairment charges, as well as other unusual items that affect the comparability of operating
performance. We also use these measures to review and assess our progress under the Value Creation Plan (as described above under “Value Creation
Plan”) and to assess operating performance in connection with our employee incentive programs. In addition, we are subject to certain debt covenants
that restrict our ability to incur additional indebtedness unless we meet certain ratios based on pre-established measures of EBITDA. We define adjusted
EBITDA as segment operating income/loss plus depreciation, amortization and non-cash stock-based compensation, and excluding other unusual items
as identified in the determination of adjusted earnings (refer above to footnote (2)). The following table presents a reconciliation of segment operating
income/loss and adjusted EBITDA from loss from continuing operations, which we consider to be the most directly comparable U.S. GAAP financial
measure. In addition, as described above under footnote (2), we have prepared this table in a columnar format to present the effect of flexible resealable
pouch and nutrition bar operations on our consolidated results for the current and comparative periods. We believe this presentation assists investors in
assessing the results of the operations we have exited and the effect of those operations on our financial performance.
(a) For 2017, stock-based compensation of $6.4 million was recorded in SG&A expenses, and the reversal of $0.7 million of previously
recognized stock-based compensation, related to forfeited awards of employees that were terminated in connection with the Value Creation
Plan, was recognized in other expense. For 2016, stock-based compensation of $3.9 million was recorded in SG&A expenses.
(b) For 2017, reflects inventory write-downs and facility closure costs of $3.2 million recorded in cost of goods sold, and consulting fees,
temporary labor, employee recruitment, relocation and retention costs, and bad debt reserves of $22.9 million recorded in SG&A expenses.
For 2016, reflects legal and other professional advisory costs of $4.0 million recorded in SG&A expenses.
(c) For 2017, reflects the estimated lost gross profit caused by the recall of certain sunflower kernel products of $0.7 million, which reflected the
shortfall in revenues in the first quarter of 2017 against first quarter 2016 volumes of approximately $3.3 million, less associated cost of goods
sold of approximately $2.6 million. For 2016, reflects costs of $1.2 million for the withdrawal of certain consumer-packaged products for
quality-related issues, which was recorded in cost of goods and the estimated lost gross profit caused by the sunflower recall of $1.7 million,
which reflected a shortfall in revenues against anticipated volumes of approximately $9.8 million, less associated cost of goods sold of
approximately $8.1 million.
(d) Reflects costs related to the acquisition accounting adjustment related to Sunrise’s inventory sold in 2016 of $15.0 million, and the integration
costs related to the closure and consolidation of our frozen fruit processing operations following the Sunrise Acquisition of $0.2 million,
which were recorded in cost of goods sold.
(e) Reflects aging reserves and low margin sales to reduce inventory exposures mainly related to certain grain varieties that we exited, which
were recorded in cost of goods sold.
(f) Reflects legal costs related to the settlement of the flexible resealable pouch product recall dispute with a customer, which were recorded in
SG&A expenses.
(g) Reflects the negative gross profit reported by the Allentown facility as the facility ramped up to break-even production levels.
Although we use adjusted EBITDA as a measure to assess the performance of our business and for the other purposes set forth above, this measure has
limitations as analytic tools, and should not be considered in isolation, or as a substitute for an analysis of our results of operations as reported in
accordance with U.S. GAAP. Some of these limitations are:
x adjusted EBITDA reflects the interest expense, or the cash requirements necessary to service interest payments on our indebtedness;
x adjusted EBITDA includes the payment of taxes, which is a necessary element of our operations;
x although depreciation and amortization are non-cash charges, the assets being depreciated and amortized will often have to be replaced in the
future, and adjusted EBITDA does not reflect any cash requirements for such replacements; and
x adjusted EBITDA includes non-cash stock-based compensation, which is an important component of our total compensation program for
employees and directors.
(4) In order to evaluate our results of operations, we use certain non-GAAP measures that we believe enhance an investor’s ability to derive meaningful
year-over-year comparisons and trends from our results of operations. In particular, we evaluate our revenues on a basis that excludes the effects of
fluctuations in commodity pricing and foreign exchange rates. In addition, we exclude specific items from our reported results that due to their nature
or size, we do not expect to occur as part of our normal business on a regular basis. These items are identified above under footnote (2), and in the
discussion of our results of operations below. These non-GAAP measures are presented solely to allow investors to more fully assess our results of
operations and should not considered in isolation of, or as substitutes for an analysis of our results as reported under U.S. GAAP.
Revenues for the year ended December 30, 2017 decreased by 5.0% to $1,279.6 million from $1,346.7 million for the year
ended December 31, 2016. Excluding the impact on revenues for the year ended December 30, 2017 of changes in commodity-
related pricing and foreign exchange rates (a decrease in revenues of $15.0 million), all sales of flexible resealable pouch and
nutrition bar products (a decrease in revenues of $6.2 million), and estimated impact of the recall of certain sunflower kernel
products based on shortfall against prior year volumes (a decrease in revenues of $3.3 million), revenues decreased by 3.3% in
2017, compared with 2016. This decrease in revenues on an adjusted basis reflected a lower sales of frozen fruit products due
to lower consumer demand and lost customer volumes; lower raw and roasted sunflower volumes, due to global competition
and reduced customer demand following the sunflower recall; and lower sales of non-dairy aseptic beverage products related
to the previously announced loss of a significant customer. These factors were partially offset by increased volumes of premium
juice products and custom fruit ingredients.
Gross profit increased $19.1 million, or 15.2%, to $145.1 million for the year ended December 30, 2017, compared with $126.0
million for the year ended December 31, 2016. As a percentage of revenues, gross profit for the year ended December 30, 2017
was 11.3% compared to 9.4% for the year ended December 31, 2016, an increase of 2.0%. The gross profit percentage for
2017 would have been approximately 11.6%, excluding the impact of the write-down of flexible resealable pouch and nutrition
bar inventories as a result of the plan to exit these product lines ($2.6 million), lost margin caused by the sunflower recall ($0.7
million), and facility closure costs under the Value Creation Plan ($0.6 million). For 2016, the gross profit percentage would
have been 10.9%, excluding the impact of an acquisition accounting adjustment related to Sunrise’s inventory sold in 2016
($15.0 million), aging reserves and low margin sales to reduce inventory exposures mainly on specialty grain varieties we
exited ($3.4 million), lost margin caused by the recall of certain sunflower kernel products ($1.7 million), start-up costs related
to the ramp-up of production at the Allentown aseptic beverage facility ($1.6 million), and an inventory reserve for certain
consumer-packaged products due to quality-related issues ($1.2 million). Excluding these items, the gross profit percentage
increased 0.7% on an adjusted basis in 2017, compared with 2016, which reflected improved operating efficiencies and raw
material pricing within our healthy fruit operations, and operational savings following the closure of the San Bernardino
premium juice facility, as well as a favorable foreign exchange impact on U.S. dollar-denominated raw material sourcing within
our international organic ingredient operations. These factors were partially offset by higher losses within our flexible
resealable pouch and nutrition bar operations, partially related to wind-down activities in the fourth quarter of 2017. In addition,
we experienced lower production volumes and operating efficiencies within our sunflower and roasting operations following
the recall.
Total segment operating income for the year ended December 30, 2017 decreased by $14.0 million, or 94.8%, to $0.8 million,
compared with $14.7 million for the year ended December 31, 2016. As a percentage of revenues, segment operating income
was 0.1% for the year ended December 30, 2017, compared with 1.1% for the year ended December 31, 2016. The decrease
in segment operating income reflected a $28.8 million increase in SG&A expenses that more than offset the higher overall
gross profit as described above. The increase in SG&A expenses mainly reflected incremental consulting fees and temporary
labor costs ($12.5 million), employee recruitment, relocation and retention costs ($6.0 million), and bad debt reserves related
to exited operations ($0.4 million) associated with the Value Creation Plan, partially offset by lower legal costs related to
settlement of a product recall dispute in 2016 ($1.9 million). Excluding these items, as well as those items identified above
affecting gross profit, segment operating income as a percentage of revenues on an adjusted basis would have been 2.1% in
2017, compared with 3.2% in 2016, which reflected higher employee compensation-related costs in 2017 related to structural
investments in new quality, sales, marketing, engineering and accounting resources. In addition, segment operating income
reflected a foreign exchange loss of $5.6 million in 2017, which mainly reflected the impact on our international organic
ingredient and frozen fruit operations of a weakening of U.S. dollar relative to the euro and Mexican peso, compared with a
loss of $1.2 million in 2016.
Further details on revenue, gross profit and segment operating income/loss variances are provided below under “Segmented
Operations Information”.
In 2017, we recognized a non-cash goodwill impairment charge of $115.0 million related to the Healthy Fruit reporting unit of
the Consumer Products operating segment, as a result of lower-than-expected sales and operating performance for frozen fruit
since the Sunrise Acquisition, and uncertainty of future sales due to lost customer volumes and declining consumer consumption
trends in 2017. In 2016, we recognized a non-cash goodwill impairment charge of $17.5 million related to the Sunflower
reporting unit of the Raw Material Sourcing and Supply operating segment, due to lower anticipated sales demand and higher
expected production and capital costs as a result of the sunflower recall.
Interest expense decreased by $10.8 million to $32.5 million for the year ended December 30, 2017, compared with $43.3
million for the year ended December 31, 2016. Interest expense included the amortization and expense of debt issuance costs
of $2.8 million and $11.3 million in 2017 and 2016, respectively. The year-over-year decrease in interest expense primarily
reflected the reduction in non-cash amortization following the one-year maturity of the initial second lien loans used to partially
fund the Sunrise Acquisition, and repayment of $79.0 million of second lien debt with the net proceeds from the Preferred
Stock offering in October 2016, and further extinguishment of $7.5 million of second lien debt in October 2017.
We recognized a recovery of income tax of $35.8 million for the year ended December 30, 2017 (including a $8.4 million
recovery related to the remeasurement of deferred tax balances to reflect the new corporate tax rates enacted in the U.S. in
December 2017, and the realization of $0.5 million of previously unrecognized tax benefits), compared with a recovery of
income tax of $23.8 million for the year ended December 31, 2016 (including the realization of $1.3 million of previously
unrecognized tax benefits). Excluding the effects of the change the U.S. corporate tax rate and the realization of unrecognized
tax benefits, the effective tax rates for 2017 and 2016 would have been 48.6% and 39.6%, respectively, of the loss before
income taxes (excluding the non-deductible goodwill impairment losses). The effective tax rates reflected the effect of a mix
of pre-tax losses in the U.S. and pre-tax earnings in certain other jurisdictions. In fiscal 2017, pre-tax losses in the U.S. mainly
reflected costs associated with the Value Creation Plan. In fiscal 2016, pre-tax losses in the U.S. reflected costs associated with
the Value Creation Plan, as well as the Sunrise Acquisition, settlement of the product recall dispute, and product withdrawal
and recall costs. With the effect of the corporate tax law changes in the U.S. beginning in fiscal 2018, we expect our effective
tax rate will be approximately 24% to 26%, excluding discrete items.
Loss from continuing operations attributable to SunOpta Inc. for the year ended December 30, 2017 was $135.3 million,
compared with a loss of $50.6 million for the year ended December 31, 2016, a decrease of $84.7 million. Diluted loss per
share from continuing operations was $1.66 for the year ended December 30, 2017, compared with diluted loss per share from
continuing operations of $0.61 for the year ended December 31, 2016.
The loss from discontinued operations of $0.6 million in 2016 was related to our investment in Opta Minerals, which we sold
in April 2016.
On a consolidated basis, we realized a loss of $135.3 million (diluted loss per share of $1.66) for the year ended December 30,
2017, compared with a loss of $51.2 million (diluted loss per share of $0.62) for the year ended December 31, 2016.
For the year ended December 30, 2017, adjusted loss was $12.3 million, or $0.14 per diluted share, on a consolidated basis,
compared with adjusted earnings of $5.8 million, or $0.07 per diluted share, on a consolidated basis for the year ended
December 31, 2016. Excluding flexible resealable pouch and nutrition bar product lines and operations, adjusted loss was $8.3
million, or $0.10 per diluted share, for the year ended December 30, 2017, compared with adjusted earnings of $7.1 million, or
$0.08 per diluted share, for the year ended December 31, 2016. Adjusted EBITDA for the year ended December 30, 2017 was
$66.8 million on a consolidated basis, compared with $81.7 million on a consolidated basis for the year ended December 31,
2016. Excluding flexible resealable pouch and nutrition bar product lines and operations, adjusted EBITDA for the year ended
Global Ingredients December 30, 2017 December 31, 2016 Change % Change
Global Ingredients contributed $550.5 million in revenues for the year ended December 30, 2017, compared to $574.3 million
for the year ended December 31, 2016, a decrease of $23.8 million, or 4.1%. Excluding the impact on revenues of changes
including foreign exchange rates and commodity-related pricing (a decrease in revenues of $9.7 million), and the recall of
certain sunflower kernel products announced in the second quarter of 2016 (a decrease in revenues of $3.3 million), Global
Ingredients revenues decreased approximately 1.9%. The table below explains the decrease in revenue:
Gross profit in Global Ingredients increased by $3.3 million to $67.7 million for the year ended December 30, 2017 compared
to $64.4 million for the year ended December 31, 2016, and the gross profit percentage increased by 1.1% to 12.3%. The
increase in gross profit as a percentage of revenue was primarily due to a favorable foreign exchange impact on U.S. dollar-
denominated raw material sourcing within our international organic ingredient operations, partially offset by an unfavorable
product mix of, and reduced pricing spreads on, certain organic commodities, and reduced operating efficiencies within our
sunflower and roasting operations due to lower volumes following the recall. The table below explains the increase in gross
profit:
Operating income in Global Ingredients decreased by $4.8 million, or 18.1%, to $22.0 million for the year ended December
30, 2017, compared to $26.8 million for the year ended December 31, 2016. The table below explains the decrease in operating
income:
Looking forward, we believe Global Ingredients is well positioned in growing organic food and non-GMO categories. We
intend to focus our efforts on (i) growing our organic sourcing and supply capabilities, making certified organic ingredients a
larger proportion of our overall sales; (ii) making strategic investments in key product categories that drive higher volume
ingredient solutions for our customers; and (iii) leveraging our international sourcing and supply capabilities internally, and
forward and backward integrating where opportunities exist. The statements in this paragraph are forward-looking statements.
See “Forward-Looking Statements” above. Increased supply pressure in the commodity-based markets in which we operate,
increased competition, volume decreases or loss of customers, unexpected delays in our ingredient expansion plans, or our
inability to secure quality inputs or achieve our product mix or cost reduction goals, along with the other factors described
above under “Forward-Looking Statements”, could adversely impact our ability to meet these forward-looking expectations.
Consumer Products December 30, 2017 December 31, 2016 Change % Change
Consumer Products contributed $729.1 million in revenues for the year ended December 30, 2017, compared to $772.4 million
for the year ended December 31, 2016, a $43.4 million, or 5.6% decrease. Excluding the impact on revenues of changes in raw
Gross profit in Consumer Products increased by $15.8 million to $77.4 million for the year ended December 30, 2017 compared
to $61.6 million for the year ended December 31, 2016, and the gross profit percentage increased by 2.6% to 10.6%. For the
year ended December 30, 2017, gross profit as a percentage of revenue was impacted by a write-down of flexible resealable
pouch and nutrition bar inventories as a result of the exit from these operations ($2.6 million), as well as costs associated with
the closure of the San Bernardino facility ($0.5 million). For the year ended December 31, 2016, gross profit as a percentage
of revenue was impacted by the acquisition accounting adjustment related to Sunrise inventory sold ($15.0 million), costs
associated with the expansion activities at the Allentown aseptic beverage facility ($1.6 million), and an inventory reserve for
certain consumer-packaged products due to quality-related issues ($1.2 million). Excluding these costs, the gross profit
percentage in Consumer Products would have been 11.1% for the year ended December 30, 2017, compared with 10.3% for
the year ended December 31, 2016. The increase in gross profit percentage primarily reflected improved operating efficiencies
and raw material pricing within our healthy fruit operations and operational savings from the closure of the San Bernardino
facility, partially offset by higher losses within our flexible resealable pouch and nutrition bar operations. The table below
explains the increase in gross profit:
Operating income in Consumer Products increased by $8.7 million to $9.9 million for the year ended December 30, 2017,
compared to $1.2 million for the year ended December 31, 2016. The table below explains the increase in operating income:
Looking forward we believe Consumer Products remains well-positioned in markets with long-term growth potential.
However, a continued decline in consumer consumption of frozen fruit could adversely affect the near-term performance of
the Consumer Products. We intend to focus our efforts on (i) leveraging our new sales and marketing resources to create greater
channel specific focus on retail and foodservice to bolster our pipeline of opportunities to diversify our portfolio and drive
incremental sales volume; (ii) continuing to invest in our facilities to enhance quality, safety, and manufacturing efficiency to
drive both incremental sales and cost reduction; (iii) executing procurement and supply chain cost reduction initiatives focused
on leveraging our buying power and creating increased network efficiency in our planning and logistics efforts; and (iv)
leveraging our innovation capabilities to bring new value-added packaged products and processes to market and to increase
our capacity utilization across Consumer Products. The statements in this paragraph are forward-looking statements. See
“Forward-Looking Statements” above. Unfavorable shifts in consumer preferences, increased competition, availability of raw
material supply, volume decreases or loss of customers, unexpected delays in our expansion and integration plans, inefficiencies
in our manufacturing processes, lack of consumer product acceptance, or our inability to successfully implement the particular
goals and strategies indicated above, along with the other factors described above under “Forward-Looking Statements”, could
have an adverse impact on these forward-looking expectations.
Corporate Services December 30, 2017 December 31, 2016 Change % Change
Operating loss at Corporate Services increased by $17.8 million to $31.1 million for the year ended December 30, 2017, from
a loss of $13.2 million for the year ended December 31, 2016. The table below explains the increase in operating loss:
Management fees mainly consist of salaries of corporate personnel who perform back office functions for operating segments,
as well as costs related to the enterprise resource management system. These expenses are allocated to the operating segments
based on (1) specific identification of allocable costs that represent a service provided to each segment and (2) a proportionate
Gross Profit
Global Ingredients 64,374 66,461 (2,087) -3.1%
Consumer Products 61,578 43,901 17,677 40.3%
Total gross profit 125,952 110,362 15,590 14.1%
(1) The following table presents a reconciliation of segment operating income/loss to earnings (loss) from continuing operations before the following, which
we consider to be the most directly comparable U.S. GAAP financial measure (refer to footnote (1) to the “Consolidated Results of Operations for Fiscal
Years 2017 and 2016” table regarding the use of this non-GAAP measure).
January 2, 2016
Segment operating income (loss) 28,184 3,208 (10,094) 21,298
Other income (expense), net (1,317) (939) (9,895) (12,151)
Earnings (loss) from continuing operations before the following 26,867 2,269 (19,989) 9,147
(2) The following table presents a reconciliation of adjusted earnings from loss from continuing operations, which we consider to be the most directly
comparable U.S. GAAP financial measure (refer to footnote (2) to the “Consolidated Results of Operations for Fiscal Years 2017 and 2016” table
regarding the use of this non-GAAP measure). In addition, in recognition of our exit flexible resealable pouch and nutrition bar product lines and
Adjusted for:
Costs related to business acquisitions(a) 27,802 - 27,802
Costs related to the Value Creation Plan(b) 18,326 - 18,326
Goodwill impairment(c) 17,540 - 17,540
Legal settlement and litigation-related legal fees(d) 10,850 - 10,850
Product withdrawal and recall costs(e) 5,693 - 5,693
Inventory reserves and liquidation sales to de-risk positions(f) 3,428 - 3,428
Plant start-up costs(g) 1,565 - 1,565
Write-off of debt issuance costs(h) 215 - 215
Other(i) 1,642 - 1,642
Gain on settlement of contingent consideration(j) (1,715) - (1,715)
Net income tax effect(k) (25,825) - (25,825)
Change in unrecognized tax benefits(l) (1,268) - (1,268)
Adjusted earnings (loss) 7,099 0.08 (1,276) (0.01) 5,823 0.07
January 2, 2016
Loss from continuing operations (1,417) (1,715) (3,132)
Less: earnings attributable to non-controlling interests 136 - 136
Loss from continuing operations available to common
shareholders (1,281) (0.02) (1,715) (0.02) (2,996) (0.04)
Adjusted for:
Costs related to business acquisitions(m) 17,192 - 17,192
Plant expansion and start-up costs(n) 4,081 - 4,081
Inventory reserves and liquidation sales to de-risk(o) 2,367 - 2,367
Downtime, spoilage and other costs due to equipment failure(p) 676 1,543 2,219
Demurrage, detention and other related expenses(q) 2,038 - 2,038
Litigation-related legal fees(d) 1,709 - 1,709
Reversal of stock-based compensation(r) (579) - (579)
Other(s) 4,384 - 4,384
Net income tax effect(l) (9,996) (602) (10,598)
Change in unrecognized tax benefits(m) (855) - (855)
Adjusted earnings (loss) 19,736 0.27 (774) (0.01) 18,962 0.26
(a) Reflects costs related to the Sunrise Acquisition, including an acquisition accounting adjustment related to Sunrise’s inventory sold during
the year of $15.0 million, which was recorded in cost of goods sold; the amortization and expense of debt issuance costs incurred in
connection with the initial financing related to the Sunrise Acquisition of $10.4 million, which were recorded in interest expense; and $2.4
million of integration costs related to the closure and consolidation of our frozen fruit processing facilities following the Sunrise
Acquisition, which were recorded in cost of goods sold and other expense.
(b) Reflects legal and other professional advisory costs associated with the strategic review and execution of the Value Creation Plan of $4.0
million, which were recorded in SG&A expenses; and asset impairment charges and employee termination costs of $14.3 million recorded
in other expense (as described above under “Value Creation Plan”).
(c) Reflects the impairment of goodwill associated with the Sunflower reporting unit of the Raw Material Sourcing and Supply operating
segment.
(d) Reflects a charge of $9.0 million for the settlement of a flexible resealable pouch product recall dispute with a customer, which was
recorded in other expense, and associated legal costs of $1.9 million (2015 - $1.7 million), which were recorded in SG&A expenses. The
settlement amount included up to $4.0 million in rebates payable to the customer over a four-year period.
(3) The following table presents a reconciliation of segment operating income/loss and adjusted EBITDA from loss from continuing operations, which we
consider to be the most directly comparable U.S. GAAP financial measure (refer to footnote (3) to the “Consolidated Results of Operations for the Fiscal
Years 2017 and 2016” table regarding the use of this non-GAAP measure). In addition, as described above under footnote (2), we have prepared this
table in a columnar format to present the effect of flexible resealable pouch and nutrition bar operations on our consolidated results for the current and
comparative period. We believe this presentation assists investors in assessing the results of the operations we have exited and the effect of those
operations on our financial performance.
January 2, 2016
Loss from continuing operations (1,417) (1,715) (3,132)
Recovery of income taxes (2,294) (1,096) (3,390)
Interest expense, net 15,669 - 15,669
Other expense, net 12,151 - 12,151
Total segment operating income (loss) 24,109 (2,811) 21,298
Depreciation and amortization 20,372 635 21,007
Stock-based compensation(a) 3,512 - 3,512
Plant expansion and start-up costs(h) 4,081 - 4,081
Costs related to business acquisitions(b) 4,000 - 4,000
Inventory reserves and liquidation sales to de-risk positions(i) 2,367 - 2,367
Downtime, spoilage and other costs due to equipment failure(j) 480 1,739 2,219
Demurrage, detention and other related expenses(k) 2,038 - 2,038
Litigation-related legal fees(f) 1,709 - 1,709
Adjusted EBITDA 62,668 (437) 62,231
(a) For 2016 and 2015, stock-based compensation of $3.9 million and $3.5 million, respectively, was recorded in SG&A expenses.
(b) For 2016, reflects costs related to the acquisition accounting adjustment related to Sunrise’s inventory sold in 2016 of $15.0 million, and the
integration costs related to the closure and consolidation of our frozen fruit processing operations following the Sunrise Acquisition of $0.2
million, which were recorded in cost of goods sold. For 2015, reflects costs related to the acquisition accounting adjustment related to
Sunrise’s inventory sold subsequent to the acquisition date of $4.0 million.
(c) Reflects legal and other professional advisory costs of $4.0 million recorded in SG&A expenses.
(d) Reflects aging reserves and low margin sales to reduce inventory exposures mainly related to certain grain varieties that we exited, which
were recorded in cost of goods sold.
(e) Reflects costs of $1.2 million for the withdrawal of certain consumer-packaged products for quality-related issues, which was recorded in
cost of goods and the estimated lost gross profit caused by the sunflower recall of $1.7 million, which reflected a shortfall in revenues against
anticipated volumes of approximately $9.8 million, less associated cost of goods sold of approximately $8.1 million.
(f) Reflects legal costs related to the settlement of the flexible resealable pouch product recall dispute with a customer, which were recorded in
SG&A expenses.
(g) Reflects the negative gross profit reported by the Allentown facility as the facility ramped up to break-even production levels.
(h) Reflects costs related to the retrofit of our San Bernardino, California, juice facility and expansion of the Allentown facility to add aseptic
beverage processing and filling capabilities, which were recorded in cost of goods sold.
(i) Reflects inventory reserves and low margin sales incurred to reduce inventory exposures in certain organic raw materials, which were recorded
in cost of goods sold.
(j) Reflects downtime and spoilage caused by equipment failures, which were recorded in cost of goods sold.
(k) Reflects additional logistics costs stemming from capacity constraints on imports and exports within the Global Ingredients segment, which
were recorded in cost of goods sold.
(4) Refer to footnote (4) to the “Consolidated Results of Operations for the Fiscal Years 2017 and 2016” table regarding the use of certain other non-GAAP
measures in the discussion of our results of operations below.
Revenues for the year ended December 31, 2016 increased by 17.6% to $1,346.7 million from $1,145.1 million for the year
ended January 2, 2016. Excluding the impact on revenues for the year ended December 31, 2016 of business acquisitions and
associated product rationalizations (an increase in revenues of approximately $230.8 million), changes in commodity-related
pricing and foreign exchange rates (a decrease in revenues of approximately $28.1 million), estimated impact of the recall of
certain sunflower kernel products based on shortfall against anticipated volumes (a decrease in revenues of approximately $9.8
million), and estimated impact on west coast pouch operations as a result of a fire at a third-party facility (a decrease in revenues
Gross profit increased $15.6 million, or 14.1%, to $126.0 million for the year ended December 31, 2016, compared with $110.4
million for the year ended January 2, 2016. As a percentage of revenues, gross profit for the year ended December 31, 2016
was 9.4% compared to 9.6% for the year ended January 2, 2016, a decrease of 0.2%. The gross profit percentage for 2016
would have been approximately 10.9%, excluding the impact of an acquisition accounting adjustment related to Sunrise’s
inventory sold in 2016 ($15.0 million), aging reserves and low margin sales to reduce inventory exposures mainly on specialty
grain varieties we were exiting ($3.4 million), lost margin caused by the recall of certain sunflower kernel products ($1.7
million), start-up costs related to the ramp-up of production at the Allentown aseptic beverage facility ($1.6 million), and an
inventory reserve for certain consumer-packaged products due to quality-related issues ($1.2 million). For 2015, the gross
profit percentage would also have been approximately 10.9%, excluding the impact of costs related to the retrofit of the San
Bernardino juice facility and expansion of the Allentown facility to add aseptic beverage production capabilities ($4.1 million),
an acquisition accounting adjustment related to the Sunrise’s inventory sold subsequent to the acquisition date ($4.0 million),
aging reserves and low margin sales to reduce inventory exposures on certain organic raw materials ($2.4 million), downtime
and spoilage caused by equipment failures at the Allentown pouch facility ($2.2 million), and demurrage, detention and other
related expenses ($2.0 million). Excluding these items, the year-over-year gross profit percentage on an adjusted basis reflected
increased efficiency and lower costs at our aseptic beverage operations and improved pricing spreads on organic ingredients.
These positive factors were offset by increased raw material costs for frozen strawberries that could not be passed on
immediately to customers, as well as production inefficiencies within our frozen fruit operations in the first half of 2016 caused
by a late harvest and the resultant shortage of strawberries. In addition, we experienced lower pricing spreads on specialty corn
and soy and reduced throughput in our sunflower and roasting operations with the implementation of new food safety and
quality processes.
Total segment operating income for the year ended December 31, 2016 decreased by $6.6 million, or 30.8%, to $14.7 million,
compared with $21.3 million for the year ended January 2, 2016. As a percentage of revenues, segment operating income was
1.1% for the year ended December 31, 2016, compared with 1.9% for the year ended January 2, 2016. The decrease in segment
operating income mainly reflected a $12.9 million increase in SG&A expenses and $6.3 million increase in intangible asset
amortization, which more than offset the higher overall gross profit as described above. The increase in SG&A expenses in
2016, compared with 2015, reflected incremental expenses from acquired businesses, and external advisory costs associated
with the strategic review and Value Creation Plan ($4.0 million). The year-over-year increase in intangible asset amortization
of $6.3 million reflected the incremental amortization of identified intangible assets of acquired businesses. Also contributing
to the decrease in segment operating income was a foreign exchange loss of $1.2 million in 2016, compared with a foreign
exchange gain of $1.6 million in 2015, mainly reflecting the negative impact of a strengthening of the U.S. dollar relative to
the peso on our Mexican frozen fruit operations in 2016, compared with the positive impact of a strengthening of the U.S.
dollar relative to the euro in 2015.
Further details on revenue, gross profit and segment operating income variances are provided below under “Segmented
Operations Information”.
Other expense for the year ended December 31, 2016 of $28.3 million reflected the impairment of long-lived assets related to
the closures of the San Bernardino and Heuvelton facilities ($11.5 million), and employee termination costs ($2.8 million)
associated with the Value Creation Plan, the cost of the settlement of the aforementioned flexible resealable pouch product
recall dispute with a customer ($9.0 million), as well as costs associated with product withdrawals and recalls ($2.8 million),
and facility rationalization and severance costs primarily related to the consolidation of our frozen fruit processing facilities
following the Sunrise Acquisition ($2.2 million). Other expenses in 2016 were partially offset by the $1.7 million gain on
settlement of the contingent consideration obligation related to the acquisition of Niagara Natural. Other expense for the year
ended January 2, 2016 of $12.2 million included business development costs of $7.8 million, primarily reflecting acquisition-
and integration-related costs incurred in connection with the Sunrise Acquisition; as well as severance and other rationalization
costs of $2.9 million.
In 2016, we recognized a non-cash goodwill impairment charge of $17.5 million related to the Sunflower reporting unit of the
Global Ingredients segment, due to lower anticipated sales demand and higher expected production and capital costs as a result
of the sunflower recall.
We recognized a recovery of income tax of $23.8 million for the year ended December 31, 2016 (including the realization of
$1.3 million of previously unrecognized tax benefits), compared with a recovery of income tax of $3.4 million for the year
ended January 2, 2016. Excluding the impact of the change in unrecognized tax benefits, the effective tax rate for 2016 was
39.6% of the loss before income taxes (excluding the non-deductible goodwill impairment loss), compared with 52.0% of loss
before income taxes for 2015. The effective tax rates reflected the impact of changes in the jurisdictional mix of earnings,
mainly as the result of pre-tax losses in the U.S. in 2016 and 2015, which reflected costs related to the Sunrise Acquisition
(including financing-related costs and acquisition accounting adjustments to Sunrise inventory sold). In addition, for 2016,
pre-tax losses in the U.S. reflected costs associated with the Value Creation Plan, settlement of the product recall dispute, and
product withdrawal and recall costs.
Loss from continuing operations, net of non-controlling interests, for the year ended December 31, 2016 was $50.6 million,
compared with a loss of $3.0 million for the year ended January 2, 2016, an increase of $47.6 million. Diluted loss per share
from continuing operations was $0.61 for the year ended December 31, 2016, compared with diluted loss per share from
continuing operations of $0.04 for the year ended January 2, 2016.
Loss from discontinued operations of $0.6 million for the year ended December 31, 2016 reflected the loss from operations of
Opta Minerals of $2.0 million, which included an asset impairment charge of $1.2 million, partially offset by a $0.6 million
gain on classification as held for sale, net of recovery of income taxes and non-controlling interest of $0.9 million. Loss from
discontinued operations of $19.5 million for the year ended January 2, 2016 primarily reflected the results of Opta Minerals,
including an asset impairment charge of $12.4 million and loss on classification as held for sale of $10.5 million, net of non-
controlling interest of $8.8 million.
On a consolidated basis, we realized a loss of $51.2 million (diluted loss per share of $0.62) for the year ended December 31,
2016, compared with a loss of $22.5 million (diluted loss per share of $0.31) for the year ended January 2, 2016.
For the year ended December 31, 2016, adjusted earnings were $5.8 million, or $0.07 per diluted share, on a consolidated basis,
compared with adjusted earnings of $19.0 million, or $0.26 per diluted share, on a consolidated basis for the year ended January
2, 2016. Excluding flexible resealable pouch and nutrition bar product lines and operations, adjusted earnings $7.1 million, or
$0.08 per diluted share, for the year ended December 31, 2016, compared with adjusted earnings of $19.7 million, or $0.27 per
diluted share, for the year ended January 2, 2016. Adjusted EBITDA for the year ended December 31, 2016 was $81.7 million
on a consolidated basis, compared with $62.2 million on a consolidated basis for the year ended January 2, 2016. Excluding
flexible resealable pouch and nutrition bar product lines and operations, adjusted EBITDA for the year ended December 31,
2016 was $83.0 million, compared with $62.7 million for the year ended January 2, 2016. Adjusted earnings and adjusted
EBITDA are non-GAAP financial measures. See footnotes (2) and (3) to the table above for a reconciliation of adjusted
earnings/loss and adjusted EBITDA from loss from continuing operations, which we consider to be the most directly
comparable U.S. GAAP financial measure.
Global Ingredients contributed $574.3 million in revenues for the year ended December 31, 2016, compared to $610.9 million
for the year ended January 2, 2016, a decrease of $36.6 million or 6.0%. Excluding the estimated impact on revenues of the
recall of certain sunflower kernel products and the impact of changes including foreign exchange rates and commodity-related
pricing, Global Ingredients revenues decreased approximately 0.2%. The table below explains the decrease in revenue:
Gross profit in Global Ingredients decreased by $2.1 million to $64.4 million for the year ended December 31, 2016 compared
to $66.5 million for the year ended January 2, 2016, and the gross profit percentage increased by 0.3% to 11.2%. The increase
in gross profit as a percentage of revenue was primarily due to a favorable sales mix driven by higher margin international
organic raw materials and improved mix in domestic raw materials as a result of a decline in acres contracted of low margin
seed and grain varieties, mark-to-market gains on commodity futures contracts, and improved transloading operating
efficiencies from the prior year, partially offset by the impact of the sunflower recall on operations and lower pricing spreads
on non-GMO soy, corn and organic feed. The table below explains the decrease in gross profit:
Operating income in Global Ingredients decreased by $1.4 million, or 5.0%, to $26.8 million for the year ended December 31,
2016, compared to $28.2 million for the year ended January 2, 2016. The table below explains the decrease in operating
income:
Consumer Products contributed $772.4 million in revenues for the year ended December 31, 2016, compared to $534.2 million
for the year ended January 2, 2016, an increase of $238.2 million or 44.6%. Excluding the impact of business acquisitions and
associated product rationalizations, as well as the estimated impact on west coast pouch operations as a result of a fire at a
third-party facility in the third quarter of 2016, Consumer Products revenues increased 1.6%. The table below explains the
increase in revenue:
Gross profit in Consumer Products increased by $17.7 million to $61.6 million for the year ended December 31, 2016 compared
to $43.9 million for the year ended January 2, 2016, and the gross profit percentage decreased by 0.2% to 8.0%. For the year
ended December 31, 2016, gross profit as a percentage of revenue was impacted by a $15.0 million acquisition accounting
adjustment related to Sunrise inventory sold, as well as costs associated with expansion activities at the Allentown aseptic
beverage facility ($1.6 million), and an inventory reserve for certain consumer-packaged products due to quality-related issues
($1.2 million). Excluding these costs, the gross profit percentage in Consumer Products would have been 10.3% for the year
ended December 31, 2016. The increase in gross profit percentage on an adjusted basis reflected the higher margin profile of
2015 business acquisitions, and increased facility utilization and operating costs within the beverage operations, partially offset
by higher costs within healthy fruit operations due to a delayed 2016 fruit harvest that led to increased labor costs and higher
raw material prices that were not immediately built into customer pricing. The table below explains the increase in gross profit:
Operating income in Consumer Products decreased by $2.0 million, or 62.4%, to $1.2 million for the year ended December 31,
2016, compared to $3.2 million for the year ended January 2, 2016. The table below explains the decrease in operating income:
Operating loss at Corporate Services increased by $3.2 million to $13.2 million for the year ended December 31, 2016, from a
loss of $10.1 million for the year ended January 2, 2016. The table below explains the increase in operating loss:
Management fees mainly consist of salaries of corporate personnel who perform back office functions for operating segments,
as well as costs related to the enterprise resource management system. These expenses are allocated to the operating segments
based on (1) specific identification of allocable costs that represent a service provided to each segment and (2) a proportionate
We have the following sources from which we can fund our operating cash requirements:
x Cash flows generated from operating activities, including working capital efficiency efforts;
x Cash flows generated from the exercise, if any, of stock options during the year;
x Potential additional long-term financing, including the offer and sale of debt and/or equity securities; and
On February 11, 2016, we entered a five-year credit agreement for the Global Credit Facility in the maximum aggregate
principal amount of $350 million, subject to borrowing base capacity. The Global Credit Facility supports the working capital
and general corporate needs of our global operations, in addition to funding strategic initiatives. In addition, subject to
customary borrowing conditions and the agreement of any such lenders to provide such increased commitments, we may
request to increase the total lending commitments under this facility to a maximum aggregate principal amount not to exceed
$450 million. The applicable margin in the Global Credit Facility ranges from 1.25% to 1.75% for loans bearing interest based
on LIBOR and from 0.25% to 0.75% for loans bearing interest based on the prime rate and, in each case, is set quarterly based
on average borrowing availability for the preceding fiscal quarter.
On September 19, 2017, we entered into an amendment to the Global Credit Facility to add an additional U.S. asset-based
credit subfacility (the “New U.S. Subfacility”) of an aggregate principal amount of $15.0 million. The principal amount of
New U.S. Subfacility is repayable in quarterly instalments of $2.5 million, commencing with the fiscal quarter ending March
31, 2019. Borrowings repaid under the New U.S. Subfacility may not be borrowed again. The applicable margin for the New
U.S. Subfacility ranges from 2.00% to 2.50% with respect to base rate and prime rate borrowings and from 3.00% to 3.50%
for eurocurrency rate and bankers’ acceptance rate borrowings.
As at December 30, 2017, we had outstanding borrowings of $230.5 million and approximately $54 million of available
borrowing capacity under the Global Credit Facility. For more information on the Global Credit Facility, see note 13(1) to the
consolidated financial statements at Item 15 of this Form 10-K.
On October 20, 2016, SunOpta Foods issued $231.0 million of 9.5% Senior Secured Second Lien Notes due October 9, 2022
(the “Notes”). The issuance of the Notes represented the culmination of the financing arrangements associated with the Sunrise
Acquisition. As at December 30, 2017, the outstanding principal amount of the Notes was $223.5 million, following the
principal repayment of $7.5 million in October 2017. For more information on the Notes, see note 13(3) to the consolidated
financial statements at Item 15 of this Form 10-K.
In order to finance significant acquisitions, if any, that may arise in the future, we may need additional sources of cash that we
could attempt to obtain through a combination of additional bank or subordinated financing, a private or public offering of debt
or equity securities, or the issuance of common stock as consideration in an acquisition. There can be no assurance that these
types of financing would be available at all or, if so, on terms that are acceptable to us.
In the event that we require additional liquidity due to market conditions, unexpected actions by our lenders, changes to our
growth strategy, or other factors, our ability to obtain any additional financing on favourable terms, if at all, could be limited.
Net cash and cash equivalents increased $1.9 million to $3.2 million as at December 30, 2017, compared with $1.3 million at
December 31, 2016, which primarily reflected the following uses of cash:
x capital expenditures of $41.1 million, mainly related to new capabilities within our aseptic beverage operations and
expansion of our Dutch cocoa and Mexican frozen fruit facilities, as well as food safety and production enhancements
across our manufacturing base;
These uses of cash were mostly offset by the following sources of cash:
Cash provided by operating activities of continuing operations was $31.5 million for the year ended December 30, 2017,
compared with cash provided of $0.7 million for the year ended December 31, 2016, an increase in cash provided of $30.7
million. The increase in cash provided by operating activities reflected cash generated through working capital efficiency
initiatives during 2017, which were focused on lowering inventory positions, maximizing purchasing terms, and augmenting
collection efforts for accounts receivable. These positive efforts were partially offset by the cash settlement of $38.6 million
of costs incurred under the Value Creation Plan in 2017, compared to $3.1 million in 2016.
Cash used in investing activities of continuing operations was $40.1 million for the year ended December 30, 2017, compared
with cash used on $21.6 million for the year ended December 31, 2016, an increase in cash used of $18.5 million, which mainly
reflected an increase in capital expenditures of $18.6 million, partially reflecting the early buyout of equipment leases associated
with the closure of the San Bernardino facility and exit from flexible resealable pouch operations ($11.9 million).
Cash provided by financing activities of continuing operations was $10.6 million for the year ended December 30, 2017,
compared with cash provided of $16.8 million for the year ended December 31, 2016, a decrease in cash provided of $6.2
million. Net borrowings under our line of credit facilities increased $22.2 million in 2017, compared with an increase of $44.3
million in 2016, a period-over-period decrease in net borrowings under the line of credit facilities of $22.1 million. This
decrease in borrowings reflected the year-over-year reductions in working capital requirements ($31.6 million) and debt
issuance costs related to the Notes and Global Credit Facility ($12.6 million), partially offset by the year-over-year increase in
capital spending of $18.6 million.
Net cash and cash equivalents related to continuing operations decreased $1.0 million to $1.3 million as at December 31, 2016,
compared with $2.3 million at January 2, 2016, which primarily reflected the following uses of cash:
x repayment of $320.0 million second lien borrowings used to initially fund the Sunrise Acquisition;
x capital expenditures of $22.6 million, mainly related to the automation of frozen fruit processing and to food safety
and quality initiatives in connection with the Value Creation Plan; and
x payment of $13.0 million of debt issuance costs related to the Notes and Global Credit Facility.
These uses of cash were mostly offset by the following sources of cash:
x proceeds of $231.0 million and $79.0 million on the issuance of the Notes and preferred stock, respectively, used to
repay the second lien borrowings; and
Cash provided by operating activities of continuing operations was $0.7 million for the year ended December 31, 2016,
compared with $26.4 million for the year ended January 2, 2016, a decrease in cash provided of $25.7 million, which reflected
lower year-over-year operating performance in the fourth quarter of 2016, resulting in reduced inventory turnover, partially
offset by the receipt of income tax refunds during 2016 related to 2015.
Cash used in investing activities of continuing operations was $21.6 million for the year ended December 31, 2016, compared
with cash used of $521.6 million for the year ended January 2, 2016, a decrease in cash used of $500.0 million, which mainly
reflected total cash paid of $490.7 million in connection with the Sunrise Acquisition, as well as upfront payments for Niagara
Natural and Citrusource in 2015. In addition, capital expenditures declined year-over-year by $8.6 million, reflecting higher
spending in 2015 related to a retrofit of the San Bernardino juice facility and the expansion of the Allentown aseptic beverage
facility. Cash provided by investing activities of discontinued operations in 2016 reflected cash proceeds from the sale of Opta
Minerals of $3.2 million, net of cash sold.
Cash provided by financing activities of continuing operations was $16.8 million for the year ended December 31, 2016,
compared with cash provided of $490.0 million for the year ended January 2, 2016, a decrease in cash provided of $473.2
million, which mainly reflected debt and equity issuances in connection with the Sunrise Acquisition in 2015 for proceeds of
$408.1 million in the aggregate, net of issuance costs. In addition, net borrowings under our line of credit facilities decreased
$41.7 million in 2016, compared with 2015, reflecting borrowings of $79.2 million to finance a portion of the Sunrise
Acquisition and upfront payments for Niagara Natural and Citrusource in 2015, partially offset by the payment of $13.0 million
of debt issuance costs incurred in 2016 in connection with the Notes and Global Credit Facility, and repayment of $10.0 million
of second line borrowings in 2016. In addition, we repaid the remaining $310.0 million outstanding under the second lien
borrowings with gross proceeds of $231.0 million from the issuance of the Notes and net proceeds of $79.0 million from the
issuance of the preferred stock. In 2016, we also repaid in full outstanding borrowings of $192.7 million under our former
North American and European credit facilities with new borrowings under the Global Credit Facility.
There are currently no off-balance sheet arrangements that have or are reasonably likely to have a current or future material
effect on our financial condition, results of operations, liquidity, capital expenditures or capital resources.
Contractual Obligations
The table below sets out our contractual obligations as at December 30, 2017:
(1) Includes borrowings of $215.5 million under the revolving facilities of the Global Credit Facility that have terms of six months or less. Outstanding
borrowings under these revolving facilities are repayable in full on February 10, 2021. Also includes borrowings of $15.0 million under the New
U.S. Subfacility that are repayable in quarterly instalments of $2.5 million beginning March 31, 2019.
(2) Interest on bank indebtedness is calculated based on scheduled repayments over the periods as indicated, using existing interest rates at December
30, 2017, as disclosed in note 13 to the consolidated financial statements included in Item 15 of this Form 10-K.
Variable and fixed rate borrowings carry different types of interest rate risk. Variable rate debt gives less predictability to
earnings and cash flows as interest rates change, while the fair value of fixed rate debt is affected by changes in interest rates.
As at December 30, 2017, we had $234.1 million and $228.0 million principal amount of variable and fixed rate debt,
respectively, with weighted-average interest rates of 3.4% and 9.2%, respectively. A 100 basis-point change in interest rates
would have a pre-tax effect of $2.3 million on our earnings and cash flows, based on current outstanding borrowings and
effective interest rates on our variable rate debt. While our variable-rate debt may impact earnings and cash flows as interest
rates change, it is not subject to changes in fair value.
As at December 30, 2017, most of our fixed rate debt was comprised of the Notes. If interest rates were to increase or decrease
by 100 basis-points, the fair value of the Notes would increase or decrease by approximately $8.0 million.
All of our U.S. subsidiaries use the U.S. dollar as their functional currency, and the U.S. dollar is also our reporting currency.
In addition, the functional currency of our Canadian and Mexican operations is the U.S. dollar. The functional currency of our
operations located in Europe are principally the euro. For these operations, gains or losses on translation of net assets to U.S.
dollars on consolidation are recorded in accumulated other comprehensive loss within shareholders’ equity. We are exposed
to foreign exchange rate fluctuations as the financial results of our European subsidiaries are translated into U.S. dollars on
consolidation. A 10% change in the exchange rates for the euro, relative to the U.S. dollar, would affect the carrying value of
our net assets by approximately $7.1 million, with a corresponding impact to accumulated other comprehensive loss.
The euro appreciated against the U.S. dollar during 2017, with closing rates moving from $1.0553 at December 31, 2016 to
$1.1998 at December 30, 2017. In 2017, the Canadian dollar also appreciated relative to the U.S. dollar, with closing rates
moving from $0.7448 at December 31, 2016 to $0.7971 at December 30, 2017.
Our operations based in the U.S. have limited exposure to other currencies since almost all sales and purchases are made in
U.S. dollars. The European operations are exposed to various currencies as they purchase product from a wide variety of
countries in several currencies and primarily sell into the European market. It is our intention to hold excess funds in the
currency in which the funds are likely to be used, which will from time to time potentially expose us to exchange rate
fluctuations when converted into U.S. dollars. In addition, we enter into forward foreign exchange contracts to reduce exposure
to fluctuations in foreign currency exchange rates. Open forward foreign exchange contracts were marked-to-market at
December 30, 2017, resulting in a loss of $2.4 million (December 31, 2016 – gain of $1.0 million), which is included in foreign
exchange on the consolidated statements of operations, and a loss of $0.4 million included in other comprehensive loss.
Commodity risk
We enter into exchange-traded commodity futures and options contracts to hedge its exposure to price fluctuations on grain
and certain other commodity transactions to the extent considered practicable for minimizing risk from market price
fluctuations. Futures contracts used for hedging purposes are purchased and sold through regulated commodity exchanges.
Inventories, however, may not be completely hedged, due in part to our assessment of our exposure from expected price
fluctuations. Exchange purchase and sales contracts may expose us to risk in the event that the counterparty to a transaction is
unable to fulfill its contractual obligation. We manage our risk by entering into purchase contracts with pre-approved growers.
We have a risk of loss from hedging activities if a grower does not deliver as scheduled. Sales contracts are entered into with
organizations of acceptable creditworthiness, as internally evaluated. All futures transactions are marked to market. Gains and
losses on futures transactions related to grain inventories are included in cost of goods sold. As at December 30, 2017, we
owned 280,558 (December 31, 2016 – 354,699) bushels of corn with a weighted-average price of $3.55 (December 31, 2016
– $3.17) and 254,022 (December 31, 2016 – 569,943) bushels of soybeans with a weighted-average price of $9.68 (December
31, 2016 – $10.74). As at December 30, 2017, we had a net long position on corn of 10,425 (December 31, 2016 – net short
position of 10,937) bushels and a net short position on soybeans of 9,354 (December 31, 2016 – net short position of 43,866).
An increase or decrease in commodity prices of either soy or corn of 10% would not result in a material change in the carrying
value of these commodities.
In addition, we enter into forward contracts to hedge our cocoa and coffee positions in an effort to minimize price fluctuations.
As at December 30, 2017, we had net open forward contracts to sell 299 lots of cocoa (December 31, 2016 – 142 lots) and 3
The consolidated financial statements required by this item are set forth immediately following the signature page to this
Form 10-K beginning on page F-1 and are incorporated herein by reference.
Item 9. Changes in and Disagreements With Accountants on Accounting and Financial Disclosure
None.
Our management has established disclosure controls and procedures designed to ensure that information required to be
disclosed by the Company in the reports that it files or submits under the Securities Exchange Act of 1934, as amended (the
“Exchange Act”) is recorded, processed, summarized and reported within time periods specified in the Securities and Exchange
Commission’s rules and forms. Such disclosure controls and procedures include, without limitation, controls and procedures
designed to ensure that information required to be disclosed by the Company in the reports that it files or submits under the
Exchange Act is accumulated and communicated to its management to allow timely decisions regarding required disclosure.
Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial
Officer, we conducted an evaluation of our disclosure controls and procedures (as such term is defined under Rule 13a-15(e)
promulgated under the Exchange Act) as of the end of the period covered by this annual report. Based on this evaluation, our
Chief Executive Officer and our Chief Financial Officer concluded that our disclosure controls and procedures were effective
as of December 30, 2017.
Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as defined
in Rule 13a-15(f) under the Exchange Act.
Our internal control framework and processes are designed to provide reasonable assurance to management and our board of
directors regarding the reliability of financial reporting and the preparation of our consolidated financial statements for external
purposes in accordance with accounting principles generally accepted in the United States of America.
All internal control systems, no matter how well designed, have inherent limitations. Because of these inherent limitations,
internal control over financial reporting may not prevent or detect misstatements. Therefore, even those systems determined to
be effective can provide only reasonable assurance with respect to financial statement preparation and presentation. Projections
of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of
changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
Management assessed the effectiveness of our internal control over financial reporting as of December 30, 2017. In making
this assessment, management used the criteria set forth by the Committee on Sponsoring Organizations of the Treadway
Commission in Internal Control—Integrated Framework (2013).
Based on its assessment, our management concluded that our internal control over financial reporting was effective as of
December 30, 2017, based on those criteria.
The effectiveness of our internal control over financial reporting as of December 30, 2017 has been audited by Deloitte LLP,
Independent Registered Public Accounting Firm, that also audited our consolidated financial statements for the year ended
December 30, 2017, as stated in their reports which appear herein.
There were no changes in our internal control over financial reporting during the quarter ended December 30, 2017 that
materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
We have audited the internal control over financial reporting of SunOpta Inc. and subsidiaries (the “Company”) as of December
30, 2017, based on criteria established in Internal Control—Integrated Framework (2013) issued by the Committee of
Sponsoring Organizations of the Treadway Commission (COSO). In our opinion, the Company maintained, in all material
respects, effective internal control over financial reporting as of December 30, 2017, based on criteria established in Internal
Control — Integrated Framework (2013) issued by COSO.
We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States)
(PCAOB), the consolidated financial statements as of and for the year ended December 30, 2017, of the Company and our
report dated February 28, 2018, expressed an unqualified opinion on those financial statements.
The Company’s management is responsible for maintaining effective internal control over financial reporting and for its
assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management’s
Annual Report on Internal Control Over Financial Reporting. Our responsibility is to express an opinion on the Company’s
internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and
are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the
applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the
audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all
material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk
that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the
assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit
provides a reasonable basis for our opinion.
A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the
reliability of financial reporting and the preparation of financial statements for external purposes in accordance with accounting
principles generally accepted in the United States of America. A company’s internal control over financial reporting includes
those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly
reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are
recorded as necessary to permit preparation of financial statements in accordance with accounting principles generally accepted
in the United States of America, and that receipts and expenditures of the company are being made only in accordance with
authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or
timely detection of unauthorized acquisition, use, or disposition of the Company’s assets that could have a material effect on
the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also,
projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate
because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
None.
The information required under this item is incorporated herein by reference to our Definitive Proxy Statement for the Annual
Meeting of Shareholders to be filed with the Securities and Exchange Commission not later than 120 days after December 30,
2017 (the “2018 Proxy Statement”).
The information required under this item is incorporated herein by reference from the 2018 Proxy Statement.
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
The information required under this item is incorporated herein by reference from the 2018 Proxy Statement.
Item 13. Certain Relationships and Related Transactions, and Director Independence
The information required under this item is incorporated herein by reference from the 2018 Proxy Statement.
The information required under this item is incorporated herein by reference from the 2018 Proxy Statement.
PART IV
The following documents are being filed as part of this annual report.
1. Financial Statements. See “Index to Consolidated Financial Statements” set forth on page F1.
2. Financial Statement Schedules. All schedules for which provision is made in the applicable accounting requirements of
the Securities and Exchange Commission are not required or the required information has been included within the
financial statements or the notes thereto.
3. Exhibits. The list of exhibits in the Exhibit Index included in this annual report is incorporated herein by reference.
EXHIBIT INDEX
Exhibits Description
2.1+ Asset Purchase Agreement, dated August 11, 2015, among SunOpta Inc., Niagara Natural Fruit Snack
Company Inc., John Boot and Guy Armstrong (incorporated by reference to Exhibit 2.1 to the Company’s
Current Report on Form 8-K filed on August 17, 2015).
3.1 Amalgamation of Stake Technology Ltd. and 3754481 Canada Ltd. (formerly George F. Pettinos (Canada)
Limited) (incorporated by reference to Exhibit 3.1 to the Company’s Annual Report on Form 10-KSB for
the year ended December 31, 2000).
3.2 Certificate of Amendment, dated October 31, 2003, to change the Company’s name from Stake
Technology Ltd. to SunOpta Inc. (incorporated by reference to Exhibit 3i(b) to the Company’s Annual
Report on Form 10-K for the year ended December 31, 2003).
3.3 Articles of Amalgamation of SunOpta Inc. and Sunrich Valley Inc., Integrated Drying Systems Inc., Kettle
Valley Dried Fruits Ltd., Pro Organics Marketing Inc., Pro Organics Marketing (East) Inc., 4157648
Canada Inc. and 4198000 Canada Ltd., dated January 1, 2004 (incorporated by reference to Exhibit 3i(c)
to the Company’s Annual Report on Form 10-K for the year ended December 31, 2003).
3.4 Articles of Amalgamation of SunOpta Inc. and 6319734 Canada Inc., 4157656 Canada Inc. Kofman-
Barenholtz Foods Limited, dated January 1, 2005 (incorporated by reference to Exhibit 3i(d) to the
Company’s Annual Report on Form 10-K for the year ended December 31, 2004).
3.5 Articles of Amalgamation of SunOpta Inc. and 4307623 Canada Inc., dated January 1, 2006 (incorporated
by reference to Exhibit 3i(e) to the Company’s Annual Report on Form 10-K for the year ended December
31, 2005).
3.6 Articles of Amalgamation of SunOpta Inc., 4208862 SunOpta Food Ingredients Canada Ltd., 4406150
Canada Inc. and 4406168 Canada Inc., dated January 1, 2007 (incorporated by reference to Exhibit 3i(f)
to the Company’s Annual Report on Form 10-K for the year ended December 31, 2007).
3.7 Articles of Amalgamation of SunOpta Inc. and 4460596 Canada Inc., dated January 1, 2008 (incorporated
by reference to Exhibit 3i(g) to the Company’s Annual Report on Form 10-K for the year ended December
31, 2007).
3.8 Amended and Restated By-law No. 14, dated May 27, 2010 (incorporated by reference to Exhibit 4.4 to
the Company’s Registration Statement on Form S-3 filed on July 3, 2014).
3.9 Certificate of Amendment, dated July 10, 2013, to authorize the directors to fix the number of directors to
be elected by the shareholders and to appoint one or more directors (incorporated by reference to Exhibit
4.3 to the Company’s Registration Statement on Form S-3 filed on July 3, 2014).
3.10 By-Law Number 15 of SunOpta Inc. (incorporated by reference to Exhibit 3.1 to the Company’s Current
Report on Form 8-K filed on November 13, 2015).
4.1 Form of Certificate representing Common Shares, no par value (incorporated by reference to Exhibit 4.9
to the Company’s Registration Statement on Form S-8 filed on September 2, 2011).
4.2 Shareholder Rights Plan Agreement, dated November 10, 2015, between SunOpta Inc. and American
Stock Transfer & Trust Company LLC, as rights agent (incorporated by reference to Exhibit 4.1 to the
Company’s Current Report on Form 8-K filed on November 13, 2015).
4.3 Amended and Restated Shareholder Rights Plan Agreement, dated November 10, 2015, amended and
restated as of April 18, 2016, between SunOpta Inc. and American Stock Transfer & Trust Company LLC,
as rights agent (incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K
filed on April 20, 2016).
4.4 Amended and Restated Certificate of Incorporation of SunOpta Foods Inc., setting forth the terms of its
Series A Preferred Stock, which is exchangeable for Common Shares of SunOpta Inc. (incorporated by
reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K filed on October 12, 2016).
4.5 Articles of Amendment of SunOpta Inc., setting forth the terms of its Special Shares, Series 1
(incorporated by reference to Exhibit 4.2 to the Company’s Current Report on Form 8-K filed on October
12, 2016).
4.6 Indenture, dated as of October 20, 2016, among SunOpta Foods, the guarantors named therein and U.S.
Bank National Association, as trustee and notes collateral agent (incorporated by reference to Exhibit 4.1
to the Company’s Current Report on Form 8-K filed on October 26, 2016).
4.7 Form of 9.5% Senior Secured Second Lien Notes due 2022 (incorporated by reference to Exhibit 4.2 to
the Company’s Current Report on Form 8-K filed on October 26, 2016).
4.8 Second Lien U.S. Security Agreement, dated as of October 20, 2016, among the grantors referred therein
and the Notes Collateral Agent (incorporated by reference to Exhibit 4.3 to the Company’s Current Report
on Form 8-K filed on October 26, 2016).
4.9 Second Lien Canadian Security Agreement, dated as of October 20, 2016, among the grantors referred
therein and the Notes Collateral Agent (incorporated by reference to Exhibit 4.4 to the Company’s Current
Report on Form 8-K filed on October 26, 2016).
4.10 Amended and Restated Intercreditor Agreement, dated as of October 20, 2016, among Bank of America,
N.A. as first lien collateral agent, the Notes Collateral Agent and the grantors referred therein
(incorporated by reference to Exhibit 4.5 to the Company’s Current Report on Form 8-K filed on October
26, 2016).
10.1† Employee Stock Purchase Plan amended March 4, 2013 (incorporated by reference to Exhibit 10.1 to the
Company’s Annual Report on Form 10-K for the year ended December 29, 2012).
10.2† Retiring Allowance Agreement, dated March 8, 2011, between the Company and Jeremy Kendall which
terminates and supersedes the Employment Agreement dated October 1, 2001 between the Company and
Mr. Jeremy Kendall, as amended (incorporated by reference to Exhibit 10.3 to the Company’s Annual
Report on Form 10-K for the year ended December 31, 2010).
10.3† SunOpta Inc. 2002 Stock Option Plan, Amended and Restated May 2011 (incorporated by reference to
Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on May 24, 2011).
10.4† Letter Agreement, dated October 10, 2011, by and between SunOpta Inc. and Robert McKeracher
(incorporated by reference to Exhibit 10.1 to the Company’s Quarterly Report on Form 10-Q for the
quarter ended October 1, 2011).
10.5 Stock Deferral Plan for Non-Employee Directors dated August 12, 2014 (incorporated by reference to
Exhibit 10.1 to the Company’s Quarterly Report on Form 10-Q for the quarter ended July 5, 2014).
10.6† Letter Agreement re Terms of Employment, dated October 10, 2011, by and between SunOpta Inc. and
John Ruelle (incorporated by reference to Exhibit 10.13 to the Company’s Annual Report on Form 10-K
for the year ended January 3, 2015).
10.7† Letter Agreement re Amendment of Terms of Employment, dated April 5, 2013, by and between SunOpta
Inc. and John Ruelle (incorporated by reference to Exhibit 10.14 to the Company’s Annual Report on
Form 10-K for the year ended January 3, 2015).
10.8† Letter Agreement re Amendment of Terms of Employment, dated December 30, 2014, by and between
SunOpta Inc. and John Ruelle (incorporated by reference to Exhibit 10.15 to the Company’s Annual
Report on Form 10-K for the year ended January 3, 2015).
10.9† Employment Agreement, dated April 2012, by and between The Organic Corporation B.V. and G.J.M.
Versteegh (incorporated by reference to Exhibit 10.16 to the Company’s Annual Report on Form 10-K
for the year ended January 3, 2015).
10.10† Separation Agreement, dated July 6, 2015, between SunOpta Inc. and Steven Bromley (incorporated by
reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed on July 7, 2015).
10.11 Commitment Letter dated July 30, 2015, among SunOpta Inc., SunOpta Foods Inc., Bank of Montreal and
BMO Capital Corp. (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form
8-K filed on August 3, 2015).
10.12+ Second Lien Loan Agreement, dated October 9, 2015, among SunOpta Inc., as Holdings, SunOpta Foods
Inc., as the Borrower, Certain Subsidiaries of SunOpta Inc., as Subsidiary Guarantors and Loan Parties,
the Several Lenders from Time to Time Parties Hereto, Bank of Montreal, as Administrative Agent and
Collateral Agent, BMO Capital Markets Corp. and Coӧperatieve Centrale Raiffeisen-Boerenleenbank
B.A., “Rabobank Nederland”, New York Branch, as Joint Lead Arrangers and Joint Bookrunners
(incorporated by reference to Exhibit 10.5 to the Company’s Quarterly Report on Form 10-Q for the
quarter ended October 3, 2015).
10.13+ Credit Agreement, dated as of February 11, 2016, among SunOpta Inc., SunOpta Foods Inc., The Organic
Corporation B.V., the other borrowers and guarantors party thereto, the lenders party thereto, Bank of
America, N.A., as U.S. Administrative Agent, Bank of America, N.A. (acting through its Canada Branch),
as Canadian Administrative Agent, Bank of America, N.A. (acting through its London Branch), as Dutch
Administrative Agent, and Bank of America, N.A., as Collateral Agent (incorporated by reference to
Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on February 17, 2016).
10.14 Support Agreement dated February 12, 2016, among SunOpta Inc., Wedge Acquisition Inc. and Wedge
Acquisition Holdings Inc. (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on
Form 8-K filed on February 18, 2016).
10.15 Second Amending Agreement, dated October 9, 2015, amending the Seventh Amended and Restated
Credit Agreement, among SunOpta Inc. and SunOpta Foods, as Borrowers, Each of the Financial
Institutions and Other Entities from Time to Time Parties Thereto, as Lenders, Certain Affiliates of the
Borrowers, as Obligors, and Bank of Montreal, as Agent (incorporated by reference to Exhibit 10.19 to
the Company’s Annual Report on Form 10-K for the year ended January 2, 2016).
10.16† Amended 2013 Stock Incentive Plan (incorporated by reference to Exhibit C to the Company’s Definitive
Proxy Statement on Schedule 14A filed on March 31, 2016).
10.17† Form of Incentive Stock Option Award Agreement under Amended 2013 Stock Incentive Plan
(incorporated by reference to Exhibit 10.2 to the Company’s Quarterly Report on Form 10-Q for the
quarter ended July 2, 2016).
10.18† Form of Restricted Stock Unit Award Agreement (Non-Employee Directors) under Amended 2013 Stock
Incentive Plan (incorporated by reference to Exhibit 10.3 to the Company’s Quarterly Report on Form 10-
Q for the quarter ended July 2, 2016).
10.19† Form of 2016 Performance Share Unit Award Agreement under 2013 Amended Stock Incentive Plan
(incorporated by reference to Exhibit 10.4 to the Company’s Quarterly Report on Form 10-Q for the
quarter ended July 2, 2016).
10.20† Employment Agreement, dated August 18, 2016, by and between SunOpta Inc. and Jill E. Barnett
(incorporated by reference to Exhibit 10.6 to the Company’s Quarterly Report on Form 10-Q for the
quarter ended October 1, 2016).
10.21† Employment Agreement, dated August 18, 2016, by and between SunOpta Inc. and James P. Gratzek
(incorporated by reference to Exhibit 10.7 to the Company’s Quarterly Report on Form 10-Q for the
quarter ended October 1, 2016).
10.22† Employment Agreement Amendment, dated August 19, 2016, by and between The Organic Corporation
B.V. and G.J.M. Versteegh (incorporated by reference to Exhibit 10.9 to the Company’s Quarterly Report
on Form 10-Q for the quarter ended October 1, 2016).
10.23 First Amendment, dated as of October 7, 2016, to the Credit Agreement, dated as of February 11, 2016,
among SunOpta Inc., SunOpta Foods Inc., The Organic Corporation B.V., each of the other borrowers
and guarantors party thereto from time to time, the lenders party thereto from time to time, Bank of
America, N.A., as U.S. Administrative Agent, Bank of America, N.A. (acting through its Canada Branch),
as Canadian Administrative Agent, Bank of America, N.A. (acting through its London Branch), as Dutch
Administrative Agent under the Dutch, and Bank of America, N.A, as Collateral Agent (incorporated by
reference to Exhibit 10.11 to the Company’s Quarterly Report on Form 10-Q for the quarter ended October
1, 2016).
10.24 First Amendment, dated as of October 7, 2016, to the Second Lien Loan Agreement, dated as of October
9, 2015, among SunOpta Inc., SunOpta Foods Inc., certain subsidiaries of SunOpta Inc., the several banks
and other financial institutions or entities from time to time party thereto, and Bank of Montreal, as
Administrative Agent and Collateral Agent (incorporated by reference to Exhibit 10.12 to the Company’s
Quarterly Report on Form 10-Q for the quarter ended October 1, 2016).
10.25 Subscription Agreement, dated October 7, 2016, between SunOpta Inc., SunOpta Foods Inc. and Oaktree
Organics, L.P. and Oaktree Huntington Investment Fund II, L.P. (incorporated by reference to Exhibit
10.1 to the Company’s Current Report on Form 8-K filed on October 12, 2016).
10.26 Investor Rights Agreement, dated October 7, 2016, between SunOpta Inc., SunOpta Foods Inc. and
Oaktree Organics, L.P. and Oaktree Huntington Investment Fund II, L.P. (incorporated by reference to
Exhibit 10.2 to the Company’s Current Report on Form 8-K filed on October 12, 2016).
10.27 Exchange and Support Agreement, dated October 7, 2016, between SunOpta Inc., SunOpta Foods Inc.,
Oaktree Organics, L.P. and Oaktree Huntington Investment Fund II, L.P. and any person that becomes a
Holder of Preferred Stock, from time to time (incorporated by reference to Exhibit 10.3 to the Company’s
Current Report on Form 8-K filed on October 12, 2016).
10.28 Voting Trust Agreement, dated October 7, 2016, between SunOpta Inc., SunOpta Foods Inc., the trustee
named therein, Oaktree Organics, L.P. and Oaktree Huntington Investment Fund II, L.P. and any other
Holder of Preferred Stock, from time to time (incorporated by reference to Exhibit 10.4 to the Company’s
Current Report on Form 8-K filed on October 12, 2016).
10.29† Letter Agreement, dated November 8, 2016, between Hendrik Jacobs and SunOpta Inc. (incorporated by
reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on November 15, 2016).
10.30† Letter Agreement, dated November 8, 2016, between Robert McKeracher and SunOpta Inc. (incorporated
by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed on November 15, 2016).
10.31† Letter Agreement, dated November 8, 2016, between John Ruelle and SunOpta Inc. (incorporated by
reference to Exhibit 10.3 to the Company’s Current Report on Form 8-K filed on November 15, 2016).
10.32† Letter Agreement, dated November 8, 2016, between Gerard Versteegh and SunOpta Inc. (incorporated
by reference to Exhibit 10.4 to the Company’s Current Report on Form 8-K filed on November 15, 2016).
10.33† Employment Agreement, effective February 6, 2017, between SunOpta Inc. and David J. Colo
(incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on
February 7, 2017).
10.34† Restricted Stock Award Agreement, dated effective February 6, 2017, between SunOpta Inc. and David
J. Colo (incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed on
February 7, 2017).
10.35† Stock Option Award Agreement, dated effective February 6, 2017, between SunOpta Inc. and David J.
Colo (incorporated by reference to Exhibit 10.3 to the Company’s Current Report on Form 8-K filed on
February 7, 2017).
10.36† Performance Share Unit Award Agreement, dated effective February 6, 2017, between SunOpta Inc. and
David J. Colo (incorporated by reference to Exhibit 10.4 to the Company’s Current Report on Form 8-K
filed on February 7, 2017).
10.37 Second Amendment and Joinder, dated September 19, 2017, to the Credit Agreement, dated as of February
11, 2016, among SunOpta Inc., SunOpta Foods Inc., The Organic Corporation B.V., the other borrowers
and guarantors party thereto, the lenders party thereto, Bank of America, N.A., as U.S. Administrative
Agent, Bank of America, N.A. (acting through its Canada Branch), as Canadian Administrative Agent,
Bank of America, N.A. (acting through its London Branch), as Dutch Administrative Agent, and Bank of
America, N.A., as Collateral Agent (incorporated by reference to Exhibit 10.1 to the Company’s Current
Report on Form 8-K filed on September 22, 2017).
10.38† Separation Agreement and Full and Final Release between SunOpta Inc. and Edward Haft (incorporated
by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on August 28, 2017).
10.39 Consent to Purchase Shares, dated May 6, 2017, between SunOpta Inc. and Oaktree Organics, L.P.
(incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K (incorporated
by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on May 8, 2017).
10.40 Amendment Agreement, dated May 6, 2017, between SunOpta Inc., Oaktree Organics, L.P., Oaktree
Huntington Investment Fund II, L.P., SunOpta Foods Inc. and OCM SunOpta Trustee, LLC. (incorporated
by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed on May 8, 2017).
10.41† Restricted Stock Award Agreement, dated effective March 9, 2017, between SunOpta Inc. and David J.
Colo (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on
March 13, 2017, as amended).
10.42† Separation Agreement, dated March 3, 2017, by and between SunOpta Inc. and Michelle Coleman
(incorporated by reference to Exhibit 10.3 to the Company’s Quarterly Report on Form 10-Q for the
quarterly period ended April 1, 2017).
10.43† Employment Agreement, dated March 13, 2017, by and between SunOpta Inc. and Robert Duchscher
(incorporated by reference to Exhibit 10.5 to the Company’s Quarterly Report on Form 10-Q for the
quarterly period ended April 1, 2017).
10.44† Employment Agreement, dated April 1, 2017, by and between SunOpta Inc. and Jeffrey Gough
(incorporated by reference to Exhibit 10.6 to the Company’s Quarterly Report on Form 10-Q for the
quarterly period ended April 1, 2017).
10.45† Amended 2013 Stock Incentive Plan (incorporated by reference to Exhibit A to the Company’s Definitive
Proxy Statement on Schedule 14A filed on April 13, 2017).
10.46† Form of 2017 Incentive Stock Option Award Agreement under Amended 2013 Stock Incentive Plan
(incorporated by reference to Exhibit 10.10 to the Company’s Quarterly Report on Form 10-Q for the
quarterly period ended July 1, 2017).
10.47† Form of 2017 Restricted Stock Unit Award Agreement under Amended 2013 Stock Incentive Plan
(incorporated by reference to Exhibit 10.11 to the Company’s Quarterly Report on Form 10-Q for the
quarterly period ended July 1, 2017).
10.48† Form of 2017 Performance Share Unit Award Agreement under Amended 2013 Stock Incentive Plan
(incorporated by reference to Exhibit 10.12 to the Company’s Quarterly Report on Form 10-Q for the
quarterly period ended July 1, 2017).
10.49† Employment Agreement, effective January 23, 2017, by and between SunOpta Inc. and Patrick McCoy
(incorporated by reference to Exhibit 10.49 to the Company’s Annual Report on Form 10-K for the year
ended December 30, 2017, filed on March 1, 2018).
10.50† Employment Agreement, effective February 21, 2017, by and between SunOpta Inc. and Michael J. Buick
(incorporated by reference to Exhibit 10.50 to the Company’s Annual Report on Form 10-K for the year
ended December 30, 2017, filed on March 1, 2018).
10.51† Employment Agreement, effective March 6, 2017, by and between SunOpta Inc. and Robert S. Grant
(incorporated by reference to Exhibit 10.51 to the Company’s Annual Report on Form 10-K for the year
ended December 30, 2017, filed on March 1, 2018).
10.52† Employment Agreement, effective April 10, 2017, by and between SunOpta Inc. and Christopher
Whitehair (incorporated by reference to Exhibit 10.52 to the Company’s Annual Report on Form 10-K for
the year ended December 30, 2017, filed on March 1, 2018).
10.53† Employment Agreement, effective November 1, 2017, by and between SunOpta Inc. and George Miketa
(incorporated by reference to Exhibit 10.53 to the Company’s Annual Report on Form 10-K for the year
ended December 30, 2017, filed on March 1, 2018).
21 List of subsidiaries (incorporated by reference to Exhibit 21 to the Company’s Annual Report on Form
10-K for the year ended December 30, 2017, filed on March 1, 2018).
23.1 Consent of Deloitte LLP, Independent Registered Public Accounting Firm (incorporated by reference to
Exhibit 23.1 to the Company’s Annual Report on Form 10-K for the year ended December 30, 2017, filed
on March 1, 2018).
31.1* Certification by David Colo, President and Chief Executive Officer, pursuant to Rule 13a – 14(a) under
the Securities Exchange Act of 1934, as amended.
31.2* Certification by Robert McKeracher, Vice President and Chief Financial Officer, pursuant to Rule 13a –
14(a) under the Securities Exchange Act of 1934, as amended.
32* Certifications by David Colo, President and Chief Executive Officer, and Robert McKeracher, Vice
President and Chief Financial Officer, pursuant to 18 U.S.C. Section 1350.
+ Exhibits and schedules to this exhibit have been omitted pursuant to Item 601(b)(2) of Regulation S-K. SunOpta will
furnish copies of the omitted exhibits and schedules to the Securities and Exchange Commission upon its request.
* Filed herewith.
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this
report to be signed on its behalf by the undersigned, thereunto duly authorized.
SUNOPTA INC.
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons
on behalf of the registrant and in the capacities and on the dates indicated.
The Company has chosen not to include an optional summary of the information required by this Form 10-K. For a reference
to information in the Form 10-K, investors should refer to the Table of Contents to this Form 10-K.
Page
Report of Independent Registered Public Accounting Firm F2
Consolidated Statements of Operations
For the years ended December 30, 2017, December 31, 2016 and January 2, 2016 F3
Consolidated Statements of Comprehensive Loss
For the years ended December 30, 2017, December 31, 2016 and January 2, 2016 F4
Consolidated Balance Sheets
As at December 30, 2017 and December 31, 2016 F5
Consolidated Statements of Shareholders’ Equity
As at and for the years ended December 30, 2017, December 31, 2016 and January
2, 2016 F6
Consolidated Statements of Cash Flows
For the years ended December 30, 2017, December 31, 2016 and January 2, 2016 F7
Notes to Consolidated Financial Statements
For the years ended December 30, 2017, December 31, 2016 and January 2, 2016 F9
We have audited the accompanying consolidated balance sheets of SunOpta Inc. and subsidiaries (the “Company”) as of
December 30, 2017 and December 31, 2016, the related consolidated statements of operations, comprehensive loss,
shareholders’ equity, and cash flows, for each of the three years in the period ended December 30, 2017, and the related notes
(collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material
respects, the financial position of the Company as of December 30, 2017 and December 31, 2016, and the results of its
operations and its cash flows for each of the three years in the period ended December 30, 2017, in conformity with accounting
principles generally accepted in the United States of America.
We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States)
(PCAOB), the Company's internal control over financial reporting as of December 30, 2017, based on criteria established in
Internal Control — Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway
Commission and our report dated February 28, 2018, expressed an unqualified opinion on the Company's internal control over
financial reporting.
These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on
the Company’s financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are
required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable
rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform
the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due
to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial
statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included
examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included
evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall
presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.
Earnings (loss) from continuing operations before the following (137,893) (31,086) 9,147
Loss from continuing operations before income taxes (170,397) (74,361) (6,522)
ASSETS
Current assets
Cash and cash equivalents 3,228 1,251
Accounts receivable (note 8) 125,152 157,369
Inventories (note 9) 354,978 368,482
Prepaid expenses and other current assets 33,213 19,794
Current income taxes recoverable 12,006 2,801
Total current assets 528,577 549,697
LIABILITIES
Current liabilities
Bank indebtedness (note 13) 234,090 201,494
Accounts payable and accrued liabilities (note 12) 161,364 173,745
Customer and other deposits 4,901 2,543
Income taxes payable 1,351 5,661
Other current liabilities 818 1,016
Current portion of long-term debt (note 13) 2,228 2,079
Current portion of long-term liabilities 5,300 5,500
Total current liabilities 410,052 392,038
EQUITY
SunOpta Inc. shareholders’ equity
Common shares, no par value, unlimited shares authorized,
86,757,334 shares issued (December 31, 2016 - 85,743,958) (note 15) 308,899 300,426
Additional paid-in capital 28,006 25,522
Retained earnings (accumulated deficit) (89,291) 53,838
Accumulated other comprehensive loss (note 17) (7,268) (13,104)
240,346 366,682
Non-controlling interests 1,575 2,731
Total equity 241,921 369,413
Retained Accumulated
Additional earnings other com- Non-
paid-in (accumu- prehensive controlling
Common shares capital lated deficit) income (loss) interests Total
000s $ $ $ $ $ $
Balance at January 3, 2015 67,074 190,668 22,490 129,309 (1,778) 12,639 353,328
Balance at January 2, 2016 85,418 297,987 22,327 106,838 (6,113) 5,140 426,179
Balance at December 31, 2016 85,744 300,426 25,522 53,838 (13,104) 2,731 369,413
Balance at December 30, 2017 86,757 308,899 28,006 (89,291) (7,268) 1,575 241,921
SunOpta Inc. (the “Company” or “SunOpta”) was incorporated under the laws of Canada on November 13, 1973. The
Company operates businesses focused on a healthy products portfolio that promotes sustainable well-being. The Company’s
two reportable segments, Global Ingredients and Consumer Products, operate in the natural, organic and specialty food sectors
and utilize an integrated business model to bring cost-effective and quality products to market.
Basis of Presentation
These consolidated financial statements have been prepared by the Company in United States (“U.S.”) dollars and in accordance
with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The consolidated financial
statements include the accounts of the Company and those of its wholly-owned and majority-owned subsidiaries. All
intercompany accounts and transactions have been eliminated on consolidation.
Fiscal Year
The fiscal year of the Company consists of a 52- or 53-week period ending on the Saturday closest to December 31. Fiscal years
2017, 2016 and 2015 were each 52-week periods ending on December 30, 2017, December 31, 2016 and January 2, 2016,
respectively. Fiscal year 2018 will be a 52-week period ending on December 29, 2018, with quarterly periods ending on March
31, June 30, and September 29, 2018.
Use of Estimates
The preparation of financial statements in conformity with U.S. GAAP requires management to make certain estimates and
assumptions that affect the reported amounts in the consolidated financial statements and accompanying notes. Areas involving
significant estimates and assumptions include: allocation of the purchase price of acquired businesses; inventory valuation
reserves; income tax liabilities and assets, and related valuation allowances; provisions for loss contingencies related to claims
and litigation; fair value of contingent consideration liabilities; useful lives of property, plant and equipment and intangible
assets; expected future cash flows used in evaluating long-lived assets for impairment; and reporting unit fair values in testing
goodwill for impairment. The estimates and assumptions made require judgment on the part of management and are based on
the Company’s historical experience and various other factors that are believed to be reasonable in the circumstances.
Management continually evaluates the information that forms the basis of its estimates and assumptions as the business of the
Company and the general business environment changes.
Business Acquisitions
Acquired businesses are accounted for using the acquisition method of accounting, which requires that assets acquired and
liabilities assumed be recorded at fair value, with limited exceptions. Any excess of the purchase price over the fair value of the
net assets acquired is recorded as goodwill. Acquisition-related transaction costs are accounted for as an expense in the period
in which the costs are incurred. Contingent consideration is measured at fair value and recognized as part of the consideration
transferred in exchange for the acquired businesses. Contingent consideration liabilities are remeasured to fair value at each
reporting date with the changes in fair value recognized in other expense/income on the consolidated statements of operations.
Financial Instruments
The Company’s financial instruments recognized in the consolidated balance sheets and included in working capital consist of
cash and cash equivalents, accounts receivable, derivative instruments, accounts payable and accrued liabilities, and customer
and other deposits. Cash and cash equivalents, inventories carried at market and derivative instruments are measured at fair
value each reporting period. The fair values of the remaining financial instruments approximate their carrying values due to
their short-term maturities.
The Company’s financial instruments exposed to credit risk include cash equivalents, accounts receivable and derivative
instruments. The Company places its cash and cash equivalents with institutions of high creditworthiness. To limit the credit
risk associated with derivative instruments, the Company contracts with counterparties that are highly-rated financial
institutions. The Company’s trade accounts receivable are not subject to a high concentration of credit risk. The Company
routinely assesses the financial strength of its customers and believes that its accounts receivable credit risk exposure is limited.
The Company maintains an allowance for losses based on the expected collectability of the accounts receivable.
The Company has various financial assets and liabilities that are measured at fair value on a recurring basis, including certain
inventories and derivatives, as well as contingent consideration. The Company also applies the provisions of fair value
measurement to various non-recurring measurements for financial and non-financial assets and liabilities measured at fair value
on a non-recurring basis.
Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction
between market participants at the measurement date (that is, an exit price). Fair value measurements are estimated based on
inputs categorized as follows:
x Level 1 inputs include quoted prices (unadjusted) for identical assets or liabilities in active markets that are observable.
x Level 2 inputs include quoted prices for similar assets or liabilities in active markets; quoted prices for identical or
similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the
asset or liability; and inputs that are derived principally from or corroborated by observable market data by correlation
or other means.
x Level 3 includes unobservable inputs that reflect the Company’s own assumptions about what factors market
participants would use in pricing the asset or liability.
When measuring fair value, the Company maximizes the use of observable inputs and minimizes the use of unobservable
inputs.
The assets and liabilities of the Company’s operations having a functional currency other than the U.S. dollar are translated
into U.S. dollars at the exchange rate prevailing at the balance sheet date, and at the average rate for the reporting period for
revenue and expense items. The cumulative currency translation adjustment is recorded as a component of accumulated other
comprehensive income in shareholders’ equity. Foreign currency gains and losses related to the remeasurement of the
Company’s Mexican operation into its U.S. dollar functional currency are recognized in earnings.
Exchange gains and losses on transactions occurring in a currency other than an operation’s functional currency are recognized
in earnings.
Cash and cash equivalents consist of cash and short-term deposits with an original maturity of 90 days or less.
Accounts Receivable
Accounts receivable includes trade receivables that are recorded at the invoiced amount and do not bear interest. The allowance
for doubtful accounts is an estimate of the amount of probable credit losses in existing accounts receivable. Account balances
are charged off against the allowance when the Company determines the receivable will not be recovered. As at December 30,
2017 and December 31, 2016, no customer’s balance represented 10% or more of the Company’s consolidated trade receivables
balance.
Inventories
Inventories (excluding commodity grains) are valued at the lower of cost and net realizable value. Shipping and handling costs
are included in cost of goods sold on the consolidated statements of operations.
Inventories of commodity grains, which include amounts acquired under deferred pricing contracts traded on the Chicago
Board of Trade (“CBoT”), are valued at market. Grain inventory quantities at year-end are multiplied by the quoted price on
the CBoT to reflect the market value of the inventory. This market value is then adjusted for a basis factor that represents
differences in local markets, and broker and dealer quotes to arrive at market. Changes in CBoT prices or the basis factor are
included in cost of goods sold on the consolidated statements of operations.
SunOpta economically hedges its commodity grain positions to protect gains and minimize losses due to market fluctuations.
Futures contracts and purchase and sale contracts are adjusted to market price and resulting gains and losses from these
transactions are included in cost of goods sold. As the Company has a risk of loss from hedge activity if the grower does not
deliver the grain as scheduled, these transactions do not qualify as hedges under U.S. GAAP and, therefore, changes in market
value are recorded in cost of goods sold on the consolidated statements of operations.
Property, plant and equipment are stated at cost, less accumulated depreciation. Depreciation is provided using the straight-
line basis at rates reflecting the estimated useful lives of the assets.
Buildings 20 - 40 years
Machinery and equipment 5 - 20 years
Enterprise software 3 - 5 years
Office furniture and equipment 3 - 7 years
Vehicles 3 - 7 years
Goodwill
Goodwill represents the excess in a business combination of the purchase price over the estimated fair value of the identifiable
net assets acquired. Goodwill is not amortized but is instead tested for impairment at least annually, or whenever events or
circumstances change between the annual impairment tests that would indicate the carrying amount of goodwill may be
impaired. The Company performs its annual test for goodwill impairment in the fourth quarter of each fiscal year. Prior to
fiscal 2017, the Company performed a quantitative test for goodwill impairment by comparing the carrying amount of each
reporting unit to its estimated fair value (Step 1). If the carrying amount exceeded the reporting unit’s fair value, there was a
potential impairment of goodwill. Any impairment of goodwill was measured by comparing the implied fair value of goodwill
with its carrying amount (Step 2). The implied fair value of goodwill was determined by deducting the fair value of all the
assets and liabilities of the reporting unit from the reporting unit’s fair value as determined in Step 1.
Effective with the fiscal 2017 annual impairment test, the Company elected the early adoption of ASU 2017-04, “Simplifying
the Test for Goodwill Impairment”, which simplifies the accounting for goodwill impairment by eliminating the requirement
to calculate the implied fair value of goodwill as contemplated by Step 2 of the prior goodwill impairment test model. Instead,
impairment charges are recognized based on the excess of a reporting unit’s carrying amount over its fair value as contemplated
by Step 1 of the goodwill impairment model. The fair values of the Company’s reporting units are determined using an income
approach (discounted cash flow method). The results of the Company annual impairment tests for goodwill are described in
note 11.
Intangible Assets
The Company’s finite-lived intangible assets consist of customer and other relationships, patents and trademarks, and other
intangible assets. These intangible assets are amortized on a straight-line basis over their estimated useful lives as follows:
The Company reviews its long-lived assets for impairment whenever events or changes in circumstances indicate that the
carrying amounts of the assets may not be recoverable through undiscounted future cash flows. If impairment exists based on
expected future undiscounted cash flows, a loss is recognized in earnings. The amount of the impairment loss is the excess of
the carrying amount of the impaired asset over the fair value of the asset, typically determined using a discounted cash flow
analysis (income approach).
Derivative Instruments
The Company is exposed to fluctuations in commodity prices and foreign currency exchange. The Company utilizes certain
derivative financial instruments to enhance its ability to manage these risks, including exchange-traded commodity futures,
commodity forward purchase and sale contracts and forward foreign exchange contracts. Derivative instruments are entered
into for periods consistent with related underlying exposures and do not constitute positions independent of those exposures.
The Company does not enter into contracts for speculative purposes.
All derivative instruments are recognized on the consolidated balance sheets at fair value. Changes in the fair value of
derivative instruments are recorded in earnings or other comprehensive earnings, based on whether the instrument is designated
as part of a hedge transaction. Gains or losses on derivative instruments reported in accumulated other comprehensive income
are reclassified to earnings in the period in which earnings are affected by the underlying hedged item. The ineffective portion
of all hedges is recognized in earnings in the current period. As at December 30, 2017, the Company utilized the following
derivative instruments to manage commodity and foreign currency risks:
x Exchange-traded commodity futures contracts to economically hedge its exposure to price fluctuations on grain and
cocoa transactions to the extent considered practicable for minimizing risk from market price fluctuations. Futures
contracts used for economical hedging purposes are purchased and sold through regulated commodity exchanges in
the U.S. However, inventories may not be completely hedged, due in part to the Company’s assessment of its exposure
from expected price fluctuations. Forward purchase and sale contracts may expose the Company to risk in the event
that a counterparty to a transaction is unable to fulfill its contractual obligation or if a grower does not deliver grain
as scheduled. The Company manages its risk by entering into purchase contracts with pre-approved growers and sale
contracts are entered into with organizations of acceptable creditworthiness, as internally evaluated. All futures and
forward purchase and sale contracts are marked-to-market. Gains and losses on these transactions are included in cost
of goods sold on the consolidated statements of operations.
x Forward foreign exchange contracts to minimize exchange rate fluctuations relating to foreign currency denominated
purchase and sale contracts and accounts payable and receivable. Forward foreign exchange contracts designated as
hedges are marked-to-market with the effective portion of the gain or loss recognized in other comprehensive earnings
and subsequently recognized in earnings in the same period the hedged item affects earnings. Gains and losses on
forward exchange contracts not specifically designated as hedging instruments are included in foreign exchange
gain/loss on the consolidated statements of operations.
Costs incurred in connection with obtaining debt financing are deferred and amortized over the term of the financing
arrangement using the effective interest method. Costs incurred to secure revolving lines of credit are recorded in other long-
term assets. All other debt issuance costs are recorded as a direct deduction from the related debt liability.
Customer and other deposits include prepayments by customers for merchandise inventory to be purchased at a future date.
Income Taxes
The Company follows the asset and liability method of accounting for income taxes whereby deferred income tax assets are
recognized for deductible temporary differences and operating loss carry-forwards, and deferred income tax liabilities are
recognized for taxable temporary differences. Temporary differences are the differences between the amounts of assets and
liabilities recorded for income tax and financial reporting purposes.
Deferred income tax assets are recognized only to the extent that management determines that it is more likely than not that the
deferred income tax assets will be realized. Deferred income tax assets and liabilities are adjusted for the effects of changes in
tax laws and rates on the date of enactment. The income tax expense or benefit is the income tax payable or recoverable for
the year plus or minus the change in deferred income tax assets and liabilities during the year.
The Company is subject to ongoing tax exposures, examinations and assessments in various jurisdictions. Accordingly, the
Company may incur additional income tax expense based upon the outcomes of such matters. In addition, when applicable,
the Company adjusts income tax expense to reflect the Company’s ongoing assessments of such matters, which requires
judgment and can materially increase or decrease its effective rate as well as impact operating results. The evaluation of tax
positions taken or expected to be taken in a tax return is a two-step process, whereby (1) the Company determines whether it
is more likely than not that the tax positions will be sustained based on the technical merits of the position, and (2) for those
tax positions that meet the more-likely-than-not recognition threshold, the Company recognizes the largest amount of tax
benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the related tax authority.
The Company maintains a stock incentive plan under which stock options and other stock-based awards may be granted to
selected employees and directors. The Company measures stock-based awards at fair value as of the date of grant.
Compensation expense is recognized on a straight-line basis over vesting period of the entire stock-based award based on the
estimated number of awards that are expected to vest. When exercised, stock-based awards are settled through the issuance of
common shares and are therefore treated as equity awards.
Revenue Recognition
Revenue is recognized when realized or realizable and earned, and when all of the following criteria are met: persuasive
evidence of an arrangement exists; delivery has occurred; the price to the customer is fixed or determinable; and collection is
reasonably assured. Revenue is recognized when title and possession of the product has transferred to the customer. Possession
is transferred to the customer at the time of shipment from the Company’s facility or at the time of delivery to a specified
destination depending on the contractual terms of the sale. Consideration given to customers such as value incentives, rebates,
early payment discounts and other discounts are recorded as reductions to revenues at the time of sale. These reductions are
estimated based on contractual sales terms with customers and historical payment experience.
Basic earnings per share is computed by dividing earnings available to common shareholders by the weighted-average number
of common shares outstanding during the year. Earnings available to common shareholders is computed by deducting
dividends and accretion on convertible preferred stock from earnings attributable to SunOpta Inc. The potential diluted effect
of stock options and other stock-based awards is computed using the treasury stock method whereby the weighted-average
number of common shares used in the basic earnings per share calculation is increased to include the number of additional
common shares that would have been outstanding if the potential dilutive common shares had been issued at the beginning of
the year. The potential dilutive effect of convertible preferred stock is computed using the if-converted method whereby
dividends and accretion on the convertible preferred stock are added back to the numerator, and the common shares resulting
from the assumed conversion of the convertible preferred stock are included in the denominator of the diluted earnings per
share calculation.
Contingencies
In the normal course of business, the Company is subject to loss contingencies, such as accrued but unpaid bonuses; tax-related
matters; and claims or litigation. Accruals for loss contingencies are recorded when the Company determines that it is both
probable that a liability has been incurred and the amount of loss can be reasonably estimated. If the estimate of the amount of
the loss is a range and some amount within the range appears to be a better estimate than any other amount within the range,
that amount is accrued as a liability. If no amount within the range is a better estimate than any other amount, the minimum
amount of the range is accrued as a liability.
The Company recognizes an asset for insurance recoveries when a loss event has occurred and recovery is considered probable,
to the extent that the potential recovery does not exceed the loss recognized.
In March 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2016-09,
“Improvements to Employee Share-Based Payment Accounting”, which is intended to simplify the accounting for share-based
payment transactions, including income tax consequences, the classification of awards as either equity or liabilities, and the
classification on the statement of cash flows. Under the new guidance, companies will record excess tax benefits and tax
deficiencies as income tax expense or benefit in the income statement rather than in additional paid-in capital. In addition, the
guidance permits companies to elect to recognize forfeitures of share-based payments as they occur, rather than estimating the
number of awards expected to be forfeited as is currently required. This guidance is effective for annual and interim periods
beginning after December 15, 2016. The Company adopted ASU 2016-09 effective January 1, 2017, and elected upon adoption
to recognize forfeitures of stock-based awards as they occur versus estimating at the time of grant. The cumulative effect of
this change in accounting policy as at January 1, 2017, was not material to the Company’s financial statements. Commencing
January 1, 2017, the Company recognizes excess tax benefits and deficiencies in the provision for income taxes on its
consolidated statements of operations and as an operating activity on the consolidated statements of cash flows.
In June 2016, the FASB issued ASU 2016-13, “Measurement of Credit Losses on Financial Instruments”, which requires
measurement and recognition of expected versus incurred credit losses for most financial assets. ASU 2016-13 is effective for
interim and annual periods beginning after December 15, 2019. The Company is currently assessing the impact that this
standard will have on its consolidated financial statements.
In February 2016, the FASB issued ASU 2016-02, “Leases”, a comprehensive new standard that amends various aspects of
existing accounting guidance for leases, including the recognition of a right of use asset and a lease liability for leases with a
duration of greater than one year. The guidance is effective for fiscal years beginning after December 15, 2018, including
interim periods within those fiscal years. Early adoption is permitted. The Company is currently assessing the impact that this
standard will have on its consolidated financial statements; however, the Company anticipates that upon adoption of the
standard it will recognize additional assets and corresponding liabilities related to leases on its balance sheet.
In May 2014, the FASB issued ASU 2014-09, “Revenue from Contracts with Customers”, which supersedes existing revenue
recognition guidance under U.S. GAAP. Under the new standard, a company recognizes revenue when it transfers promised
goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in
exchange for those goods or services. ASU 2014-09 defines a five-step process to achieve this principle and, in doing so, it is
possible more judgment and estimates may be required within the revenue recognition process than are required under existing
U.S. GAAP, including identifying performance obligations in the contract, estimating the amount of variable consideration to
include in the transaction price and allocating the transaction price to each separate performance obligation. In August 2015,
the FASB issued ASU 2015-14, which defers by one year the effective date of ASU 2014-09. During 2016, the FASB issued
ASU 2016-08, ASU 2016-10, 2016-11, 2016-12 and 2016-20, all of which clarify certain implementation guidance within ASU
2014-09. ASU 2014-09, as amended, is effective for annual and interim periods beginning on or after December 15, 2017, and
is to be applied on either a full retrospective or modified retrospective basis.
With the assistance of third-party consultants, the Company analyzed its significant customer contracts to determine the effects
of ASU 2014-09. In particular, the Company assessed under the new guidance whether its contracts with customers to produce
certain consumer-packaged goods would permit the Company to recognize revenue over time versus at a point in time, based
on whether the given product has an alternative use or not and whether there is an enforceable right to payment under the
contract for product produced to date. Based on its assessment, the Company concluded that it does not satisfy the criteria to
recognize revenue over time. The Company will continue to recognize revenue at a point in time consistent with its current
policies and processes, which is typically when title and physical possession of the product has transferred to the customer.
The Company also transacts with certain customers on a bill-and-hold basis, whereby the Company bills a customer for product
to be delivered at a later date. Prior to the adoption of ASU 2014-09, the Company deferred the recognition of revenue related
to these bill-and-hold arrangements, as the arrangements did not typically include a fixed delivery schedule. As this criterion
is no longer a consideration under ASU 2014-09, these arrangements now qualify for revenue recognition at the point in time
that the customer obtains control of the product and the Company has a present right to payment. With the exception of bill-
and-hold arrangements, the adoption of ASU 2014-09 is not expected to have a significant impact on the Company’s
consolidated financial statements and revenue recognition practices, or its internal controls.
The Company will adopt ASU 2014-09 using the modified retrospective approach, which is expected to result in a cumulative
effect adjustment to opening accumulated deficit as at December 31, 2017 of $0.2 million, related to the recognition of $4.8
million of bill-and-hold revenue deferred under existing U.S. GAAP as at December 30, 2017. The Company is currently in
the process of reviewing its disclosures for revenue recognition to conform with the disclosure requirements of the standard
beginning with the first quarter of 2018.
2. Business Acquisitions
On October 9, 2015, the Company completed the acquisition of 100% of the issued and outstanding common shares of Sunrise
Holdings (Delaware), Inc. (“Sunrise”), pursuant to a Purchase and Sale Agreement dated July 30, 2015 (the “Sunrise
Acquisition”). Sunrise is a processor of conventional and organic frozen fruit in the U.S. and Mexico. The acquisition of
Sunrise was accounted for as a business combination under the acquisition method of accounting. The results of Sunrise have
been included in the Company’s consolidated financial statements since the date of acquisition and are reported in the Consumer
Products operating segment. The acquisition of Sunrise is aligned with the Company’s strategic focus on organic and healthy
foods.
Total consideration for the Sunrise Acquisition was $472.7 million in cash paid at the acquisition date, which included the
repayment of all outstanding obligations under Sunrise’s senior credit facility in the amount of $171.5 million. In addition, the
total consideration included $23.0 million paid by the Company to the holders of Sunrise stock options. As all outstanding
Sunrise stock options vested upon the consummation of the Sunrise Acquisition, pursuant to the terms of Sunrise’s pre-existing
stock option agreements, the cash consideration paid to the option holders was attributed to services prior to the Sunrise
Acquisition and included as a component of the purchase price. The total consideration also included $20.9 million paid by
the Company to settle acquisition-related transaction costs incurred by Sunrise in connection with the Sunrise Acquisition. As
none of these costs were incurred by Sunrise on behalf of the Company, the cash consideration paid to settle these costs was
included as a component of the purchase price.
The following table summarizes the fair values of the assets acquired and liabilities assumed as at the acquisition date:
$
Cash and cash equivalents 1,728
Accounts receivable 26,090
Inventories(1) 124,829
Income taxes recoverable 12,025
Other current assets 3,982
Property, plant and equipment 46,068
Intangible assets(2) 170,000
Accounts payable and accrued liabilities (24,169)
Long-term debt, including current portion (7,620)
Deferred income taxes, net (75,193)
Net identifiable assets acquired 277,740
Goodwill(3) 196,709
Non-controlling interest(4) (1,781)
Net assets acquired 472,668
(1) Includes an estimated fair value adjustment to inventory of $19.0 million, of which $15.0 million and $4.0 million was
recognized in costs of goods sold for inventory sold during 2016 and in the fourth quarter of 2015, respectively.
(2) The identified intangible assets relate to customer relationships in existence at the acquisition date between Sunrise and
major U.S. retail and foodservice customers. The customer relationships intangible assets will be amortized over an
estimated weighted-average useful life of approximately 23 years. The estimated fair value of the intangible asset was
determined using an income approach (discounted cash flow method), which applied a risk-adjusted discount rate of
approximately 12.0%.
(3) Goodwill is calculated as the difference between the acquisition-date fair values of the total consideration and the net assets
acquired. The total amount of goodwill has been assigned to the Consumer Products operating segment and is not expected
to be deductible for tax purposes. The goodwill recognized is attributable to: (i) cost savings, operating synergies, and
other benefits expected to result from combining the operations of Sunrise with those of the Company; (ii) the value of
longer-term growth prospects in the private label frozen fruit market; (iii) the value of acquiring the current capabilities
and low-cost position of the existing Sunrise business (i.e., the higher rate of return on the assembled net assets versus
acquiring all of the net assets separately); and (iv) the value of Sunrise’s assembled workforce.
In 2017, the Company recorded a $115.0 million impairment charge related to the goodwill that arose from the Sunrise
Acquisition (see note 11).
(4) Represents the estimated fair value of the non-controlling interest in Sunrise’s 75%-owned Mexican subsidiary, Opus
Foods Mexico, S.A. de C.V. (“Opus”). In 2017, the Company acquired all of the non-controlling interests in Opus (see
note 3).
On August 11, 2015, the Company acquired the net operating assets of Niagara Natural Fruit Snack Company Inc. (“Niagara
Natural”). Niagara Natural is a manufacturer of all-natural fruit snacks located in the Niagara Region of Ontario. The
acquisition of the net operating assets of Niagara Natural was accounted for as a business combination under the acquisition
method of accounting. The results of Niagara Natural have been included in the Company’s consolidated financial statements
since the date of acquisition and are reported in the Consumer Products operating segment. The transaction included a cash
purchase price of $6.5 million, subject to certain post-closing adjustments, plus contingent consideration of up to approximately
$2.8 million based on specific performance targets. The fair value of the contingent consideration obligation was determined
to be $2.3 million as at the acquisition date.
The following table summarizes the fair values of the assets acquired and liabilities assumed as at the acquisition date:
Provisional
Amounts Final Amounts
Recognized as at Measurement Recognized as at
the Acquisition Period the Acquisition
Date Adjustment(1) Date
$ $ $
Current assets 2,220 (292) 1,928
Machinery and equipment 3,414 - 3,414
Intangible assets(2) 2,459 - 2,459
Current liabilities (687) - (687)
Net identifiable assets acquired 7,406 (292) 7,114
Goodwill(3) 1,636 - 1,636
Net assets acquired 9,042 (292) 8,750
(1) The measurement period adjustment reflected the final determination of net working capital as at the acquisition date.
(2) Intangible assets comprise customer relationships and non-competition arrangements, which will be amortized over an
estimated weighted-average useful life of approximately 19 years.
(3) The total amount of goodwill was assigned to the Consumer Products operating segment.
On May 5, 2016, the Company and the owners of Niagara Natural entered into an agreement to settle the contingent
consideration obligation in exchange for a one-time cash payment of $0.6 million. In 2016, the Company recognized a gain of
$1.7 million in connection with this settlement, based on the difference between the fair value of the contingent consideration
obligation and the cash payment, which is recorded in other expense on the consolidated statement of operations for the year
ended December 31, 2016.
Citrusource, LLC
On March 2, 2015, the Company acquired 100% of the issued and outstanding units of Citrusource, LLC (“Citrusource”), a
producer of premium not-from-concentrate private label organic and conventional orange juice and citrus products in the U.S.
The acquisition of Citrusource was accounted for as a business combination under the acquisition method of accounting. The
results of Citrusource have been included in the Company’s consolidated financial statements since the date of acquisition and
are reported in the Consumer Products operating segment. The transaction included a cash purchase price of $13.3 million,
subject to certain post-closing adjustments, plus contingent consideration based on the incremental growth in Citrusource’s
base business. The fair value of the contingent consideration obligation was determined to be $18.0 million as at the acquisition
date. In 2017 and 2016, the Company paid $4.1 million and $3.9 million, respectively, to the former unitholders of Citrusource
in partial settlement of the contingent consideration obligation.
The following table summarizes the fair values of the assets acquired and liabilities assumed as at the acquisition date:
$
Accounts receivable 2,351
Inventories 1,745
Machinery and equipment 164
Customer relationships intangible asset(1) 14,000
Accounts payable and accrued liabilities (1,666)
Net identifiable assets acquired 16,594
Goodwill(2) 15,136
Net assets acquired 31,730
(1) The customer relationships intangible asset was recognized based on contracts in existence at the acquisition date between
Citrusource and major U.S. retail customers. This intangible asset will be amortized over an estimated useful life of
approximately 12 years.
(2) Goodwill is calculated as the difference between the acquisition-date fair values of the consideration transferred and net
assets acquired. The total amount of goodwill has been assigned to the Consumer Products operating segment and is
expected to be fully deductible for tax purposes. The goodwill recognized is attributable to: (i) operating synergies
expected to result from combining the operations of Citrusource with those of the Company; and (ii) opportunities to
leverage the business experience of Citrusource’s management team to grow the Company’s existing citrus beverage
program.
On July 28, 2017, the Company acquired all the capital stock of Opus held by non-controlling interests for $1.7 million, which
increased the Company’s equity ownership in Opus from 75% to 100%. The Company acquired its initial 75% interest in Opus
through the Sunrise Acquisition (see note 2). Opus owns and operates a frozen fruit processing facility located in central
Mexico. The increase in the Company’s ownership position in Opus was accounted for as an equity transaction, with the
difference between the cash consideration paid and the amount of the non-controlling interest related to Opus being recognized
in additional paid-in capital.
Overview
On October 7, 2016, the Company entered into a strategic partnership with Oaktree Capital Management L.P., a private equity
investor (together with its affiliates, “Oaktree”). On October 7, 2016, Oaktree invested $85.0 million through the purchase of
cumulative, non-participating Series A Preferred Stock (the “Preferred Stock”) of the Company’s wholly-owned subsidiary,
SunOpta Foods Inc. (“SunOpta Foods”) (see note 14). Following the strategic partnership, with the assistance of Oaktree, the
Company conducted a thorough review of its operations, management and governance, with the objective of maximizing the
Company’s ability to deliver long-term value to its shareholders. As a product of this review, the Company developed a Value
Creation Plan built on four pillars: portfolio optimization, operational excellence, go-to-market effectiveness and process
sustainability. The Company engaged third-party management consulting firms to support the design and implementation of
the Value Creation Plan.
In 2016, measures taken under the Value Creation Plan included the closure of the Company’s San Bernardino, California, juice
facility and the Company’s soy extraction facility in Heuvelton, New York. In addition, effective November 11, 2016, Hendrik
Jacobs stepped down as the Company’s President and Chief Executive Officer (“CEO”).
In 2017, further measures were taken under the Value Creation Plan, including the exits from flexible resealable pouch and
nutrition bar product lines and operations (as described below), as well as the consolidation of grain operations and related
closure of a grain-handling facility in Moorhead, Minnesota, and the planned consolidation of roasted snack operations and
related closure of the Company’s Wahpeton, North Dakota, roasting facility. In addition, the Company made organizational
changes within its management and executive teams, including the appointment of David Colo as President and CEO effective
February 6, 2017, along with new leadership to many corporate, commercial and operational functions. The Company also
added new employees in the areas of quality, sales, marketing, operations and engineering, and made capital investments at
several of its manufacturing facilities to enhance food safety and production efficiencies.
Exit from Flexible Resealable Pouch and Nutrition Bar Product Lines and Operations
On July 26, 2017, SunOpta Foods entered an agreement with Skjodt-Barrett Contract Packaging LLC to sell equipment used
in the production of flexible resealable pouches at the Company’s Allentown, Pennsylvania facility for gross proceeds of $2.0
million ($1.3 million net of costs to sell). The transaction closed on November 3, 2017. The Company continued to produce
flexible resealable pouch products for existing customers until the closing date. The Company’s aseptic beverage operations
were not affected by the sale of assets, and the Company will continue to produce aseptic beverages at its Allentown facility.
On September 27, 2017, the Company announced its intention to exit its nutrition bar product lines and operations in Carson
City, Nevada, with final production for customers ending on December 20, 2017. On November 21, 2017, the Company entered
into an agreement to sell the nutrition bar equipment for gross proceeds of $0.9 million, of which $0.2 million was received on
signing and $0.7 million was received at closing on January 3, 2018. The Company is pursuing potential parties interested
assuming the facility lease.
As the flexible resealable pouch and nutrition bar product lines and operations do not qualify for presentation as discontinued
operations, operating results from these activities were reported in continuing operations on the consolidated statements of
operations for the current and comparative periods. Revenues from sales of these product lines were $53.1 million, $59.3
million and $58.1 million for the years ended December 30, 2017, December 31, 2016 and January 2, 2016, respectively.
Losses before income taxes from these operations were $24.4 million, $2.1 million and $2.8 million for the years ended
December 30, 2017, December 31, 2016 and January 2, 2016, respectively. For the year ended December 30, 2017, the loss
before income taxes from these operations included write-offs of accounts receivable and inventory ($2.9 million) and
impairments of long-lived assets ($13.2 million) related to the exit activities, as well as employee termination costs of $1.7
million. These operations were included in the Consumer Products operating segment.
The following table summarizes costs incurred since the inception of the Value Creation Plan to December 30, 2017:
Fiscal 2017
Costs incurred and charged to expense 21,766 11,618 16,528 49,912
Cash payments, net of proceeds on disposal of assets (10,746) (9,683) (18,185) (38,614)
Non-cash adjustments (11,720) 689 - (11,031)
Balance payable (receivable), December 30, 2017 (1) (700) 4,427 - 3,727
(1) Balance payable was included in accounts payable and accrued liabilities and balance receivable was included in accounts receivable on the
consolidated balance sheets.
For 2017, includes an additional asset impairment loss of $3.7 million on the disposal of the San Bernardino assets, and
facility closure costs of $0.6 million incurred by the Company for rent and maintenance of the San Bernardino facility
prior to its disposal. In addition, includes asset impairment losses related to the exits from flexible resealable pouch and
nutrition bar operations of $16.1 million, and consolidation of the Company’s roasted snack operations of $1.3 million.
Cash payments in 2017 related to the early buy-outs of the San Bernardino and flexible resealable pouch equipment leases,
net of proceeds on the disposal of those assets, as well as on the sale of the nutrition bar equipment. Balance receivable as
at December 30, 2017, represents remaining proceeds on the sale of the nutrition bar equipment received on January 3,
2018.
For 2016, represents asset impairment losses of $11.5 million related to the closures of the San Bernardino and Heuvelton
facilities.
Represents third-party recruiting fees incurred to identify and retain new employees; reimbursement of relocation costs for
new employees; retention and signing bonuses accrued for certain existing and new employees; and severance benefits,
net of forfeitures of stock-based awards, and legal costs related to employee terminations. Some employee termination
costs will be paid out in periods after termination. Retention bonuses will be paid out to employees who remain employed
by the Company through specified retention dates. Certain employees will be entitled to pro-rata payouts of their retention
bonuses if their employment terminates earlier than their retention payment date.
Represents the cost for third-party consultants and temporary labor engaged to support the design and implementation of
the Value Creation Plan. In addition, consulting fees incurred in the third quarter of 2016 were related to external financial
and legal advisors engaged to review the Company’s operating plan and evaluate a range of strategic and financial actions
that the Company could take to maximize shareholder value, which concluded with the strategic partnership with Oaktree.
For the years ended December 30, 2017 and December 31, 2016, costs incurred and charged to expense were recorded in the
consolidated statement of operations as follows:
5. Discontinued Operation
On April 6, 2016, the Company completed the sale of its 66% holding of common shares of Opta Minerals Inc. (“Opta
Minerals”) to Speyside Equity Fund I LP for aggregate gross proceeds of $4.8 million (C$6.2 million), of which $3.2 million
(C$4.2 million) was received in cash, and $1.5 million (C$2.0 million) was received in the form of a subordinated promissory
note bearing interest at 2.0% per annum that will mature on October 6, 2018. The sale of Company’s equity interest in Opta
Minerals was consistent with its objective of divesting its non-core assets in order to become a pure-play organic and healthy
foods company. The Company has no continuing involvement with Opta Minerals.
The following table reconciles the major components of the results of discontinued operations to the amounts reported in the
consolidated statement of operations:
December 31,
2016 January 2, 2016
$ $
Revenues 24,896 113,805
Cost of goods sold (22,133) (99,256)
Selling, general and administrative expenses (3,024) (11,170)
Intangible asset amortization - (1,987)
Other expense, net(1) (794) (15,097)
Foreign exchange gain (loss) (454) 717
Interest expense (484) (4,389)
Loss before income taxes (1,993) (17,377)
Gain (loss) on classification as held for sale before income taxes 560 (10,515)
Total pre-tax loss from discontinued operations (1,433) (27,892)
Recovery of (provision for) income taxes 599 (402)
Loss from discontinued operations (834) (28,294)
Loss from discontinued operations attributable to non-controlling interest 264 8,819
Loss from discontinued operations attributable to SunOpta Inc. (570) (19,475)
(1) For the years ended December 31, 2016 and January 2, 2016, other expense, net includes charges related to the impairment of long-lived assets of
Opta Minerals of $0.4 million and $12.4 million, respectively.
6. Product Recall
During the second quarter of 2016, the Company announced a voluntary recall of certain roasted sunflower kernel products
due to potential contamination with Listeria monocytogenes bacteria. The affected sunflower products were produced between
May 31, 2015 and April 21, 2016. Estimated losses related to the recall totaled $47.5 million as at December 30, 2017,
compared to $40.0 million as at December 31, 2016, comprised of estimates for customer losses and direct incremental costs
incurred by the Company. The estimates for customer losses reflected the cost of the affected sunflower kernel products
returned to or replaced by the Company and the estimated cost to reimburse customers for costs incurred by them related to the
recall of their retail products that contain the affected sunflower kernels as an ingredient or component. The incremental costs
incurred directly by the Company do not include lost earnings associated with the interruption of production at the Company’s
roasting facilities, or the costs to put into place corrective and preventive actions at those facilities.
The Company’s estimates for customer losses related to the recall are provisional and were determined based on an assessment
of the information available up to the date of filing of this report, including a review of customer claims received as of that date
and consideration of the extent of potential additional claims that have yet to be received. The Company’s estimates reflect the
amount of losses that it determined as at December 30, 2017 to be both probable and reasonably estimable. The Company may
need to revise its estimates in subsequent periods as the Company continues to work with its customers and insurance providers
to substantiate the claims received to date and any additional claims that may be received. These revisions may occur at any
time and may be material.
The Company has general liability and product recall insurance policies with aggregate limits of $47.0 million under which it
expects to recover recall-related costs, less applicable deductibles. The Company recognizes expected insurance recoveries in
the period in which the recoveries are determined to be probable of realization. As at December 30, 2017, the Company had
recognized recoveries up to the limit of the coverage available under its insurance policies. Consequently, to the extent any
losses are excluded under the insurance policies or additional losses are recognized related to existing or new claims, these
excluded or excess losses will be recognized as a charge to future earnings.
As at December 30, 2017, the Company had settled customer claims and direct costs in the amount of $40.5 million, which
was fully funded under the Company’s general liability and product recall insurance policies. As at December 30, 2017, $7.0
million of the estimated recall-related costs were unsettled and were recorded in accounts payable and accrued liabilities on the
consolidated balance sheet. As at December 30, 2017, the Company had received $44.2 million in advances from its insurance
providers. The remaining estimated insurance recovery of $2.7 million was included in accounts receivable on the consolidated
balance sheet as at December 30, 2017.
The following table presents for each of the fair value hierarchies, the assets and liabilities that are measured at fair value on a
recurring basis as at December 30, 2017 and December 31, 2016:
(1) Unrealized short-term derivative asset was included in prepaid expenses and other current assets, unrealized short-term derivative liability was
included in other current liabilities and unrealized long-term derivative liability was included in long-term liabilities on the consolidated balance
sheets.
(2) Inventories carried at market were included in inventories on the consolidated balance sheets.
(3) Forward foreign currency contracts not designated as a hedge were included in accounts receivable or accounts payable and accrued liabilities on the
consolidated balance sheets.
(4) Forward foreign currency contracts designated as a hedge were included in other assets or other current liabilities on the consolidated balance sheets.
(5) Contingent consideration obligations were included in long-term liabilities (including the current portion thereof) on the consolidated balance sheets.
(6) The embedded derivative was included in other assets (long-term) on the consolidated balance sheets.
The Company’s derivative contracts that are measured at fair value include exchange-traded commodity futures and
forward commodity purchase and sale contracts. Exchange-traded futures are valued based on unadjusted quotes for
identical assets priced in active markets and are classified as level 1. Fair value for forward commodity purchase and sale
contracts is estimated based on exchange-quoted prices adjusted for differences in local markets. Local market adjustments
use observable inputs or market transactions for similar assets or liabilities, and, as a result, are classified as level 2. Based
on historical experience with the Company’s suppliers and customers, the Company’s own credit risk, and the Company’s
knowledge of current market conditions, the Company does not view non-performance risk to be a significant input to fair
value for the majority of its forward commodity purchase and sale contracts.
These exchange-traded commodity futures and forward commodity purchase and sale contracts are used as part of the
Company’s risk management strategy, and represent economic hedges to limit risk related to fluctuations in the price of
certain commodity grains, as well as the prices of cocoa and coffee. These derivative instruments are not designated as
hedges for accounting purposes. Gains and losses on changes in fair value of these derivative instruments are included in
cost of goods sold on the consolidated statement of operations. For the year ended December 30, 2017, the Company
recognized a gain of $0.6 million (December 31, 2016 – gain of $0.5 million; January 2, 2016 – loss of $0.1 million)
related to changes in the fair value of these derivatives.
As at December 30, 2017, the notional amounts of open commodity futures and forward purchase and sale contracts were
as follows (in thousands of bushels):
In addition, as at December 30, 2017, the Company had open forward contracts to sell 299 lots of cocoa and 3 lots of
coffee.
Grains inventory carried at fair value is determined using quoted market prices from the CBoT. Estimated fair market
values for grains inventory quantities at period end are valued using the quoted price on the CBoT adjusted for differences
in local markets, and broker or dealer quotes. These assets are placed in level 2 of the fair value hierarchy, as there are
observable quoted prices for similar assets in active markets. Gains and losses on commodity grains inventory are included
in cost of goods sold on the consolidated statements of operations. As at December 30, 2017, the Company had 280,558
bushels of commodity corn and 254,022 bushels of commodity soybeans in inventories carried at market.
As part of its risk management strategy, the Company enters into forward foreign exchange contracts to reduce its exposure
to fluctuations in foreign currency exchange rates. For any open forward foreign exchange contracts at period end, the
contract rate is compared to the forward rate, and a gain or loss is recorded. These contracts are placed in level 2 of the fair
value hierarchy, as the inputs used in making the fair value determination are derived from and are corroborated by
observable market data. Certain of these forward foreign exchange contracts may be designated as cash flow hedges for
accounting purposes, while other of these contracts represent economic hedges that are not designated as hedging
instruments.
As at December 30, 2017, the Company had open forward foreign exchange contracts to sell euros to buy U.S. dollars with
a notional value of €33.4 million ($39.2 million), and to sell British pounds to buy euros with a notional value of £0.4
million (€0.4 million). As these contracts were not designated as hedging instruments, gains and losses on changes in the
fair value of the derivative instruments are included in foreign exchange loss or gain on the consolidated statement of
operations. For the year ended December 30, 2017, the Company recognized a loss of $2.4 million (December 31, 2016 –
gain of $1.0 million; January 2, 2016 – loss of $0.7 million) related to changes in the fair value of these derivatives.
In 2017, the Company initiated a foreign currency cash flow hedging program with the objective of managing the
variability of cash flows associated with a portion of forecasted purchases of raw fruit inventories denominated in Mexican
pesos. As at December 30, 2017, the Company had net open forward foreign exchange contracts to sell U.S. dollars to
buy Mexican pesos with a notional value of $15.0 million (M$292.0 million). As these contracts have been designated as
hedging instruments, the effective portion of the gains and losses on changes in the fair value of the derivative instruments
are included in other comprehensive earnings and reclassified to cost of goods sold in the same period the hedged
transaction affects earnings, which is upon the sale of the inventories. For the year ended December 30, 2017, the Company
recognized net unrealized gains in other comprehensive earnings of $1.8 million related to changes in the fair value of
these derivatives, and the Company reclassified from other comprehensive earnings realized gains on these derivatives of
$1.4 million to cost of goods sold. In addition, in 2017, the Company reclassified an unrealized gain of $0.9 million related
to the ineffective portion of the hedge to foreign exchange loss on the consolidated statements of operations. The Company
expects to reclassify the $0.4 million amount of the unrealized loss recorded in accumulated other comprehensive loss as
at December 30, 2017, to earnings over the next twelve months.
The fair value measurement of contingent consideration arising from business acquisitions is determined using
unobservable (level 3) inputs. These inputs include: (i) the estimated amount and timing of the projected cash flows on
which the contingency is based; and (ii) the risk-adjusted discount rate used to present value those cash flows. The
following table presents a reconciliation of contingent consideration obligations for the years ended December 30, 2017
and December 31, 2016:
(1) For all periods presented, reflected the accretion for the time value of money, which was included in other income/expense (see note 18). In
addition, for the year ended December 31, 2016, included a gain of $1.7 million on the settlement of the contingent consideration obligation related
to Niagara Natural (see note 2).
(2) For the year ended December 30, 2017, reflected the second payment against the contingent consideration obligation related to Citrusource, and
payment of the remaining deferred consideration to a former shareholder of Organic Land Corporation OOD, which was acquired by the Company
in December 2012. For the year ended December 31, 2016, reflected the first payment related to Citrusource obligation, and cash settlement of the
remaining obligation related to Niagara Natural.
On August 5, 2011 and August 29, 2014, the Company invested $0.5 million and $0.9 million, respectively, in convertible
subordinated notes issued by Enchi Corporation (“Enchi”), a developer of advanced bioconversion products for the
renewable fuels industry. The Company’s investment includes the value of an accelerated payment option embedded in
the notes, which may result in a maximum payout to the Company of $5.1 million. Due to a lack of level 1 or level 2
observable market quotes for the notes, the Company used a discounted cash flow analysis (income approach) to estimate
the original fair value of the embedded derivative based on unobservable level 3 inputs. The Company assesses changes
in the fair value of the embedded derivative based on the performance of actual cash flows derived from certain royalty
rights owned by Enchi, which are expected to be the primary source of funds available to settle the embedded derivative,
relative to the financial forecasts used in the valuation analysis. As at December 30, 2017 and December 31, 2016, the
Company determined that the fair value of this embedded derivative was $2.7 million and $2.9 million, respectively, based
on distributions received from Enchi on the notes up to those dates and on expectations related to the remaining royalty
rights.
8. Accounts Receivable
The change in the allowance for doubtful accounts provision for the years ended December 30, 2017 and December 31, 2016
is comprised as follows:
9. Inventories
The change in the inventory reserve for the years ended December 30, 2017 and December 31, 2016 is comprised as follows:
The major components of property, plant and equipment as at December 30, 2017 and December 31, 2016 were as follows:
As at December 30, 2017 property, plant and equipment included construction in process assets of $23.7 million (December
31, 2016 – $13.7 million), which were not being depreciated as they had not yet reached the stage of commercial viability. In
addition, as at December 30, 2017, machinery and equipment included equipment under capital leases with a cost of $11.9
million (December 31, 2016 – $11.9 million) and a net book value of $5.4 million (December 31, 2016 – $10.7 million), as
well as $5.0 million (December 31, 2016 – $6.1 million) of spare parts inventory.
Total depreciation expense included in cost of goods sold and selling, general and administrative expense on the consolidated
statements of operations related to property, plant and equipment for the year ended December 30, 2017 was $21.7 million
(December 31, 2016 – $22.9 million; January 2, 2016 – $16.1 million).
(1) Based on the results of the annual impairment test performed for the year ended December 31, 2016, the Company
determined that the carrying value of the goodwill associated with the Sunflower reporting unit of the Raw Material
Sourcing and Supply operating segment exceeded its implied fair value, reflecting lower anticipated sales demand and
higher expected production and capital costs as a result of the sunflower recall. As a result, the Company recognized a
goodwill impairment charge of $17.5 million in 2016.
(2) Based on the results of the annual impairment test performed for the year ended December 30, 2017, the Company
determined that the carrying value of the Healthy Fruit reporting unit of the Consumer Products reporting unit exceeded
its fair value, reflecting lower-than-expected sales and operating performance for frozen fruit since the Sunrise Acquisition,
and uncertainty of future sales due to lost customer volumes and declining consumer consumption trends in 2017. As a
result, the Company recognized a goodwill impairment charge of $115.0 million in 2017.
The major components of intangible assets as at December 30, 2017 and December 31, 2016 were as follows:
(1) Represents impairment of customer relationship intangible asset related to the exited nutrition bar product lines (see note 4).
The Company estimates that the aggregate future amortization expense associated with finite-life intangible assets in each of
the next five fiscal years and thereafter will be as follows:
$
2018 11,135
2019 11,021
2020 10,324
2021 10,112
2022 10,112
Thereafter 119,355
172,059
Long-term debt:
Senior Secured Second Lien Notes, net of unamortized debt issuance costs
of $7,716 (December 31, 2016 - $8,835)(3) 215,782 222,163
Asset-backed term loan(4) 3,600 -
Capital lease obligations(5) 5,651 7,454
Other 3,000 1,470
228,033 231,087
Less: current portion 2,228 2,079
225,805 229,008
On February 11, 2016, the Company entered into a five-year credit agreement for a senior secured asset-based revolving
credit facility with a syndicate of banks in the maximum aggregate principal amount of $350.0 million, subject to
borrowing base capacity (the “Global Credit Facility”). The Global Credit Facility is used to support the working capital
and general corporate needs of the Company’s global operations, in addition to funding future strategic initiatives. The
Global Credit Facility also includes borrowing capacity available for letters of credit and provides for borrowings on same-
day notice, including in the form of swingline loans. Subject to customary borrowing conditions and the agreement of any
such lenders to provide such increased commitments, the Company may request to increase the total lending commitments
under the Global Credit Facility to a maximum aggregate principal amount not to exceed $450.0 million. Outstanding
principal amounts under the Global Credit Facility are repayable in full on the maturity date of February 10, 2021.
Individual borrowings under the Global Credit Facility have terms of six months or less and bear interest based on various
reference rates, including prime rate and LIBOR plus an applicable margin. The applicable margin in the Global Credit
Facility ranges from 1.25% to 1.75% for loans bearing interest based on LIBOR and from 0.25% to 0.75% for loans bearing
interest based on the prime rate and, in each case, is set quarterly based on average borrowing availability for the preceding
fiscal quarter. As at December 30, 2017, the weighted-average interest rate on the facilities was 3.45%.
On September 19, 2017 (the “Effective Date”), the Company entered into an amendment to the Global Credit Facility to
add an additional U.S. asset-based credit subfacility of an aggregate principal amount of $15.0 million (the “New U.S.
Subfacility”).
The New U.S. Subfacility was fully drawn on the Effective Date. Amortization payments on the aggregate principal
amount of the New U.S. Subfacility are equal to $2.5 million payable at the end of each fiscal quarter, commencing with
the fiscal quarter ending March 31, 2019. Optional prepayment of borrowings under the New U.S. Subfacility are not
permitted until the first anniversary of the Effective Date and are subject to certain availability conditions. Borrowings
repaid under the New U.S. Subfacility may not be borrowed again.
Borrowings under the New U.S. Subfacility bear interest at a margin over various reference rates. The applicable margin
for the New U.S. Subfacility will be set quarterly based on average borrowing availability for the preceding fiscal quarter
and will range from 2.00% to 2.50% with respect to base rate and prime rate borrowings and from 3.00% to 3.50% for
eurocurrency rate and bankers’ acceptance rate borrowings. The initial margin for the New U.S. Subfacility is 2.50% with
respect to base rate and prime rate borrowings and 3.50% with respect to eurocurrency rate borrowings.
Obligations under the Global Credit Facility are guaranteed by substantially all of the Company’s subsidiaries and, subject
to certain exceptions, such obligations are secured by first priority liens on substantially all of the assets of the Company.
The Global Credit Facility contains a number of covenants that, among other things, restrict, subject to certain exceptions,
the Company’s ability to create liens on assets; sell assets and enter into sale and leaseback transactions; pay dividends,
prepay junior lien and unsecured indebtedness and make other restricted payments; incur additional indebtedness and make
guarantees; make investments, loans or advances, including acquisitions; and engage in mergers or consolidations. The
foregoing covenants are subject to certain threshold amounts and exceptions as set forth in the credit agreement.
On June 28, 2017, a subsidiary of The Organic Corporation B.V. (“TOC”), a wholly-owned subsidiary of the Company,
extended its revolving credit facility agreement dated May 22, 2013, to provide up to €4.5 million to cover the working
capital needs of TOC’s Bulgarian operations. The facility is secured by the accounts receivable and inventories of the
Bulgarian operations and is fully guaranteed by TOC. Interest accrues under the facility based on EURIBOR plus a margin
of 2.75%, and borrowings under the facility are repayable in full on April 30, 2018. As at December 30, 2017, the
weighted-average interest rate on the Bulgarian credit facility was 2.75%.
On October 20, 2016, SunOpta Foods issued $231.0 million of 9.5% Senior Secured Second Lien Notes due 2022 (the
“Notes”). The Company incurred $9.3 million of debt issuance costs related to the Notes, which were recorded as a
reduction against the principal amount of the Notes and are being amortized over the six-year term of the Notes. Interest
on the Notes is payable semi-annually in arrears on April 15 and October 15 at a rate of 9.5% per annum, commencing on
April 15, 2017. The Notes will mature on October 9, 2022. Giving effect to the amortization of debt issuance costs, the
effective interest rate on the Notes is approximately 10.4% per annum.
Prior to October 9, 2018, SunOpta Foods may redeem some or all of the Notes at any time and from time to time at a
“make-whole” redemption price set forth in the indenture governing the Notes. On or after October 9, 2018, SunOpta
Foods may redeem the Notes, in whole or in part, at any time at the redemption prices equal to 107.125% through October
8, 2019, 104.750% from October 9, 2019 through October 8, 2020, 102.375% from October 9, 2020 through October 8,
2021 and at par thereafter, plus accrued and unpaid interest, if any, to but excluding the date of redemption. In addition,
prior to October 9, 2018, SunOpta Foods may, on one or more occasions, redeem up to 35% of the aggregate principal
amount of the Notes with the proceeds of certain equity offerings at a redemption price equal to 109.500% of the principal
amount of the Notes redeemed, plus accrued and unpaid interest, if any, to but excluding the date of redemption. At any
time prior to October 9, 2018, SunOpta Foods may also redeem, during each twelve-month period beginning on October
20, 2016, up to 10% of the aggregate principal amount of the Notes at a price equal to 103.000% of the aggregate principal
amount of the Notes being redeemed, plus accrued and unpaid interest, if any, to but excluding the date of redemption. In
the event of a change of control, SunOpta Foods will be required to make an offer to repurchase the Notes at 101.000% of
their principal amount, plus accrued and unpaid interest, if any, to the date of purchase.
On October 19, 2017, the Company repaid $7.5 million principal amount of the Notes at 103.000%. The premium paid
and write-off of a pro-rata portion of debt issuance costs were charged to interest expense on the consolidated statement
of operations.
The Notes are secured by second-priority liens on substantially all of the assets that secure the credit facilities provided
under the Global Credit Facility, subject to certain exceptions and permitted liens. The Notes are senior secured obligations
and rank equally in right of payment with SunOpta Foods’ existing and future senior debt and senior in right of payment
to any future subordinated debt. The Notes are effectively subordinated to debt under the Global Credit Facility and any
future indebtedness secured on a first priority basis. The Notes are initially guaranteed on a senior secured second-priority
basis by the Company and each of its subsidiaries (other than SunOpta Foods) that guarantees indebtedness under the
Global Credit Facility, subject to certain exceptions.
The Notes are subject to covenants that, among other things, limit the Company’s ability to (i) incur additional debt or
issue preferred stock; (ii) pay dividends and make certain types of investments and other restricted payments; (iii) create
liens; (iv) enter into transactions with affiliates; (v) sell assets; and (vi) create restrictions on the ability of restricted
subsidiaries to pay dividends, make loans or advances or transfer assets to the Company, SunOpta Foods or any guarantor
of the Notes. The foregoing covenants are subject to certain threshold amounts and exceptions as set forth in the indenture
governing the Notes. In addition, the indenture provides for customary events of default (subject in certain cases to
customary grace and cure periods), which include nonpayment, breach of covenants in the indenture, certain payment
defaults or acceleration of other indebtedness, a failure to pay certain judgments and certain events of bankruptcy and
insolvency. If an event of default occurs and is continuing, the trustee or holders of at least 25% in principal amount of
the outstanding Notes may declare the principal of and accrued and unpaid interest on, if any, all the Notes to be due and
payable.
As at December 30, 2017, the estimated fair value of the outstanding Notes was approximately $240 million, based on
quoted prices of recent over-the-counter transactions (Level 2).
On December 28, 2017, TOC entered into a €3.0 million asset-backed term loan. The loan is secured by a first priority
lien on equipment owned by TOC for a second processing line at its cocoa processing facility in the Netherlands. Interest
on this loan accrues at an effective rate of 3.06% and the loan matures on December 28, 2027. Principal and accrued
interest is repayable in equal monthly installments. The loan is fully guaranteed by TOC.
The Company leases certain equipment under capital lease agreements. The cost and accumulated depreciation of assets
under capital lease are included in machinery and equipment.
$
2018 2,228
2019 2,149
2020 3,822
2021 993
2022 224,530
Thereafter 2,027
Total gross repayments 235,749
Unamortized debt issuance costs (7,716)
228,033
On October 7, 2016 (the “Closing Date”), the Company and SunOpta Foods entered into a subscription agreement (the
“Subscription Agreement”) with Oaktree Organics, L.P. and Oaktree Huntington Investment Fund II, L.P. (collectively, the
“Investors”). Pursuant to the Subscription Agreement, SunOpta Foods issued an aggregate of 85,000 shares of Preferred Stock
to the Investors for consideration in the amount of $85.0 million. In connection with the issuance of the Preferred Stock, the
Company incurred direct and incremental expenses of $6.0 million, which reduced the carrying value of the Preferred Stock.
At any time on or after the fifth anniversary of the Closing Date, SunOpta Foods may redeem all of the Preferred Stock for an
amount, per share of Preferred Stock, equal to the value of the liquidation preference at such time. The carrying value of the
Preferred Stock is being accreted to the redemption amount of $85.0 million through charges to retained earnings over the
period preceding the fifth anniversary of the Closing Date, which accretion amounted to $1.0 million and $0.2 million for the
year ended December 30, 2017 and period ended December 31, 2016.
In connection with the Subscription Agreement, the Company agreed to, among other things (i) ensure SunOpta Foods has
sufficient funds to pay its obligations under the terms of the Preferred Stock and (ii) grant each holder of Preferred Stock (the
“Holder”) the right to exchange the Preferred Stock for shares of common stock of the Company (the “Common Shares”). The
Preferred Stock is non-participating with the Common Shares in dividends and undistributed earnings of the Company.
The Preferred Stock has a stated value and initial liquidation preference of $1,000 per share. Cumulative preferred dividends
accrue daily on the Preferred Stock at an annualized rate of 8.0% prior to October 5, 2025 and 12.5% thereafter, in each case
of the liquidation preference (subject to an increase of 1.0% per quarter, up to a maximum rate of 5.0% per quarter on the
occurrence of certain events of non-compliance). Prior to October 5, 2025, SunOpta Foods may pay dividends in cash or elect,
in lieu of paying cash, to add the amount that would have been paid to the liquidation preference. After October 4, 2025, the
failure to pay dividends in cash will be an event of non-compliance. The Preferred Stock ranks senior to the shares of common
stock of SunOpta Foods with respect to dividend rights and rights on the distribution of assets on any liquidation, winding up
or dissolution of the Company or SunOpta Foods. For the year ended December 30, 2017, the Company paid cash dividends
on the Preferred Stock of $6.7 million, and, as at December 30, 2017, the Company had accrued unpaid dividends of $1.7
million, which were recorded in accounts payable and accrued liabilities on the consolidated balance sheet.
At any time, the Holders may exchange their shares of Preferred Stock, in whole or in part, into the number of Common Shares
equal to, per share of Preferred Stock, the quotient of the liquidation preference divided by $7.50 (such price, the “Exchange
Price” and such quotient, the “Exchange Rate”). As at December 30, 2017, the aggregate shares of Preferred Stock outstanding
were exchangeable into 11,333,333 Common Shares. The Exchange Price is subject to certain anti-dilution adjustments,
including a weighted-average adjustment for issuances of Common Shares below the Exchange Price, provided that the
Exchange Price may not be lower than $7.00 (subject to adjustment in certain circumstances). SunOpta Foods may cause the
Holders to exchange all of the Preferred Stock into a number of Common Shares based on the applicable Exchange Price if (i)
fewer than 10% of the shares of Preferred Stock issued on the Closing Date remain outstanding or (ii) on or after the third
anniversary of the Closing Date, the average volume-weighted average price of the Common Shares during the then preceding
20 trading day period is greater than 200% of the Exchange Price.
In connection with the Subscription Agreement, the Company issued 11,333,333 Special Shares, Series 1 (the “Special Voting
Shares”) to the Investors, which entitle the Investors to one vote per Special Voting Share on all matters submitted to a vote of
the holders of Common Shares, together as a single class, subject to certain exceptions. Additional Special Voting Shares will
be issued, or existing Special Voting Shares will be redeemed, as necessary to ensure that the aggregate number of Special
Voting Shares outstanding is equal to the number of shares of Preferred Stock outstanding from time to time multiplied by the
Exchange Rate in effect at such time. As at December 30, 2017, 11,333,333 Special Voting Shares were issued and outstanding,
which represented an approximate 11.7% voting interest in the Company. The Special Voting Shares are not transferable and
the voting rights associated with the Special Voting Shares will terminate upon the transfer of the Preferred Stock to a third
party, other than a controlled affiliate of the Investors. The Investors are entitled to designate up to two nominees for election
to the Board of Directors of the Company (the “Board”) and have the right to designate one individual to attend meetings of
the Board as a non-voting observer, subject to the Investors maintaining certain levels of beneficial ownership of Common
Shares on an as-exchanged basis. For so long as the Investors beneficially own or control at least 50% of the Preferred Stock
issued on the Closing Date, including any corresponding Common Shares into which such Preferred Stock are exchanged, the
Investors will be entitled to (i) participation rights with respect to future equity offerings of the Company; and (ii) governance
rights, including the right to approve certain actions proposed to be taken by the Company and its subsidiaries.
The Company is authorized to issue an unlimited number of Common Shares without par value and an unlimited number of
special shares without par value.
On September 30, 2015, the Company completed a registered offering of 16,670,000 of Common Shares at a price of $6.00
per share, for aggregate gross proceeds of $100.0 million. Underwriting and other issuance costs of $4.4 million incurred in
connection with the issuance of these new Common Shares were recorded as a reduction to the gross proceeds from the offering,
net of income taxes of $1.6 million. The net proceeds from the offering were used by the Company to fund a portion of the
purchase price of the Sunrise Acquisition (see note 2).
On May 28, 2013, the Company’s shareholders approved the 2013 Stock Incentive Plan (the “2013 Plan”), which permits the
grant of a variety of stock-based awards, including stock options, restricted stock units (“RSUs”) and performance share units
(“PSUs”) to selected employees and directors of the Company. As at December 30, 2017, 3,674,298 securities remained
available for issuance under the 2013 Plan.
For the years ended December 30, 2017, December 31, 2016 and January 2, 2016, total stock-based compensation expense
amounted to $5.7 million, $4.1 million and $4.4 million, respectively.
Stock Options
Stock options granted to selected employees during the year ended December 30, 2017 and December 31, 2016, vest ratably
on each of the first through third anniversaries of the grant date and expire on the tenth anniversary of the grant date. Stock
options granted during the year ended January 2, 2016, vest ratably on each of the first through fifth anniversaries of the grant
date and expire on the tenth anniversary of the grant date. Stock options granted by the Company contain an exercise price
that is equal to the closing market price of the shares on the day prior to the grant date. Any consideration paid by employees
or directors on exercise of stock options or purchase of stock is credited to capital stock.
The following table summarizes stock option activity for the year ended December 30, 2017:
Weighted-
average
Weighted- remaining
average contractual Aggregate
Options exercise price term (years) intrinsic value
Outstanding, beginning of year 4,579,850 $ 6.47
Granted 1,120,406 9.29
Exercised (827,272) 5.34
Forfeited (1,260,767) 6.74
Expired (305,489) 7.56
Outstanding at end of year 3,306,728 $ 7.51 6.92 $ 4,145
Exercisable, end of year 1,157,507 $ 7.16 5.12 $ 1,615
The following table summarizes non-vested stock option activity during the year ended December 30, 2017:
Weighted-
average grant-
Stock options date fair value
Non-vested, beginning of year 2,843,676 $ 3.06
Granted 1,120,406 4.12
Vested (756,075) 3.19
Forfeited (1,058,786) 3.05
Non-vested, end of year 2,149,221 $ 3.57
The weighted-average grant-date fair values of all stock options granted in the years ended December 30, 2017, December 31,
2016 and January 2, 2016, were $4.12, $1.86 and $4.37, respectively. The weighted-average assumptions used in the Black-
Scholes option pricing model to determine the fair value of the stock options granted in those years were as follows:
(1) Determined based on expected annual dividend yield at the time of grant.
(2) Determined based on historical volatility of the Company’s Common Shares over the expected life of the option.
(3) Determined based on the yield on U.S. Treasury zero-coupon issues with maturity dates equal to the expected life of the option.
(4) Determined using simplified method, as the Company changed the vesting period of its stock option grants from five years to three years in 2016,
and, as a result, historical exercise data may not provide a reasonable basis upon which to estimate expected life.
The following table summarizes stock options outstanding and exercisable as at December 30, 2017:
Weighted-
average
remaining Weighted- Weighted-
Exercise price range Outstanding contractual life average exercise Exercisable average exercise
Low High options (years) price options price
$ 3.27 $ 5.14 664,048 6.43 $ 3.41 184,866 $ 3.78
5.15 7.28 636,177 6.47 6.01 383,844 5.74
7.29 9.38 704,499 6.53 8.00 294,900 7.40
9.39 9.60 706,052 9.40 9.50 - -
9.61 13.86 595,952 5.46 10.75 293,897 10.89
3,306,728 6.92 $ 7.51 1,157,507 $ 7.16
Total compensation costs related to non-vested stock option awards not yet recognized as an expense was $5.3 million as at
December 30, 2017, which will be amortized over a weighted-average remaining vesting period of 2.2 years.
For the year ended December 30, 2017, the Company granted 762,710 RSUs to selected employees and directors. RSUs
granted to employees vest ratably on each of the first through third anniversaries of the grant date. RSUs granted to directors
vest 100% on the first anniversary of the grant date. Each vested RSU will entitle the employee or director to receive one
common share of the Company. The weighted-average grant-date fair value of the RSUs was estimated to be $9.18, based on
the stock price of the Common Shares as of the dates of grant.
The following table summarizes non-vested RSU activity during the year ended December 30, 2017:
Weighted-
average grant-
RSUs date fair value
Non-vested, beginning of year 175,860 $ 6.10
Granted 762,710 9.18
Vested (95,724) 6.31
Forfeited (67,490) 9.50
Non-vested, end of year 775,356 $ 8.85
Total compensation costs related to non-vested RSU awards not yet recognized as an expense was $4.9 million as at December
30, 2017, which will be amortized over a weighted-average remaining vesting period of 2.2 years.
For the year ended December 30, 2017, the Company granted 1,560,535 PSUs to selected employees. The vesting of the PSUs
is subject to the satisfaction of certain stock price performance conditions during a three-year performance period ending May
24, 2020. One-third of the PSUs will vest upon achieving a stock price of $11.00, one-third will vest upon achieving a stock
price of $14.00, and one-third will vest upon achieving a stock price of $18.00, in each case for 20 consecutive trading days
and subject to the employee’s continued employment throughout the performance period. Each vested PSU will entitle the
employee to receive one common share of the Company without payment of additional consideration.
The fair value of the PSUs was estimated using a Monte Carlo valuation model, which simulates the potential outcomes for the
Company’s stock price performance and determines the payouts that would occur under each scenario. Fair value is based on
the average of those results. The grant-date weighted-average fair value of the PSUs was determined to be $5.64, based on the
following inputs to the valuation model:
The following table summarizes non-vested PSU activity during the year ended December 30, 2017:
Weighted-
average grant-
PSUs date fair value
Non-vested, beginning of year 454,425 $ 6.75
Granted 1,560,535 5.64
Forfeited or cancelled (495,208) 6.70
Non-vested, end of year 1,519,752 $ 5.68
Total compensation costs related to non-vested PSU awards not yet recognized as an expense was $6.4 million as at December
30, 2017, which will be amortized over a weighted-average remaining vesting period of 2.4 years.
CEO Plan
On February 6, 2017, David Colo was appointed President and CEO of the Company. In connection with his appointment, the
Company granted Mr. Colo 473,940 performance-based stock options (the “Special Stock Options”) and 277,780 PSUs. In
addition, Mr. Colo was granted 100,000 RSUs, of which 50,000 were contingent on Mr. Colo purchasing Common Shares with
an aggregate value of $1.0 million in the open market.
The vesting of the Special Stock Options and PSUs is subject to: (i) Mr. Colo’s continued employment with the Company
during a three-year performance period ending February 6, 2020; and (ii) the satisfaction of certain stock price performance
conditions during the performance period. One-third of the Special Stock Options and PSUs will vest upon achieving a stock
price of $11.00, one-third will vest upon achieving a stock price of $14.00, and one-third will vest upon achieving a stock price
of $18.00, in each case for 20 consecutive trading days and subject to Mr. Colo’s continued employment through the
performance period. Each vested Special Stock Option will entitle Mr. Colo to purchase one common share of the Company
at an exercise price of $7.00, which was equal to the closing price of the Common Shares as at February 6, 2017. Each vested
PSU will entitle Mr. Colo to receive one common share of the Company without payment of additional consideration.
The grant-date weighted-average fair values of the Special Stock Options and PSUs were estimated using a Monte Carlo
valuation model and determined to be $1.84 and $2.79, respectively, based on the following inputs to the valuation model:
Special Stock
Options PSUs
Grant-date stock price $ 7.00 $ 7.00
Exercise price $ 7.00 NA
Dividend yield 0% 0%
Expected volatility(1) 42.0% 42.0%
Risk-free interest rate(2) 2.2% 1.5%
Expected life (in years)(3) 6.5 3.0
(1) Determined based on the historical volatility of the Common Shares over the expected life of the Special Stock Options.
(2) Determined based on U.S. Treasury yields with a remaining term equal to the respective expected lives of the Special Stock Options and PSUs.
(3) Determined using the simplified method for the Special Stock Options, based on the mid-point of vesting (three years) and expiration (ten years).
Determined based on vesting for the PSUs.
The aggregate grant-date fair value of the Special Stock Options and PSUs awarded to Mr. Colo was $1.6 million, which will
be recognized on a straight-line basis over the requisite three-year performance period.
The RSUs granted to Mr. Colo vest in three equal installments beginning on February 6, 2018. Each vested RSU will entitle
Mr. Colo to receive one common share of the Company. The grant-date fair value of the RSUs was estimated to be $7.00 based
on the stock price of the Common Shares as of the date of grant. The aggregate grant-date fair value of the RSUs awarded to
Mr. Colo of $0.7 million will be recognized on a straight-line basis over the three-year vesting period.
The Company maintains an employee share purchase plan whereby employees can purchase common shares through payroll
deductions. In the year ended December 30, 2017, the Company’s employees purchased 61,796 common shares (December
31, 2016 – 82,841; January 2, 2016 – 55,024) for total proceeds of $0.4 million (December 31, 2016 – $0.4 million; January 2,
2016 – $0.4 million). As at December 30, 2017, 1,112,073 common shares are remaining to be granted under this plan.
Net unrealized losses recorded in accumulated other comprehensive loss were as follows:
For the year ended December 30, 2017, represents the impairment of assets associated with the exits from flexible
resealable pouch and nutrition bar products lines and operations, and consolidation of roasted snack operations, as well as
the early buyout of the San Bernardino equipment leases (see note 4).
For the year ended December 31, 2016, represents the impairment of assets associated with the closures of the San
Bernardino and Heuvelton facilities (see note 4). In addition, includes the impairment of leasehold improvements at the
Company’s Buena Park, California, facility on the consolidation of Company’s frozen fruit processing operations
following the Sunrise Acquisition.
For the year ended December 30, 2017, represents severance benefits, net of forfeitures of stock-based awards, and legal
costs incurred in connection with the Value Creation Plan (see note 4), including employees affected by the exits from
flexible resealable pouch and nutrition bar product lines and operations, and consolidation of roasted snack operations.
For the year ended December 31, 2016, represents contractual severance benefits and previously unrecognized stock-based
compensation expense recognized in connection with the departure of Mr. Jacobs as President and CEO in November
2016, as well as costs for employees affected by the closures of the Company’s San Bernardino, Heuvelton and Buena
Park facilities.
For the year ended December 30, 2017, represents product withdrawal and recall costs that were not eligible for
reimbursement under the Company’s insurance policies, including certain direct costs related to the sunflower recall.
For the year ended December 31, 2016, represents costs related to the voluntary withdrawal of certain consumer-packaged
products due to quality-related issues, as well as certain direct costs and insurance deductibles related to the sunflower
recall.
For all years presented, reflects the accretion of contingent consideration obligations to reflect the time value of money.
In addition, for the year ended December 31, 2016, includes a gain of $1.7 million on the settlement of the contingent
consideration obligation related to the acquisition of Niagara Natural (see note 2).
In 2016, the Company recorded a charge of $9.0 million related to the settlement of a product recall dispute with a customer
involving certain flexible resealable pouch products manufactured by the Company in 2013. The settlement amount
included up to $4.0 million in rebates payable to the customer over a four-year period. In connection with the exit from
the flexible resealable pouch product lines and operations, the Company agreed to an upfront cash settlement of the
remaining rebate obligation, resulting in a recovery of $1.0 million recognized in 2017.
Represents transaction costs incurred in connection with the acquisitions of Sunrise, Niagara Natural and Citrusource (see
note 2).
The recovery of income taxes differs from the amount that would have resulted from applying the combined Canadian federal
and provincial statutory income tax rate to loss from continuing operations before income taxes due to the following:
(1) For the year ended December 30, 2017, the impact of changes in enacted tax rates reflected the remeasurement of deferred tax balances to reflect
new U.S. corporate tax rates enacted in December 2017.
The components of loss from continuing operations before income taxes are shown below:
The components of the provision for (recovery of) income taxes are shown below:
The components of the deferred income tax asset (liability) are shown below:
The components of the deferred income tax valuation allowance are as follows:
As at December 30, 2017, the Company had approximately $0.4 million (December 31, 2016 – $0.4 million) in U.S. federal
scientific research investment tax credits and $0.9 million (December 31, 2016 – $0.8 million) in U.S. State research and
development tax credits, which will expire in varying amounts up to 2029.
As at December 30, 2017, the Company had U.S. federal non-capital loss carry-forwards of approximately $46.0 million
(December 31, 2016 – $51.3 million). In addition, the Company had state loss carry-forwards of approximately $62.6 million as
at December 30, 2017 (December 31, 2016 – $64.2 million). These amounts are available to reduce future federal and state income
taxes.
As at December 30, 2017, the Company had Canadian capital losses of approximately $27.7 million (December 31, 2016 – $29.7
million) for which a full valuation allowance exists. These amounts are available to reduce future capital gains and do not expire.
The Company records net deferred tax assets to the extent it believes these assets will more likely than not be realized. In making
such determinations, the Company considers all available positive and negative evidence, including future reversals of existing
temporary differences, projected future taxable income, tax planning strategies and recent financial operations. Based on this
evaluation, as at December 30, 2017, a valuation allowance of $9.2 million (December 31, 2016 – $9.1 million) had been recorded
against certain assets to reduce the net benefit recorded in the consolidated financial statements.
Undistributed earnings of the Company’s non-Canadian affiliates and associated companies are considered to be indefinitely
reinvested; accordingly, no provision for deferred taxes has been provided thereon.
The Company believes it has adequately examined its tax positions taken or expected to be taken in a tax return; however, amounts
asserted by taxing authorities could differ from the Company’s positions. Accordingly, additional provisions on federal,
provincial, state and foreign tax-related matters could be recorded in the future as revised estimates are made or the underlying
matters are settled or otherwise resolved. A reconciliation of the beginning and ending amount of unrecognized tax benefits
(excluding interest and penalties) is presented below:
The Company’s opening unrecognized tax benefits position largely included a possible reduction to prior year losses for U.S.
exposures relating to the deductibility of certain interest amount accrued. The amount has become fully statute barred in the
U.S. and the liability reduced to zero.
Consistent with its historical financial reporting, the Company has classified interest and penalties related to income tax
liabilities, when applicable, as part of interest expense in its consolidated statements of operations, and with the related liability
on the consolidated balance sheets.
The number of years with open tax audits varies depending on the tax jurisdiction. The Company’s major taxing jurisdictions
include Canada (including Ontario), the U.S. (including multiple states), and the Netherlands. The Company’s 2010 through
2016 tax years (and any tax year for which available non-capital loss carry-forwards were generated up to the amount of non-
capital loss carry-forward) remain subject to examination by the Internal Revenue Service for U.S. federal tax purposes, and
the 2010 through 2016 tax years remain subject to examination by the appropriate governmental agencies for Canadian federal
tax purposes. There are other ongoing audits in various other jurisdictions that are not considered material to the Company’s
consolidated financial statements.
Basic and diluted loss per share were calculated as follows (shares in thousands):
(1) For the years ended December 30, 2017 and December 31, 2016, it was more dilutive to assume the Preferred Stock was
not converted into Common Shares, and, therefore, the numerator of the diluted loss per share calculation was not adjusted
to add back the dividends and accretion on the Preferred Stock and the denominator was not adjusted to include
11,333,333 and 2,670,320 Common Shares issuable on an if-converted basis for the years ended December 30, 2017 and
December 31, 2016, respectively.
(2) For the years ended December 30, 2017, December 31, 2016, and January 2, 2016, stock options to purchase 815,952,
66,166 and 54,316 Common Shares, respectively, were excluded from the calculation of diluted loss per share due to
their anti-dilutive effect of reducing the loss per share. In addition, for the years ended December 30, 2017, December
31, 2016 and January 2, 2016, options to purchase 2,540,189, 2,321,448 and 856,492 Common Shares were anti-dilutive
because the exercise prices of these options were greater than the average market price.
The following table summarizes transactions between the Company and related parties:
(1) Represents sales of agronomy products to employees at market prices, which are included in revenues on the consolidated
statements of operations.
(2) Represents purchases of raw fruit and fruit processing services at market prices from former shareholders of Opus who
remain employed by the Company, as well as purchases of grains and seeds at market prices from employees of the Company,
which are included in cost of goods sold on the consolidated statements of operations.
(3) Represents the sale of coffee beans at market prices from TOC to a company that is owned by the non-controlling shareholder
of Trabocca B.V., a less-than-wholly-owned subsidiary of TOC. These sales are included in revenues on the consolidated
statement of operations.
(4) Includes rental payments at market rates for the lease of production, warehouse and/or office facilities from former owners
of acquired businesses who remain or were employed by the Company. These payments are included in cost of goods sold
or selling, general and administrative expenses on the consolidated statements of operations.
Employment Matter
On April 19, 2013, a class-action complaint, in the case titled De Jesus, et al. v. Frozsun, Inc. d/b/a Frozsun Foods, was filed
against Sunrise Growers, Inc. (then named Frozsun, Inc.) in California Superior Court, Santa Barbara County seeking damages,
equitable relief and reasonable attorneys’ fees for alleged wage and hour violations. This case includes claims for failure to
pay all hours worked, failure to pay overtime wages, meal and rest period violations, waiting-time penalties, improper wage
statements and unfair business practices. The putative class includes approximately 10,000 non-exempt hourly employees from
Sunrise’s production facilities in Santa Maria and Oxnard, California. The parties attended mediation on October 12, 2017 and
reached a general agreement to resolve the matter on a class-wide basis. The parties are negotiating the remaining details of
the settlement which is subject to court approval. It is anticipated that the parties will seek preliminary approval of the
settlement from the court in March 2018. The Company expects to recover the full amount payable under the settlement
through insurance coverage and an escrow account established in connection with the Sunrise Acquisition.
Product Recall
On November 20, 2017, Treehouse Foods, Inc., several of its related entities, and its insurer filed a lawsuit against the Company
in the Circuit Court of Cook County, Illinois titled Treehouse Foods, Inc. et al. v. SunOpta Grains and Food, Inc. The
Company was served with the Summons and Complaint on January 24, 2018. The plaintiffs allege economic damages resulting
from the Company’s 2016 voluntary recall of certain roasted sunflower kernel products due to the potential for Listeria
monocytogenes contamination. The case includes claims for breach of express and implied warranty, negligence, strict liability,
and indemnity seeking $16.2 million in damages. There are no allegations of personal injury. The Company intends to
vigorously defend itself against these claims. The Company cannot reasonably predict the outcome of this claim, nor can it
estimate the amount of loss, or range of loss, if any, that may result from this claim.
Other Claims
In addition, various claims and potential claims arising in the normal course of business are pending against the Company. It
is the opinion of management that these claims or potential claims are without merit and the amount of potential liability, if
any, to the Company is not determinable. Management believes the final determination of these claims or potential claims will
not materially affect the financial position or results of the Company.
Environmental Laws
The Company believes that, with respect to both its operations and real property, it is in material compliance with current
environmental laws. Based on known existing conditions and the Company’s experience in complying with emerging
environmental issues, the Company is of the view that future costs relating to environmental compliance will not have a material
adverse effect on its consolidated financial position, but there can be no assurance that unforeseen changes in the laws or
enforcement policies of relevant governmental bodies, the discovery of changed conditions on the Company’s real property or
in its operations, or changes in the use of such properties and any related site restoration requirements, will not result in the
incurrence of significant costs.
As at December 30, 2017, the Company held grain for the benefit of others in the amount of $0.4 million (December 31, 2016
– $0.5 million). The Company is liable for any deficiencies of grade or shortage of quantity that may arise in connection with
such grain.
Letters of Credit
The Company has outstanding letters of credit at December 30, 2017 totaling $9.4 million (December 31, 2016 – $4.3 million).
The Company has entered into various leasing arrangements, which have fixed monthly rents that are adjusted annually each
year for inflation.
Minimum commitments under operating leases, principally for processing facilities, warehouse and distribution facilities, and
equipment for the next five fiscal years and thereafter are as follows:
$
2018 19,048
2019 15,820
2020 13,250
2021 8,902
2022 7,011
Thereafter 7,868
71,899
In the years ended December 30, 2017, December 31, 2016 and January 2, 2016, net minimum rents, including contingent rents
and sublease rental income, were $28.0 million, $27.9 million and $21.6 million, respectively.
x Global Ingredients aggregates our North American-based Raw Material Sourcing and Supply and European-based
International Sourcing and Supply operating segments focused on the procurement and sale of specialty and organic
grains and seeds, raw material ingredients, value-added grain- and cocoa-based ingredients, and organic commodities.
x Consumer Products consists of three main commercial platforms: Healthy Beverages, Healthy Fruit and Healthy
Snacks. Healthy Beverages includes aseptic packaged products including non-dairy beverages, broths and teas;
refrigerated premium juices; and shelf-stable juices and functional waters. Healthy Fruit includes individually quick
frozen (“IQF”) fruits for retail; IQF and bulk frozen fruit for foodservice; and custom fruit preparations for industrial
use. Healthy Snacks is focused on fruit snack offerings, and included flexible resealable pouch and nutrition bar
product lines, which were exited in 2017.
In addition, Corporate Services provides a variety of management, financial, information technology, treasury and
administration services to each of the Company’s operating segments from the Company’s headquarters in Mississauga,
Ontario and administrative office in Edina, Minnesota.
When reviewing the operating results of the Company’s operating segments, management uses segment revenues from external
customers and segment operating income/loss to assess performance and allocate resources. Segment operating income/loss
excludes other income/expense items and goodwill impairment losses. In addition, interest expense and income amounts, and
provisions for income taxes are not allocated to the operating segments.
Reportable segment operating results for the years ended December 30, 2017, December 31, 2016 and January 2, 2016 were
as follows:
January 2, 2016
Global Consumer
Ingredients Products Consolidated
$ $ $
Segment revenues from external customers 610,890 534,244 1,145,134
Segment operating income 28,184 3,208 31,392
Corporate Services (10,094)
Other expense, net (see note 18) (12,151)
Interest expense, net (15,669)
Loss from continuing operations before income taxes (6,522)
Segment Assets
Total assets and goodwill by reportable segment as at December 30, 2017 and December 31, 2016 were as follows:
Segment goodwill:
Global Ingredients 9,177 8,255
Consumer Products 100,356 215,356
Total segment goodwill 109,533 223,611
Capital expenditures, depreciation and amortization by reportable segment for the years ended December 30, 2017, December
31, 2016 and January 2, 2016 were as follows:
Geographic Information
The Company’s assets, operations and employees are principally located in the U.S., Canada, Europe, Mexico and Ethiopia.
Revenues from external customers are attributed to countries based on the location of the customer. Revenues from external
customers by geographic area for the years ended December 30, 2017, December 31, 2016 and January 2, 2016 were as follows:
Long-lived assets consist of property, plant and equipment, net of accumulated depreciation, which are attributed to countries
based on the physical location of the assets. Long-lived assets by geographic area as at December 30, 2017 and December 31,
2016 were as follows:
Major Customers
For the years ended December 30, 2017 and December 31, 2016, Costco Wholesale (“Costco”) accounted for approximately
10% and 11%, respectively, of consolidated revenues. Revenues from Costco are included in the Consumer Products operating
segment. The Company did not have any customers that exceeded 10% of total revenues for the year ended January 2, 2016.
Summarized below is the Consolidated Statement of Operations for the quarters ended December 30, 2017, September 30,
2017, July 1, 2017 and April 1, 2017, as well as the fiscal 2016 quarterly comparatives.
Quarter ended
December 30, 2017 December 31, 2016
$ $
(1) Fourth quarters of 2017 and 2016 included revenues from exited flexible resealable pouch and nutrition bar product lines of $9.1 million and $14.4
million, respectively (see note 4 to the consolidated financial statements).
(2) Fourth quarters of 2017 and 2016 included asset impairment charges of $10.0 million and $1.2 million, respectively, associated with the Value Creation
Plan (see note 4 to the consolidated financial statements).
(3) Fourth quarters of 2017 and 2016 reflected the impairment of goodwill associated with the Frozen Fruit and Sunflower reporting units, respectively (see
note 11 to the consolidated financial statements).
Quarter ended
September 30, 2017 October 1, 2016
$ $
(1) Third quarters of 2017 and 2016 included revenues from exited flexible resealable pouch and nutrition bar product lines of $13.5 million and $14.3
million, respectively (see note 4 to the consolidated financial statements).
(2) Third quarters of 2017 and 2016 included asset impairment charges of $4.5 million and $10.3 million, respectively, associated with the Value Creation
Plan (see note 4 to the consolidated financial statements).
Quarter ended
July 1, 2017 July 2, 2016
$ $
(1) Second quarters of 2017 and 2016 included revenues from exited flexible resealable pouch and nutrition bar product lines of $15.2 million and $15.0
million, respectively (see note 4 to the consolidated financial statements).
Quarter ended
April 1, 2017 April 2, 2016
$ $
(1) First quarters of 2017 and 2016 included revenues from exited flexible resealable pouch and nutrition bar product lines of $15.4 million and $15.7 million,
respectively (see note 4 to the consolidated financial statements).
(2) First quarter of 2017 included an asset impairment charge of $3.7 million associated the Value Creation Plan (see note 4 to the consolidated financial
statements). First quarter of 2016 included asset impairment charge of $1.7 million associated with the consolidation of the Company’s frozen fruit
processing operations (see note 18 to the consolidated financial statements).
(1) I have reviewed this Amendment No. 1 to the Annual Report on Form 10-K/A of SunOpta Inc.
(2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a
material fact necessary to make the statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this report;
(3) Based on my knowledge, the financial statements, and other financial information included in this report, fairly
present in all material respects the financial condition, results of operations and cash flows of the registrant as of,
and for, the periods presented in this report;
(4) The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls
and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial
reporting (as defined in Exchange Act Rules 13a -15(f) and 15d -15(f)) for the registrant and have:
a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be
designed under our supervision, to ensure that material information relating to the registrant, including its
consolidated subsidiaries, is made known to us by others within those entities, particularly during the
period in which this report is being prepared;
b. Designed such internal control over financial reporting, or caused such internal control over financial
reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability
of financial reporting and the preparation of financial statements for external purposes in accordance with
generally accepted accounting principles;
c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this
report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of
the period covered by this report based on such evaluation; and
d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred
during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an
annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s
internal control over financial reporting; and
(5) The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal
control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of
directors (or persons performing the equivalent functions):
a. All significant deficiencies and material weaknesses in the design or operation of internal control over
financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process,
summarize and report financial information; and
b. Any fraud, whether or not material, that involves management or other employees who have a significant
role in the registrant’s internal control over financial reporting.
David Colo
President and Chief Executive Officer
SunOpta Inc.
Date: March 7, 2018
Exhibit 31.2
(1) I have reviewed this Amendment No. 1 to the Annual Report on Form 10-K/A of SunOpta Inc.
(2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a
material fact necessary to make the statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this report;
(3) Based on my knowledge, the financial statements, and other financial information included in this report, fairly
present in all material respects the financial condition, results of operations and cash flows of the registrant as of,
and for, the periods presented in this report;
(4) The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls
and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial
reporting (as defined in Exchange Act Rules 13a -15(f) and 15d -15(f)) for the registrant and have:
a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be
designed under our supervision, to ensure that material information relating to the registrant, including its
consolidated subsidiaries, is made known to us by others within those entities, particularly during the
period in which this report is being prepared;
b. Designed such internal control over financial reporting, or caused such internal control over financial
reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability
of financial reporting and the preparation of financial statements for external purposes in accordance with
generally accepted accounting principles;
c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this
report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of
the period covered by this report based on such evaluation; and
d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred
during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an
annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s
internal control over financial reporting; and
(5) The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal
control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of
directors (or persons performing the equivalent functions):
a. All significant deficiencies and material weaknesses in the design or operation of internal control over
financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process,
summarize and report financial information; and
b. Any fraud, whether or not material, that involves management or other employees who have a significant
role in the registrant’s internal control over financial reporting.
Robert McKeracher
Vice President and Chief Financial Officer
SunOpta Inc.
Date: March 7, 2018
Exhibit 32
CERTIFICATION
PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with Amendment No. 1 to the Annual Report on Form 10-K/A of SunOpta Inc. (the “Company”) for the year
ended December 30, 2017, as filed with the Securities and Exchange Commission (the “Report”), I, David Colo, President and
Chief Executive Officer of the Company, and I, Robert McKeracher, Vice President and Chief Financial Officer of the
Company, certify pursuant to 18 U.S.C. Section 1350, that to our knowledge:
1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of
operations of the Company.
A signed original of this written statement, or other document authenticating, acknowledging, or otherwise adopting the
signature that appears in typed form within the electronic version of this written statement, has been provided to the Company
and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.
The foregoing certification is being furnished solely pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and should not
be deemed to be filed under the Exchange Act by the Company or the certifying officers.
[This page intentionally left blank]
SUSTAINABILITY IS
AN INTEGRAL PART
OF SUNOPTA’S
BUSINESS
SunOpta’s passion for bringing well-
being to life drives everything we do.
Sustainability plays a vital role in fulfilling
this purpose. Our approach is built on
five platforms that are integrated into
our overall business strategy: workplace,
community, partnerships, environment
and marketplace. These platforms
address each dimension of sustainability
in a way that serves our customers’ best-
interests, improves the communities in
which we operate, maximizes value for
our shareholders and guides our efforts
to become an increasingly sustainable
organization.